Healthcare Virtual Assistant Academy

Pathophysiology Reference Library

H
HVA AcademyPathophysiology Reference
Free HVA Reference Library

Pathophysiology Reference Library

Explore how diseases and disorders develop, progress, and appear in the medical record. Use this library to connect normal anatomy and physiology with disease mechanisms, clinical manifestations, diagnostic evidence, complications, and documentation concepts you may encounter in healthcare administrative work.

Reference library

Pathophysiology Index

Select a subject from the left menu. Open any entry to review disease mechanism, progression, clinical manifestations, diagnostic evidence, complications, treatment categories, and medical-record relevance.

400reference entries
20clinical-science sections
60verified source authorities
Pathophysiology section 1

Cell Injury, Adaptation & Death

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Cellular adaptationGeneral / cellular · CROSS-LINK

Normal function anchor: Cells adjust structure and function to changing demands.

Etiology / risk factors: Physiologic demand or nonlethal stress.

Pathophysiologic mechanism: Adaptive signaling changes cell size, number, phenotype, or metabolic activity without immediate cell death.

Progression: Adaptation may resolve after stress removal or progress to injury if stress exceeds cellular capacity.

Clinical manifestations: Often clinically silent; effects reflect the involved tissue.

Diagnostics / labs / imaging: Histology; imaging or organ-function testing when tissue effects are present.

Complications: Persistent stress can progress to dysfunction or irreversible injury.

Treatment categories: Address underlying stressor; condition-specific management.

Medical-record relevance: Helps distinguish adaptive change from overt tissue injury in pathology and imaging reports.

Related terminology: adaptation; stress response

Related anatomy: Cells; tissues

Source: StatPearls — Cell Liquefactive Necrosis

HypertrophyGeneral / cellular · A&P LINK

Normal function anchor: Normal cells maintain size appropriate to workload.

Etiology / risk factors: Increased workload, hormonal stimulation, or compensatory demand.

Pathophysiologic mechanism: Existing cells enlarge through increased synthesis of structural proteins and organelles.

Progression: May be adaptive; prolonged pathologic hypertrophy can impair organ function.

Clinical manifestations: Depends on organ; may include enlargement-related symptoms.

Diagnostics / labs / imaging: Imaging, physical exam, organ-function studies.

Complications: Functional decline, remodeling, decompensation in pathologic settings.

Treatment categories: Treat cause; condition-specific monitoring and therapy.

Medical-record relevance: Common descriptor in imaging and pathology; can support severity and chronicity context.

Related terminology: hypertrophy

Related anatomy: Cells; muscle; organs

Source: StatPearls — Cell Liquefactive Necrosis

HyperplasiaGeneral / cellular · CROSS-LINK

Normal function anchor: Cell populations are regulated by controlled proliferation.

Etiology / risk factors: Hormonal stimulation, growth factors, compensation, or pathologic signaling.

Pathophysiologic mechanism: Cell number increases through proliferation in tissues capable of division.

Progression: May regress when stimulus ends or persist if pathologic drivers remain.

Clinical manifestations: Organ enlargement or tissue-specific manifestations.

Diagnostics / labs / imaging: Histology; imaging; laboratory testing depending on tissue.

Complications: Obstruction, bleeding, or neoplastic risk in selected disorders.

Treatment categories: Remove driver when possible; surveillance or targeted therapy by condition.

Medical-record relevance: Important when documentation distinguishes increased cell number from hypertrophy or neoplasia.

Related terminology: hyperplasia

Related anatomy: Cells; tissues

Source: StatPearls — Cell Liquefactive Necrosis

AtrophyGeneral / cellular · A&P LINK

Normal function anchor: Cells maintain size and metabolic activity with normal trophic input.

Etiology / risk factors: Disuse, denervation, ischemia, malnutrition, loss of endocrine stimulation, aging.

Pathophysiologic mechanism: Reduced protein synthesis and increased breakdown decrease cell and organ size.

Progression: Can be reversible early; prolonged causes functional loss.

Clinical manifestations: Weakness, reduced organ volume, tissue-specific dysfunction.

Diagnostics / labs / imaging: Imaging; physical exam; histology; functional testing.

Complications: Loss of reserve and impaired recovery.

Treatment categories: Correct underlying cause; rehabilitation or condition-specific care.

Medical-record relevance: Supports interpretation of chronicity and functional decline in clinical records.

Related terminology: atrophy

Related anatomy: Cells; tissues; muscle

Source: StatPearls — Cell Liquefactive Necrosis

MetaplasiaEpithelial / mesenchymal tissues · CROSS-LINK

Normal function anchor: Differentiated cells maintain tissue-specific phenotype.

Etiology / risk factors: Chronic irritation or environmental stress.

Pathophysiologic mechanism: Stem-cell reprogramming replaces one mature cell type with another better suited to stress.

Progression: May reverse if stimulus stops; persistent metaplasia can predispose to dysplasia.

Clinical manifestations: Often asymptomatic until organ function changes.

Diagnostics / labs / imaging: Histology; cytology; endoscopy depending on site.

Complications: Functional alteration; increased risk of dysplastic change in some tissues.

Treatment categories: Remove irritant; surveillance or treatment by underlying condition.

Medical-record relevance: Pathology wording can change diagnostic follow-up and coding specificity.

Related terminology: metaplasia

Related anatomy: Epithelia; tissues

Source: StatPearls — Cell Liquefactive Necrosis

DysplasiaEpithelial tissues · MED TERM LINK

Normal function anchor: Normal tissue shows orderly maturation and architecture.

Etiology / risk factors: Persistent injury, infection, carcinogenic exposure, or abnormal proliferative signaling.

Pathophysiologic mechanism: Cells develop disordered growth, atypia, and architectural abnormalities.

Progression: May regress, persist, or progress toward neoplasia depending on cause and grade.

Clinical manifestations: Usually detected by screening or tissue evaluation rather than symptoms alone.

Diagnostics / labs / imaging: Cytology; biopsy; histopathology.

Complications: Progression to carcinoma in selected contexts.

Treatment categories: Remove cause when possible; surveillance; excision or other site-specific treatment.

Medical-record relevance: Grade and site are key pathology documentation elements.

Related terminology: dysplasia; atypia

Related anatomy: Epithelia; tissues

Source: StatPearls — Cell Liquefactive Necrosis

Reversible cell injuryGeneral / cellular · NEW

Normal function anchor: Cells preserve ATP, membrane integrity, and organelle function.

Etiology / risk factors: Mild or brief hypoxia, toxins, metabolic stress, physical injury.

Pathophysiologic mechanism: Metabolic and organelle dysfunction occurs without permanent loss of viability.

Progression: Recovery is possible if the stressor is removed before critical damage occurs.

Clinical manifestations: Tissue-specific dysfunction; may be subclinical.

Diagnostics / labs / imaging: Laboratory markers; imaging; histology when evaluated.

Complications: Progression to irreversible injury if stress persists.

Treatment categories: Remove cause; supportive care as clinically indicated.

Medical-record relevance: Explains early abnormal findings that may precede permanent tissue damage.

Related terminology: reversible injury

Related anatomy: Cells; organelles

Source: StatPearls — Cell Liquefactive Necrosis

Irreversible cell injuryGeneral / cellular · NEW

Normal function anchor: Membranes, mitochondria, and homeostatic systems remain intact.

Etiology / risk factors: Severe or prolonged ischemia, toxins, infection, trauma, or metabolic failure.

Pathophysiologic mechanism: Critical mitochondrial and membrane damage prevents recovery and commits the cell to death.

Progression: Progresses to necrosis, apoptosis, or other regulated death pathways.

Clinical manifestations: Loss of tissue function; inflammatory findings may appear with necrosis.

Diagnostics / labs / imaging: Biomarkers, imaging, histology, organ-function studies.

Complications: Permanent tissue loss, scarring, organ dysfunction.

Treatment categories: Urgent cause-directed and supportive treatment where applicable.

Medical-record relevance: Provides mechanistic context for infarction, necrosis, and end-organ injury documentation.

Related terminology: irreversible injury

Related anatomy: Cells; organelles

Source: StatPearls — Cell Liquefactive Necrosis

Hypoxic cell injuryGeneral / cellular · CROSS-LINK

Normal function anchor: Oxidative phosphorylation supplies ATP using oxygen.

Etiology / risk factors: Low oxygen delivery or utilization.

Pathophysiologic mechanism: ATP depletion disrupts ion pumps, cellular metabolism, and organelle stability.

Progression: Can be reversible initially; sustained hypoxia progresses to irreversible injury.

Clinical manifestations: Depends on affected organ; may include fatigue, confusion, dyspnea, ischemic symptoms.

Diagnostics / labs / imaging: Pulse oximetry; blood gases; organ-specific testing.

Complications: Necrosis, organ failure, neurologic injury.

Treatment categories: Restore oxygenation and treat cause.

Medical-record relevance: Connects hypoxemia/hypoxia documentation to tissue-level injury mechanisms.

Related terminology: hypoxia

Related anatomy: Cells; mitochondria; circulation

Source: StatPearls — Cell Liquefactive Necrosis

Ischemic cell injuryCardiovascular / tissue perfusion · CROSS-LINK

Normal function anchor: Blood flow delivers oxygen and substrates and removes waste.

Etiology / risk factors: Arterial obstruction, low perfusion, vascular compromise.

Pathophysiologic mechanism: Reduced blood flow causes combined oxygen and nutrient deprivation with impaired waste removal.

Progression: Rapid progression in highly metabolic tissues; prolonged ischemia can cause infarction.

Clinical manifestations: Pain, weakness, organ-specific dysfunction, or silent injury.

Diagnostics / labs / imaging: Vascular imaging; ECG/troponin for heart; organ-specific studies.

Complications: Infarction, necrosis, permanent functional loss.

Treatment categories: Restore perfusion when appropriate; manage underlying vascular cause.

Medical-record relevance: Supports distinction between ischemia and established infarction/necrosis.

Related terminology: ischemia; infarction

Related anatomy: Vasculature; cells

Source: StatPearls — Cell Liquefactive Necrosis

Oxidative cellular injuryGeneral / cellular · NEW

Normal function anchor: Redox systems neutralize reactive oxygen species.

Etiology / risk factors: Inflammation, toxins, radiation, ischemia-reperfusion, metabolic stress.

Pathophysiologic mechanism: Reactive oxygen species damage lipids, proteins, and DNA when antioxidant defenses are exceeded.

Progression: Accumulated damage can impair membranes, enzymes, and genetic material.

Clinical manifestations: Usually indirect; manifestations reflect affected tissue.

Diagnostics / labs / imaging: Oxidative-stress markers mainly research/specialized; routine testing targets affected organ.

Complications: Membrane damage, mutation, cell death.

Treatment categories: Remove cause; disease-specific supportive care.

Medical-record relevance: Mechanistic term relevant to toxic, inflammatory, ischemic, and degenerative disease narratives.

Related terminology: oxidative stress; reactive oxygen species

Related anatomy: Cells; mitochondria

Source: StatPearls — Cell Liquefactive Necrosis

Mitochondrial dysfunction in cell injuryGeneral / cellular · CROSS-LINK

Normal function anchor: Mitochondria generate ATP and regulate apoptosis.

Etiology / risk factors: Hypoxia, toxins, inherited defects, oxidative damage.

Pathophysiologic mechanism: Loss of ATP generation and membrane-potential stability disrupts cell survival and can activate death pathways.

Progression: May remain reversible early or trigger irreversible injury and apoptosis.

Clinical manifestations: Energy failure and organ-specific dysfunction.

Diagnostics / labs / imaging: Metabolic labs; lactate; genetic testing when inherited disease suspected; tissue studies.

Complications: Cell death, lactic acidosis, organ dysfunction.

Treatment categories: Cause-specific metabolic/supportive management.

Medical-record relevance: Links metabolic findings and tissue injury to energy failure.

Related terminology: mitochondrial dysfunction

Related anatomy: Mitochondria; cells

Source: StatPearls — Cell Liquefactive Necrosis

Plasma membrane injuryGeneral / cellular · A&P LINK

Normal function anchor: Cell membranes regulate permeability and ionic gradients.

Etiology / risk factors: Ischemia, toxins, free radicals, mechanical damage.

Pathophysiologic mechanism: Membrane disruption causes ion imbalance, enzyme leakage, and loss of cellular homeostasis.

Progression: Severe disruption is a hallmark of irreversible injury and necrotic death.

Clinical manifestations: Tissue dysfunction; elevated intracellular enzymes may appear in blood.

Diagnostics / labs / imaging: Serum injury biomarkers; histology.

Complications: Inflammation, necrosis, tissue breakdown.

Treatment categories: Treat underlying injury.

Medical-record relevance: Explains why damaged tissues release biomarkers such as intracellular enzymes.

Related terminology: membrane permeability; enzyme leakage

Related anatomy: Plasma membrane

Source: StatPearls — Cell Liquefactive Necrosis

Intracellular calcium overloadGeneral / cellular · A&P LINK

Normal function anchor: Calcium is tightly compartmentalized for signaling.

Etiology / risk factors: ATP depletion, membrane injury, ischemia, toxins.

Pathophysiologic mechanism: Excess cytosolic calcium activates phospholipases, proteases, endonucleases, and ATPases.

Progression: Amplifies structural damage and can promote irreversible injury.

Clinical manifestations: Indirect, tissue-specific manifestations.

Diagnostics / labs / imaging: No single routine diagnostic test; inferred from disease context and cellular injury.

Complications: Membrane, cytoskeletal, mitochondrial, and DNA damage.

Treatment categories: Treat underlying cause.

Medical-record relevance: Mechanistic concept explaining progression from stress to cell death.

Related terminology: calcium homeostasis

Related anatomy: Cytosol; ER; mitochondria

Source: StatPearls — Cell Liquefactive Necrosis

ApoptosisGeneral / cellular · NEW

Normal function anchor: Programmed cell turnover removes unwanted or damaged cells without widespread inflammation.

Etiology / risk factors: Developmental signaling, DNA damage, growth-factor withdrawal, immune regulation, severe intracellular stress.

Pathophysiologic mechanism: Caspase-driven programmed death causes cell shrinkage, chromatin condensation, fragmentation, and phagocytic clearance.

Progression: Usually affects individual cells rather than broad contiguous tissue.

Clinical manifestations: Often clinically silent; effects depend on excessive or deficient apoptosis.

Diagnostics / labs / imaging: Histology; molecular assays in specialized settings.

Complications: Tissue loss if excessive; abnormal cell survival if insufficient.

Treatment categories: Treat underlying disease process; pathway-targeted therapy in selected diseases.

Medical-record relevance: Distinguishes programmed cell death from necrotic tissue injury in pathology.

Related terminology: apoptosis; programmed cell death

Related anatomy: Cells; nucleus

Source: Molecular Biology of the Cell — Programmed Cell Death (Apoptosis)

NecrosisGeneral / cellular · MED TERM LINK

Normal function anchor: Cells maintain membrane integrity and controlled metabolism.

Etiology / risk factors: Severe ischemia, infection, toxins, trauma, enzymatic injury.

Pathophysiologic mechanism: Uncontrolled cell death with membrane failure and release of intracellular contents.

Progression: Usually affects groups of cells and provokes inflammation.

Clinical manifestations: Pain, swelling, fever, loss of organ function depending on location.

Diagnostics / labs / imaging: Imaging; serum injury markers; gross pathology; histology.

Complications: Inflammation, tissue loss, abscess or scarring depending on cause/site.

Treatment categories: Cause-directed treatment; debridement or drainage in selected settings.

Medical-record relevance: Necrosis may be explicitly documented in pathology, imaging, wound, or operative records.

Related terminology: necrosis

Related anatomy: Cells; tissues

Source: StatPearls — Cell Liquefactive Necrosis

Liquefactive necrosisNeurologic / infectious / tissue injury · NEW

Normal function anchor: Tissue architecture is normally maintained after cell turnover.

Etiology / risk factors: Commonly severe enzymatic digestion after infection or certain ischemic injuries.

Pathophysiologic mechanism: Dead tissue is digested into a liquid or viscous mass.

Progression: May form cavities or pus-filled collections depending on cause.

Clinical manifestations: Neurologic deficits in brain injury or local infection findings in abscesses.

Diagnostics / labs / imaging: Imaging; culture when infection suspected; histology.

Complications: Abscess, cavitation, tissue destruction.

Treatment categories: Treat cause; antimicrobial therapy and drainage when clinically indicated.

Medical-record relevance: Pathology and imaging descriptors may identify liquefaction or abscess formation.

Related terminology: liquefactive necrosis

Related anatomy: Brain; soft tissue

Source: StatPearls — Cell Liquefactive Necrosis

Cell swellingGeneral / cellular · NEW

Normal function anchor: Ion pumps maintain intracellular sodium and water balance.

Etiology / risk factors: ATP depletion during early cell injury.

Pathophysiologic mechanism: Pump failure causes sodium and water influx and organelle swelling.

Progression: Often reversible if energy metabolism recovers.

Clinical manifestations: Usually microscopic/subclinical; organ effects depend on severity.

Diagnostics / labs / imaging: Histology; microscopy.

Complications: Progression to membrane damage if stress persists.

Treatment categories: Correct underlying cause.

Medical-record relevance: Classic early morphology of reversible injury.

Related terminology: cellular swelling

Related anatomy: Cells; membranes

Source: StatPearls — Cell Liquefactive Necrosis

Cellular stress thresholdGeneral / cellular · A&P LINK

Normal function anchor: Homeostasis adapts within physiologic limits.

Etiology / risk factors: Increasing intensity or duration of stress.

Pathophysiologic mechanism: When adaptive capacity is exceeded, biochemical and structural injury accumulates.

Progression: Normal adaptation → reversible injury → irreversible injury → cell death.

Clinical manifestations: Varies by tissue and stressor.

Diagnostics / labs / imaging: Clinical monitoring targets the affected organ or cause.

Complications: Permanent damage when threshold crossed.

Treatment categories: Remove or reduce stressor early where possible.

Medical-record relevance: Useful framework for interpreting progression and acuity in clinical documentation.

Related terminology: cell stress; homeostasis

Related anatomy: Cells; tissues

Source: StatPearls — Cell Liquefactive Necrosis

Cell injury biomarker releaseOrgan-specific · CROSS-LINK

Normal function anchor: Intact membranes retain intracellular proteins and enzymes.

Etiology / risk factors: Membrane disruption from tissue injury.

Pathophysiologic mechanism: Damaged cells release intracellular molecules into blood or other fluids.

Progression: Marker levels may rise and fall with injury timing and clearance.

Clinical manifestations: Symptoms reflect the underlying organ injury.

Diagnostics / labs / imaging: Serum biomarkers such as organ-specific enzymes/proteins; serial testing.

Complications: May indicate worsening or ongoing tissue damage.

Treatment categories: Treat underlying injury.

Medical-record relevance: Connects pathophysiology to why labs can support, but do not independently replace, a documented diagnosis.

Related terminology: biomarker; enzyme leakage

Related anatomy: Cells; plasma membrane

Source: StatPearls — Cell Liquefactive Necrosis

Pathophysiology section 2

Genetic Disease Mechanisms

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Pathogenic genetic variantGenetic / multisystem · NEW

Normal function anchor: DNA sequence supports normal protein expression and regulation.

Etiology / risk factors: Inherited or de novo DNA sequence change.

Pathophysiologic mechanism: A variant alters gene function or regulation enough to contribute to disease.

Progression: Phenotype depends on gene, variant effect, inheritance, modifiers, and environment.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Molecular genetic testing; family history; phenotype evaluation.

Complications: Depends on affected gene and organ systems.

Treatment categories: Condition-specific surveillance and treatment.

Medical-record relevance: Variant classification and whether a condition is confirmed versus suspected are critical documentation distinctions.

Related terminology: mutation; pathogenic variant

Related anatomy: DNA; chromosomes

Source: Understanding Genetics — Genetics 101

Germline variantGenetic / multisystem · MED TERM LINK

Normal function anchor: Germ cells transmit inherited genetic information.

Etiology / risk factors: Inherited or de novo variant present in egg/sperm lineage.

Pathophysiologic mechanism: Variant can be present across many tissues and transmitted to offspring.

Progression: May cause inherited disease or susceptibility depending on penetrance.

Clinical manifestations: Condition-specific; may be asymptomatic.

Diagnostics / labs / imaging: Germline genetic testing; pedigree analysis.

Complications: Hereditary disease risk; familial recurrence.

Treatment categories: Genetic counseling; disease-specific management.

Medical-record relevance: Supports hereditary versus acquired disease distinction.

Related terminology: germline; hereditary

Related anatomy: Germ cells; chromosomes

Source: An Evidence Framework for Genetic Testing — Understanding Genetic Variance and Phenotype Expression

Somatic variantGenetic / acquired disease · CROSS-LINK

Normal function anchor: Somatic cells maintain tissue function without transmitting DNA to offspring.

Etiology / risk factors: Acquired replication error or exposure-related DNA damage.

Pathophysiologic mechanism: Variant arises after conception in a subset of cells and is not generally inherited.

Progression: Can drive clonal expansion, mosaicism, or sporadic cancer.

Clinical manifestations: Tissue-specific.

Diagnostics / labs / imaging: Tumor sequencing; tissue molecular testing.

Complications: Clonal disease, malignancy, organ-specific dysfunction.

Treatment categories: Targeted therapy or condition-specific management.

Medical-record relevance: Clarifies acquired molecular findings versus hereditary risk.

Related terminology: somatic mutation

Related anatomy: Somatic cells

Source: An Evidence Framework for Genetic Testing — Understanding Genetic Variance and Phenotype Expression

Autosomal dominant inheritanceGenetic / multisystem · NEW

Normal function anchor: One allele from each autosomal gene is inherited from each parent.

Etiology / risk factors: Disease-causing variant in one allele is sufficient for phenotype in many disorders.

Pathophysiologic mechanism: A heterozygous pathogenic variant can be transmitted vertically across generations.

Progression: Expression can vary with penetrance and expressivity.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Pedigree; molecular testing.

Complications: Familial recurrence and variable severity.

Treatment categories: Genetic counseling; condition-specific care.

Medical-record relevance: Family history and confirmed molecular diagnosis may affect documentation and screening.

Related terminology: autosomal dominant

Related anatomy: Autosomes; genes

Source: StatPearls — Genetics: Inheritance Patterns

Autosomal recessive inheritanceGenetic / multisystem · NEW

Normal function anchor: Two functional alleles usually provide normal gene activity.

Etiology / risk factors: Pathogenic variants affect both copies of an autosomal gene.

Pathophysiologic mechanism: Disease manifests when biallelic loss or dysfunction crosses a functional threshold.

Progression: Parents may be unaffected carriers; disease may cluster among siblings.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Pedigree; molecular testing; carrier testing.

Complications: Severe inherited disease in some disorders.

Treatment categories: Genetic counseling; disease-specific management.

Medical-record relevance: Distinguishes carrier status from affected diagnosis.

Related terminology: autosomal recessive; carrier

Related anatomy: Autosomes; genes

Source: StatPearls — Genetics: Inheritance Patterns

X-linked inheritanceGenetic / multisystem · NEW

Normal function anchor: X chromosome carries many genes expressed in both sexes.

Etiology / risk factors: Pathogenic variant on X chromosome.

Pathophysiologic mechanism: Phenotype and transmission differ by sex chromosome complement and gene dosage.

Progression: Can show carrier states and variable expression.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Pedigree; molecular testing.

Complications: Familial recurrence; variable severity.

Treatment categories: Genetic counseling; condition-specific care.

Medical-record relevance: Important for accurate family-history and carrier documentation.

Related terminology: X-linked

Related anatomy: X chromosome

Source: StatPearls — Genetics: Inheritance Patterns

Mitochondrial inheritanceGenetic / metabolic · CROSS-LINK

Normal function anchor: Mitochondria generate ATP and contain mitochondrial DNA.

Etiology / risk factors: Pathogenic mitochondrial DNA variant.

Pathophysiologic mechanism: Mitochondrial variants are typically maternally transmitted and may show heteroplasmy.

Progression: Severity varies by tissue energy demand and proportion of affected mitochondria.

Clinical manifestations: Neurologic, muscular, metabolic, sensory, or multisystem manifestations.

Diagnostics / labs / imaging: Mitochondrial genetic testing; lactate/metabolic studies; organ-specific testing.

Complications: Progressive multisystem dysfunction.

Treatment categories: Supportive and disease-specific care; genetic counseling.

Medical-record relevance: Maternal inheritance and multisystem findings may be central to diagnosis.

Related terminology: mitochondrial inheritance; heteroplasmy

Related anatomy: Mitochondria

Source: StatPearls — Genetics: Inheritance Patterns

PenetranceGenetic / multisystem · NEW

Normal function anchor: Genotype and phenotype usually correlate within biologic variability.

Etiology / risk factors: Modifier genes, environment, age, and variant-specific effects.

Pathophysiologic mechanism: Not every person with a disease-associated genotype manifests the phenotype.

Progression: Can be complete, reduced, or age-dependent.

Clinical manifestations: May range from no manifestations to overt disease.

Diagnostics / labs / imaging: Family studies; longitudinal phenotype evaluation; genetic testing.

Complications: Risk uncertainty and missed family-history patterns.

Treatment categories: Surveillance and counseling based on condition and risk.

Medical-record relevance: A positive variant does not always equal an active clinical diagnosis.

Related terminology: penetrance

Related anatomy: Genes; phenotype

Source: An Evidence Framework for Genetic Testing — Understanding Genetic Variance and Phenotype Expression

Variable expressivityGenetic / multisystem · NEW

Normal function anchor: Gene effects produce phenotype within a range.

Etiology / risk factors: Modifier genes, environment, variant effect, stochastic factors.

Pathophysiologic mechanism: The same pathogenic genotype can produce different manifestations or severity.

Progression: Severity may differ among relatives with the same disorder.

Clinical manifestations: Mild to severe disease depending on condition.

Diagnostics / labs / imaging: Clinical phenotyping plus genetic testing.

Complications: Under-recognition or unexpected complications.

Treatment categories: Condition-specific surveillance and treatment.

Medical-record relevance: Documentation should describe actual manifestations rather than assume a uniform phenotype.

Related terminology: expressivity

Related anatomy: Genes; phenotype

Source: An Evidence Framework for Genetic Testing — Understanding Genetic Variance and Phenotype Expression

Multifactorial diseaseGenetic / environmental · CROSS-LINK

Normal function anchor: Health reflects interaction among many genes and environmental exposures.

Etiology / risk factors: Multiple susceptibility variants plus behavior, exposures, age, and other factors.

Pathophysiologic mechanism: No single variant is sufficient; combined genetic and non-genetic factors alter risk.

Progression: Risk accumulates and may cross a threshold for disease expression.

Clinical manifestations: Common chronic disease phenotypes.

Diagnostics / labs / imaging: Clinical risk assessment; family history; selected genetic studies.

Complications: Complex recurrence risk and comorbidity.

Treatment categories: Risk-factor modification and disease-specific care.

Medical-record relevance: Avoids overstating a single genetic cause when disease is multifactorial.

Related terminology: multifactorial; polygenic

Related anatomy: Genes; environment

Source: Understanding Genetics — Genetics 101

De novo variantGenetic / multisystem · NEW

Normal function anchor: Inherited DNA is normally copied with high fidelity.

Etiology / risk factors: New mutation in a germ cell or early embryo.

Pathophysiologic mechanism: Variant appears in an affected individual without being present in either parent’s tested germline.

Progression: May cause sporadic single-gene disease.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Trio genetic testing; parental testing.

Complications: Recurrence risk depends on mechanism including possible germline mosaicism.

Treatment categories: Genetic counseling; condition-specific care.

Medical-record relevance: Explains a genetic diagnosis despite negative parental history.

Related terminology: de novo mutation

Related anatomy: DNA; germ cells

Source: Understanding Genetics — Genetics 101

Chromosomal abnormalityGenetic / multisystem · NEW

Normal function anchor: Chromosome number and structure support balanced gene dosage.

Etiology / risk factors: Nondisjunction, deletion, duplication, translocation, inversion, or other structural change.

Pathophysiologic mechanism: Large-scale genomic imbalance alters dosage or disrupts genes.

Progression: Effects depend on chromosome segment, mosaicism, and viability.

Clinical manifestations: Developmental, reproductive, congenital, or multisystem findings.

Diagnostics / labs / imaging: Karyotype; chromosomal microarray; FISH; sequencing-based methods.

Complications: Developmental disability, congenital anomalies, infertility, pregnancy loss.

Treatment categories: Supportive and specialty care; counseling.

Medical-record relevance: Specific cytogenetic result often determines diagnostic specificity.

Related terminology: aneuploidy; deletion; duplication; translocation

Related anatomy: Chromosomes

Source: Understanding Genetics — Genetics 101

Gene dosage alterationGenetic / multisystem · NEW

Normal function anchor: Two-copy autosomal gene dosage supports normal expression for many genes.

Etiology / risk factors: Deletion, duplication, copy-number variant, aneuploidy.

Pathophysiologic mechanism: Too little or too much gene product disrupts normal cellular pathways.

Progression: May affect development, metabolism, or organ function.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Chromosomal microarray; copy-number analysis.

Complications: Variable multisystem disease.

Treatment categories: Condition-specific management.

Medical-record relevance: Supports interpretation of copy-number findings in genetics reports.

Related terminology: copy-number variant; gene dosage

Related anatomy: Chromosomes; genes

Source: Understanding Genetics — Genetics 101

Loss-of-function variantGenetic / multisystem · NEW

Normal function anchor: Gene product performs a required cellular role.

Etiology / risk factors: Variant reduces or abolishes gene-product activity.

Pathophysiologic mechanism: Insufficient functional protein impairs the pathway controlled by the gene.

Progression: Phenotype depends on whether one or both alleles must be affected and on residual activity.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Molecular testing; functional assays in selected cases.

Complications: Depends on pathway and organ system.

Treatment categories: Condition-specific; sometimes replacement or pathway-directed treatment.

Medical-record relevance: Mechanism may explain why zygosity matters in a genetic diagnosis.

Related terminology: loss of function

Related anatomy: Genes; proteins

Source: Understanding Genetics — Genetics 101

Gain-of-function variantGenetic / multisystem · NEW

Normal function anchor: Protein activity is normally regulated.

Etiology / risk factors: Variant increases, constitutively activates, or creates abnormal protein function.

Pathophysiologic mechanism: Excess or novel activity disrupts signaling or cell behavior.

Progression: Often dominant at the molecular level but varies by disease.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Molecular testing; functional assays in selected cases.

Complications: Progressive or systemic effects depending on pathway.

Treatment categories: Targeted pathway inhibition when available; condition-specific care.

Medical-record relevance: Mechanism can clarify why one altered allele produces disease.

Related terminology: gain of function

Related anatomy: Genes; proteins

Source: Understanding Genetics — Genetics 101

GenotypeGenetic · MED TERM LINK

Normal function anchor: DNA sequence variants constitute the genetic state at a locus.

Etiology / risk factors: Inherited or acquired sequence composition.

Pathophysiologic mechanism: Genotype influences but does not always determine phenotype.

Progression: Effect modified by penetrance, expressivity, environment, and epigenetics.

Clinical manifestations: None by itself.

Diagnostics / labs / imaging: Genetic testing.

Complications: Misinterpretation if genotype is equated automatically with active disease.

Treatment categories: Counseling and phenotype-based care.

Medical-record relevance: Separates molecular finding from clinically expressed disease.

Related terminology: genotype

Related anatomy: DNA; genes

Source: An Evidence Framework for Genetic Testing — Understanding Genetic Variance and Phenotype Expression

PhenotypeGenetic / clinical · MED TERM LINK

Normal function anchor: Observable traits reflect gene expression and environment.

Etiology / risk factors: Genetic, epigenetic, environmental, developmental, and stochastic influences.

Pathophysiologic mechanism: Clinical characteristics emerge from the combined effects of genotype and modifiers.

Progression: Can vary over time and among people with the same genotype.

Clinical manifestations: Observed signs, symptoms, traits, lab findings.

Diagnostics / labs / imaging: Clinical examination; laboratory and imaging assessment.

Complications: Variable disease burden.

Treatment categories: Treat manifested disease and risk.

Medical-record relevance: Documentation captures the actual phenotype supporting diagnosis and severity.

Related terminology: phenotype

Related anatomy: Whole body

Source: An Evidence Framework for Genetic Testing — Understanding Genetic Variance and Phenotype Expression

Genetic susceptibilityGenetic / multisystem · NEW

Normal function anchor: Risk pathways remain below disease threshold under normal conditions.

Etiology / risk factors: Risk alleles plus environmental or behavioral exposures.

Pathophysiologic mechanism: Variants increase probability of disease without being sufficient alone.

Progression: Disease may never develop or may emerge after additional exposures/aging.

Clinical manifestations: Condition-specific or absent.

Diagnostics / labs / imaging: Risk assessment; family history; selected genetic testing.

Complications: Potential future disease.

Treatment categories: Preventive/risk-reduction strategies as appropriate.

Medical-record relevance: Susceptibility is not equivalent to a confirmed diagnosis.

Related terminology: susceptibility; risk allele

Related anatomy: Genes; environment

Source: Understanding Genetics — Genetics 101

Gene–environment interactionGenetic / environmental · CROSS-LINK

Normal function anchor: Gene expression and physiology respond to environment.

Etiology / risk factors: Diet, toxins, medications, infection, activity, stress, and other exposures interact with genotype.

Pathophysiologic mechanism: Environmental factors modify the effect of genetic susceptibility or disease-causing variants.

Progression: Risk and severity change with exposure and time.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Exposure history; clinical evaluation; selected biomarkers/genetic testing.

Complications: Variable disease expression.

Treatment categories: Modify relevant exposure when possible; condition-specific care.

Medical-record relevance: Supports nuanced documentation of risk factors versus established disease.

Related terminology: gene–environment interaction

Related anatomy: Genes; environment

Source: Understanding Genetics — Genetics 101

MosaicismGenetic / multisystem · NEW

Normal function anchor: Cells in an individual usually share the same inherited genome.

Etiology / risk factors: Post-zygotic mutation creates genetically distinct cell populations.

Pathophysiologic mechanism: Only a subset of cells carries the variant, so phenotype depends on tissue distribution and proportion.

Progression: Can produce patchy, segmental, or variable disease.

Clinical manifestations: Variable and tissue-specific.

Diagnostics / labs / imaging: Testing may require affected tissue rather than blood alone.

Complications: Diagnostic false negatives; variable severity.

Treatment categories: Condition-specific management and counseling.

Medical-record relevance: Specimen source matters when interpreting a negative or low-level genetic result.

Related terminology: mosaicism

Related anatomy: Cells; tissues; DNA

Source: Understanding Genetics — Genetics 101

Pathophysiology section 3

Epigenetics & Disease

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Epigenetic regulationGenetic / cellular · NEW

Normal function anchor: Cells with the same DNA sequence express different gene programs by tissue and state.

Etiology / risk factors: Development, environment, aging, disease signaling.

Pathophysiologic mechanism: Chemical and chromatin changes alter gene activity without changing the underlying DNA sequence.

Progression: Can be stable, dynamic, tissue-specific, or disease-associated.

Clinical manifestations: Usually indirect; manifestations reflect altered gene expression.

Diagnostics / labs / imaging: Methylation assays; chromatin studies; sequencing-based methods in specialized settings.

Complications: Abnormal development, cancer, immune or metabolic dysregulation depending on genes affected.

Treatment categories: Disease-specific; some pathways are pharmacologically targetable.

Medical-record relevance: Explains altered gene expression when DNA sequence alone does not account for phenotype.

Related terminology: epigenetics

Related anatomy: DNA; chromatin

Source: Introduction to Epigenetics

DNA methylationGenetic / cellular · NEW

Normal function anchor: CpG methylation contributes to regulated gene expression and chromatin state.

Etiology / risk factors: Developmental programming, aging, exposures, disease-associated enzyme changes.

Pathophysiologic mechanism: Methyl groups added to DNA can alter transcriptional accessibility and gene expression.

Progression: Patterns can be maintained through cell division yet also change in disease.

Clinical manifestations: Depends on genes and tissues affected.

Diagnostics / labs / imaging: Methylation-specific assays; sequencing.

Complications: Gene silencing or dysregulation.

Treatment categories: Disease-specific; epigenetic drugs in selected malignancies.

Medical-record relevance: Methylation results may appear in oncology and genetics reports.

Related terminology: DNA methylation; CpG

Related anatomy: DNA

Source: Introduction to Epigenetics

Histone modificationGenetic / cellular · NEW

Normal function anchor: Histones package DNA and help regulate chromatin accessibility.

Etiology / risk factors: Enzyme activity, signaling, mutations in epigenetic regulators.

Pathophysiologic mechanism: Acetylation, methylation and other histone marks alter chromatin and transcriptional programs.

Progression: Abnormal patterns can sustain inappropriate activation or repression.

Clinical manifestations: Tissue- and disease-specific.

Diagnostics / labs / imaging: Chromatin immunoprecipitation and molecular profiling in specialized settings.

Complications: Cancer, immune and developmental dysregulation.

Treatment categories: Disease-specific; histone-modifying drugs in selected diseases.

Medical-record relevance: Mechanism may be referenced in molecular oncology or research-oriented reports.

Related terminology: histone modification

Related anatomy: Histones; chromatin

Source: Introduction to Epigenetics

Histone acetylationGenetic / cellular · NEW

Normal function anchor: Balanced histone acetylation supports regulated transcription.

Etiology / risk factors: Altered HAT or HDAC activity, mutations, signaling changes.

Pathophysiologic mechanism: Acetylation generally loosens chromatin and can facilitate transcription; deacetylation can favor repression.

Progression: Persistent imbalance can reprogram gene expression.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Molecular/chromatin assays.

Complications: Dysregulated cell growth or differentiation depending on context.

Treatment categories: HDAC-targeted therapy in selected diseases; condition-specific care.

Medical-record relevance: Relevant to molecular mechanisms but not a diagnosis by itself.

Related terminology: histone acetylation; HAT; HDAC

Related anatomy: Histones

Source: Introduction to Epigenetics

Chromatin remodelingGenetic / cellular · NEW

Normal function anchor: Chromatin dynamically exposes or compacts DNA for transcription and repair.

Etiology / risk factors: Mutations or dysregulation of remodeling complexes.

Pathophysiologic mechanism: ATP-dependent complexes reposition nucleosomes and alter DNA accessibility.

Progression: Abnormal remodeling can lock cells into inappropriate transcriptional states.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Genomic sequencing; molecular profiling.

Complications: Developmental disorders or malignancy depending on affected complex.

Treatment categories: Disease-specific targeted or supportive care.

Medical-record relevance: Molecular reports may identify pathogenic variants in chromatin-remodeling genes.

Related terminology: chromatin remodeling

Related anatomy: Chromatin; nucleosomes

Source: Introduction to Epigenetics

Non-coding RNA regulationGenetic / cellular · NEW

Normal function anchor: Non-coding RNAs help regulate translation and gene expression.

Etiology / risk factors: Development, cellular stress, disease-associated dysregulation.

Pathophysiologic mechanism: MicroRNAs and other non-coding RNAs can suppress or coordinate target-gene expression.

Progression: Altered networks can amplify disease pathways.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Molecular expression assays mainly specialized/research.

Complications: Cancer and other regulatory disorders depending on network.

Treatment categories: Disease-specific; experimental/targeted approaches in selected settings.

Medical-record relevance: Generally mechanistic context rather than routine standalone diagnosis.

Related terminology: microRNA; non-coding RNA

Related anatomy: RNA; cells

Source: Epigenetics — World Cancer Report

Epigenetic tissue specificityGenetic / multisystem · CROSS-LINK

Normal function anchor: Different tissues express distinct gene programs despite shared DNA sequence.

Etiology / risk factors: Cell lineage, developmental history, local environment.

Pathophysiologic mechanism: Tissue-specific epigenetic marks determine which genes are active or silent.

Progression: Disease-associated changes may be detectable only in relevant tissue.

Clinical manifestations: Organ-specific phenotype.

Diagnostics / labs / imaging: Tissue-specific molecular testing.

Complications: False reassurance if an irrelevant specimen is tested.

Treatment categories: Specimen selection based on clinical question.

Medical-record relevance: Specimen type is critical when interpreting epigenetic results.

Related terminology: tissue-specific expression

Related anatomy: Tissues; DNA

Source: Epigenetic tools in autoimmune diseases

EpimutationGenetic / cellular · NEW

Normal function anchor: Stable epigenetic marks support normal gene regulation.

Etiology / risk factors: Primary epigenetic error or secondary effect of genetic/environmental change.

Pathophysiologic mechanism: Abnormal epigenetic state changes gene expression without necessarily altering DNA sequence.

Progression: May be constitutional, mosaic, or acquired.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Methylation and expression testing.

Complications: Disease phenotype from inappropriate gene silencing or activation.

Treatment categories: Condition-specific.

Medical-record relevance: Distinguishes regulatory abnormality from sequence mutation.

Related terminology: epimutation

Related anatomy: DNA; chromatin

Source: Introduction to Epigenetics

Promoter hypermethylationCancer / genetic regulation · NEW

Normal function anchor: Promoter accessibility permits appropriate gene transcription.

Etiology / risk factors: Cancer-associated methylation dysregulation.

Pathophysiologic mechanism: Excess promoter methylation can silence genes, including tumor suppressor genes.

Progression: Clonal selection may preserve silencing during tumor progression.

Clinical manifestations: Cancer-specific manifestations.

Diagnostics / labs / imaging: Tumor methylation profiling; sequencing-related assays.

Complications: Tumor progression, treatment resistance depending on gene.

Treatment categories: Cancer-specific therapy; epigenetic therapy in selected malignancies.

Medical-record relevance: May be reported as a biomarker or molecular tumor feature.

Related terminology: promoter hypermethylation

Related anatomy: Promoters; DNA

Source: Introduction to Epigenetics — Epigenetics and Cancer

Global DNA hypomethylation in cancerCancer / genetic regulation · NEW

Normal function anchor: Genome-wide methylation contributes to chromosomal stability and regulated expression.

Etiology / risk factors: Malignant transformation and dysregulated epigenetic machinery.

Pathophysiologic mechanism: Loss of methylation across broad genomic regions can increase instability and aberrant gene expression.

Progression: May accumulate with tumor progression.

Clinical manifestations: Cancer-specific.

Diagnostics / labs / imaging: Molecular profiling.

Complications: Genomic instability and tumor evolution.

Treatment categories: Cancer-specific.

Medical-record relevance: Mechanistic feature supporting understanding of tumor biology.

Related terminology: hypomethylation; genomic instability

Related anatomy: DNA; chromosomes

Source: Introduction to Epigenetics — Epigenetics and Cancer

Epigenetic silencing of tumor suppressor genesCancer · NEW

Normal function anchor: Tumor suppressor genes restrain proliferation and preserve genome integrity.

Etiology / risk factors: Promoter hypermethylation or repressive chromatin changes.

Pathophysiologic mechanism: Epigenetic repression reduces protective gene expression without requiring DNA deletion.

Progression: Can cooperate with genetic mutations to promote neoplasia.

Clinical manifestations: Cancer-specific.

Diagnostics / labs / imaging: Methylation profiling; tumor molecular testing.

Complications: Progression, resistance, recurrence depending on pathway.

Treatment categories: Cancer-specific targeted/systemic therapy; epigenetic agents in selected malignancies.

Medical-record relevance: Shows that loss of gene function can occur without a coding mutation.

Related terminology: tumor suppressor; gene silencing

Related anatomy: Genes; chromatin

Source: Introduction to Epigenetics — Epigenetics and Cancer

Epigenetic activation of oncogenic programsCancer · NEW

Normal function anchor: Growth genes are normally activated only when appropriate.

Etiology / risk factors: Aberrant chromatin or methylation patterns.

Pathophysiologic mechanism: Regulatory changes increase expression of genes that promote proliferation or survival.

Progression: Clonal expansion reinforces malignant phenotype.

Clinical manifestations: Cancer-specific.

Diagnostics / labs / imaging: Tumor molecular profiling.

Complications: Progression and metastasis depending on pathway.

Treatment categories: Cancer-specific targeted therapy where available.

Medical-record relevance: Mechanistic bridge between molecular findings and tumor behavior.

Related terminology: oncogene; transcriptional activation

Related anatomy: Genes; chromatin

Source: Introduction to Epigenetics — Epigenetics and Cancer

Epigenetic–genetic interactionGenetic / cancer · CROSS-LINK

Normal function anchor: Genetic sequence and epigenetic regulation jointly control cell behavior.

Etiology / risk factors: Mutations in epigenetic regulators or epigenetic silencing of genetically intact genes.

Pathophysiologic mechanism: Genetic changes can alter epigenetic enzymes, while epigenetic states can modify effects of variants.

Progression: Feedback can stabilize disease-associated expression programs.

Clinical manifestations: Condition-specific.

Diagnostics / labs / imaging: Sequencing plus methylation/expression profiling.

Complications: Complex disease progression.

Treatment categories: Disease-specific.

Medical-record relevance: Prevents false separation of genetic and epigenetic mechanisms in molecular reports.

Related terminology: epigenetic regulator

Related anatomy: Genes; chromatin

Source: Introduction to Epigenetics — Epigenetics and Cancer

DNA methyltransferase activityGenetic / cellular · NEW

Normal function anchor: DNMT enzymes establish and maintain DNA methylation.

Etiology / risk factors: Developmental regulation, mutations, altered enzyme expression.

Pathophysiologic mechanism: DNMT activity changes methylation patterns and therefore transcriptional potential.

Progression: Aberrant activity can create stable disease-associated silencing patterns.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Methylation assays; genomic studies.

Complications: Developmental or malignant disease depending on context.

Treatment categories: DNMT-inhibiting therapy in selected hematologic malignancies; otherwise condition-specific.

Medical-record relevance: May appear in molecular mechanism discussions and oncology treatment rationale.

Related terminology: DNMT

Related anatomy: DNA; enzymes

Source: Epigenetics — World Cancer Report

TET-mediated DNA demethylationGenetic / cellular · NEW

Normal function anchor: DNA methylation can be actively remodeled.

Etiology / risk factors: Developmental signaling or mutation/dysfunction of TET enzymes.

Pathophysiologic mechanism: TET proteins participate in active demethylation and dynamic epigenetic regulation.

Progression: Abnormal activity can alter hematopoietic and other gene programs.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Molecular sequencing; methylation studies.

Complications: Clonal hematopoietic or malignant effects depending on gene/context.

Treatment categories: Disease-specific.

Medical-record relevance: Relevant when molecular testing identifies TET-pathway abnormalities.

Related terminology: TET; demethylation

Related anatomy: DNA; enzymes

Source: Epigenetics — World Cancer Report

Epigenetic inheritance through cell divisionGenetic / cellular · NEW

Normal function anchor: Cell identity requires stable maintenance of gene-expression programs.

Etiology / risk factors: Maintenance methylation and chromatin mechanisms.

Pathophysiologic mechanism: Epigenetic marks can be copied during mitosis, preserving lineage-specific states.

Progression: Stable patterns can perpetuate both normal differentiation and disease-associated silencing.

Clinical manifestations: Indirect.

Diagnostics / labs / imaging: Methylation/chromatin assays.

Complications: Persistent abnormal gene expression.

Treatment categories: Disease-specific.

Medical-record relevance: Explains durability of epigenetic states even without DNA sequence change.

Related terminology: mitotic inheritance

Related anatomy: Cells; chromatin

Source: Introduction to Epigenetics

Epigenetic reversibilityGenetic / cellular · NEW

Normal function anchor: Regulatory chromatin marks are dynamic.

Etiology / risk factors: Cell signaling, environmental change, pharmacologic intervention.

Pathophysiologic mechanism: Because many epigenetic marks are enzymatically written and removed, some abnormal states can be modified.

Progression: Reversal may restore or shift gene expression but is context-dependent.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Serial molecular profiling in selected settings.

Complications: Incomplete or transient response possible.

Treatment categories: Epigenetic-targeted therapy in selected diseases.

Medical-record relevance: Supports why some molecular states are treatment targets rather than fixed sequence defects.

Related terminology: epigenetic therapy

Related anatomy: Chromatin; enzymes

Source: Introduction to Epigenetics

Environmental influence on epigenetic stateGenetic / environmental · CROSS-LINK

Normal function anchor: Gene regulation adapts to developmental and environmental signals.

Etiology / risk factors: Nutrition, toxins, inflammation, stressors, aging and other exposures.

Pathophysiologic mechanism: Environmental signals can alter regulatory pathways that modify chromatin and gene expression.

Progression: Effects may be transient, persistent, tissue-specific, or disease-associated.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Exposure history; molecular studies in selected contexts.

Complications: Potential contribution to chronic disease risk.

Treatment categories: Risk reduction and disease-specific management.

Medical-record relevance: Supports documentation of environmental risk factors without implying deterministic causation.

Related terminology: environmental epigenetics

Related anatomy: Genes; environment

Source: Introduction to Epigenetics

Epigenetic dysregulation in autoimmunityImmune / genetic regulation · CROSS-LINK

Normal function anchor: Immune cells require controlled activation and tolerance programs.

Etiology / risk factors: Genetic susceptibility, environmental triggers, immune activation.

Pathophysiologic mechanism: Abnormal methylation and histone patterns can alter expression of immune-regulatory genes.

Progression: May reinforce persistent inflammatory or autoreactive states.

Clinical manifestations: Disease-specific autoimmune manifestations.

Diagnostics / labs / imaging: Autoantibodies/clinical criteria; epigenetic testing mainly research.

Complications: Chronic inflammation and organ damage.

Treatment categories: Immune-directed therapy by disease.

Medical-record relevance: Mechanistic layer; routine diagnosis still depends on clinical and laboratory criteria.

Related terminology: autoimmunity; epigenetics

Related anatomy: Immune cells; chromatin

Source: Epigenetics and autoimmune diseases

Epigenetic biomarkerGenetic / oncology / diagnostics · NEW

Normal function anchor: Molecular state can reflect cell lineage or disease process.

Etiology / risk factors: Disease-associated methylation or chromatin patterns.

Pathophysiologic mechanism: A reproducible epigenetic pattern may correlate with diagnosis, prognosis, tissue origin, or treatment response.

Progression: Utility depends on assay validation and clinical context.

Clinical manifestations: None independently.

Diagnostics / labs / imaging: Validated methylation or molecular assay.

Complications: Misclassification if used outside validated context.

Treatment categories: Use only within disease-specific diagnostic/treatment pathways.

Medical-record relevance: Biomarker result should be distinguished from the diagnosis it supports.

Related terminology: methylation biomarker

Related anatomy: DNA; tissue

Source: Introduction to Epigenetics — Epigenetics and Cancer

Pathophysiology section 4

Inflammation & Abnormal Wound Healing

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Acute inflammationImmune / tissue injury · CROSS-LINK

Normal function anchor: Innate defense rapidly responds to injury and pathogens.

Etiology / risk factors: Infection, trauma, ischemia, toxins, immune reactions.

Pathophysiologic mechanism: Vascular changes and soluble mediators recruit neutrophils and other innate immune cells.

Progression: Usually begins rapidly and resolves after the trigger is controlled; may progress to chronic inflammation if unresolved.

Clinical manifestations: Heat, redness, swelling, pain, loss of function when clinically apparent.

Diagnostics / labs / imaging: CBC; CRP/ESR; cultures or imaging based on suspected cause.

Complications: Abscess, tissue damage, systemic inflammation, transition to chronic inflammation.

Treatment categories: Treat underlying cause; supportive/anti-inflammatory therapy when appropriate.

Medical-record relevance: Provides mechanism for inflammatory signs and abnormal labs but does not itself identify etiology.

Related terminology: acute inflammation

Related anatomy: Immune system; microvasculature

Source: StatPearls — Acute Inflammatory Response

Chronic inflammationImmune / multisystem · NEW

Normal function anchor: Inflammation normally resolves after threat clearance.

Etiology / risk factors: Persistent infection, autoimmune disease, prolonged exposure, unresolved injury.

Pathophysiologic mechanism: Ongoing macrophage/lymphocyte signaling causes simultaneous tissue injury and repair.

Progression: Persists for months or years and may lead to remodeling or fibrosis.

Clinical manifestations: Fatigue, pain, organ-specific symptoms; may be subtle.

Diagnostics / labs / imaging: Inflammatory markers; imaging; biopsy; disease-specific tests.

Complications: Fibrosis, tissue destruction, chronic organ dysfunction.

Treatment categories: Treat underlying driver; disease-specific anti-inflammatory or immune therapy.

Medical-record relevance: Chronicity and cause should be separately documented when known.

Related terminology: chronic inflammation

Related anatomy: Immune system; tissues

Source: StatPearls — Chronic Inflammation

Vasodilation in inflammationImmune / vascular · A&P LINK

Normal function anchor: Local blood flow is regulated to tissue demand.

Etiology / risk factors: Histamine and other inflammatory mediators.

Pathophysiologic mechanism: Arteriolar dilation increases blood flow to injured tissue.

Progression: Occurs early in acute inflammation.

Clinical manifestations: Redness and heat.

Diagnostics / labs / imaging: Clinical exam; indirectly supported by inflammatory context.

Complications: May contribute to edema and local discomfort.

Treatment categories: Treat underlying inflammatory cause.

Medical-record relevance: Mechanistic explanation for classic inflammatory signs.

Related terminology: vasodilation; erythema

Related anatomy: Microvasculature

Source: StatPearls — Acute Inflammatory Response

Increased vascular permeabilityImmune / vascular · A&P LINK

Normal function anchor: Endothelium limits uncontrolled fluid and protein leakage.

Etiology / risk factors: Inflammatory mediators and endothelial injury.

Pathophysiologic mechanism: Endothelial gaps or damage allow plasma proteins and fluid into tissues.

Progression: Produces exudate and edema during acute inflammation.

Clinical manifestations: Swelling; tissue pressure; pain.

Diagnostics / labs / imaging: Clinical exam; imaging in deeper tissues.

Complications: Impaired function; fluid accumulation.

Treatment categories: Treat underlying cause.

Medical-record relevance: Explains edema/exudate language in notes and imaging.

Related terminology: vascular permeability; exudate

Related anatomy: Capillaries; interstitium

Source: StatPearls — Acute Inflammatory Response

Neutrophil recruitmentImmune · CROSS-LINK

Normal function anchor: Innate immune cells circulate and migrate to threats.

Etiology / risk factors: Chemokines and inflammatory signals.

Pathophysiologic mechanism: Neutrophils adhere, migrate into tissue, phagocytose microbes/debris, and release antimicrobial enzymes and reactive species.

Progression: Dominant early in many acute inflammatory responses.

Clinical manifestations: Purulent drainage or neutrophilia may occur depending on cause.

Diagnostics / labs / imaging: CBC differential; tissue/fluid microscopy; culture when infection suspected.

Complications: Collateral tissue injury if excessive or prolonged.

Treatment categories: Treat cause; infection-directed therapy when appropriate.

Medical-record relevance: Neutrophilia supports inflammatory/infectious context but is not disease-specific.

Related terminology: neutrophil; chemotaxis

Related anatomy: Blood; tissues

Source: StatPearls — Acute Inflammatory Response

Macrophage responseImmune / tissue repair · CROSS-LINK

Normal function anchor: Macrophages clear debris and coordinate immune and repair signals.

Etiology / risk factors: Tissue injury, infection, persistent inflammation.

Pathophysiologic mechanism: Macrophages phagocytose debris, secrete cytokines, and help transition wounds from inflammation toward repair.

Progression: Become prominent as inflammation evolves; can sustain chronic inflammation if activation persists.

Clinical manifestations: Indirect, tissue-specific.

Diagnostics / labs / imaging: Biopsy/histology; inflammatory markers.

Complications: Fibrosis or chronic tissue injury when dysregulated.

Treatment categories: Treat underlying cause.

Medical-record relevance: Macrophage-rich infiltrates may help characterize chronic inflammatory pathology.

Related terminology: macrophage; monocyte

Related anatomy: Immune cells; tissues

Source: StatPearls — Physiology, Wound Healing

Cytokine-mediated inflammationImmune · MED TERM LINK

Normal function anchor: Cytokines coordinate controlled cell-to-cell immune signaling.

Etiology / risk factors: Infection, tissue injury, immune activation.

Pathophysiologic mechanism: Mediator release amplifies leukocyte recruitment, vascular change, fever, and acute-phase responses.

Progression: Usually subsides with resolution; can become self-sustaining in chronic disease.

Clinical manifestations: Fever, malaise, inflammatory symptoms.

Diagnostics / labs / imaging: CRP/ESR; selected cytokine assays mainly specialized.

Complications: Systemic inflammatory effects, tissue damage.

Treatment categories: Cause-directed; targeted cytokine therapy in selected diseases.

Medical-record relevance: Links systemic symptoms and inflammatory-marker changes to immune signaling.

Related terminology: cytokine; chemokine

Related anatomy: Immune system

Source: StatPearls — Acute Inflammatory Response

Acute-phase responseImmune / hepatic · CROSS-LINK

Normal function anchor: Liver protein synthesis is regulated by physiologic demand.

Etiology / risk factors: Systemic cytokine signaling during inflammation.

Pathophysiologic mechanism: Hepatic production of acute-phase proteins changes in response to inflammatory mediators.

Progression: Tracks inflammatory activity but is nonspecific.

Clinical manifestations: Fever, malaise; may be clinically silent.

Diagnostics / labs / imaging: CRP; ESR indirectly; fibrinogen and other proteins depending on context.

Complications: May obscure underlying etiology if interpreted alone.

Treatment categories: Treat underlying cause.

Medical-record relevance: Inflammatory markers support activity/monitoring but do not establish a specific diagnosis.

Related terminology: acute-phase protein; CRP

Related anatomy: Liver; blood

Source: StatPearls — Acute Inflammatory Response

Resolution of inflammationImmune / tissue repair · NEW

Normal function anchor: Inflammation terminates after threat removal and tissue repair begins.

Etiology / risk factors: Clearance of trigger plus pro-resolving immune signaling.

Pathophysiologic mechanism: Neutrophils undergo apoptosis/clearance, macrophage phenotype shifts, and inflammatory mediators decline.

Progression: Transitions tissue toward proliferation and repair.

Clinical manifestations: Improving pain, swelling, fever, and function.

Diagnostics / labs / imaging: Clinical trend; inflammatory markers; wound assessment.

Complications: Failure to resolve can produce chronic inflammation.

Treatment categories: Treat cause and support healing.

Medical-record relevance: Improvement over time helps distinguish resolving acute disease from persistent inflammation.

Related terminology: resolution; efferocytosis

Related anatomy: Immune cells; tissues

Source: StatPearls — Physiology, Wound Healing

Hemostasis phase of wound healingIntegumentary / vascular · CROSS-LINK

Normal function anchor: Vessels and coagulation maintain blood integrity.

Etiology / risk factors: Tissue disruption and bleeding.

Pathophysiologic mechanism: Vasoconstriction, platelet activation, and fibrin clot formation limit blood loss and provide a provisional matrix.

Progression: Begins immediately after injury and overlaps with inflammation.

Clinical manifestations: Bleeding control and clot formation.

Diagnostics / labs / imaging: Clinical wound exam; coagulation studies if bleeding abnormal.

Complications: Hematoma, continued bleeding, impaired downstream healing.

Treatment categories: Hemostasis and cause-directed wound care.

Medical-record relevance: Important postoperative and wound-care phase; abnormal bleeding should be separately documented.

Related terminology: hemostasis; fibrin clot

Related anatomy: Skin; vessels; platelets

Source: StatPearls — Physiology, Wound Healing

Inflammatory phase of wound healingIntegumentary / immune · CROSS-LINK

Normal function anchor: Early immune response removes contaminants and damaged tissue.

Etiology / risk factors: Tissue injury.

Pathophysiologic mechanism: Neutrophils and macrophages clear microbes/debris and produce signals that initiate repair.

Progression: Predominates early and should transition toward proliferation.

Clinical manifestations: Tenderness, erythema, swelling can occur within expected limits.

Diagnostics / labs / imaging: Wound exam; CBC/culture if infection suspected.

Complications: Prolonged inflammation delays healing.

Treatment categories: Wound care; treat infection or perfusion problems when present.

Medical-record relevance: Expected postoperative inflammation should be distinguished from infection or complication.

Related terminology: wound inflammation

Related anatomy: Skin; immune cells

Source: StatPearls — Physiology, Wound Healing

Proliferative phase of wound healingIntegumentary / tissue repair · A&P LINK

Normal function anchor: Tissue repair restores barrier and vascular supply.

Etiology / risk factors: Resolution of initial inflammation and adequate perfusion.

Pathophysiologic mechanism: Fibroblasts, endothelial cells, and keratinocytes generate granulation tissue, angiogenesis, extracellular matrix, and re-epithelialization.

Progression: Typically follows the inflammatory phase and may last days to weeks.

Clinical manifestations: Granulation tissue and wound contraction.

Diagnostics / labs / imaging: Serial wound measurements; visual assessment.

Complications: Delayed closure if perfusion, infection, nutrition, or immune function is poor.

Treatment categories: Wound care and correction of barriers to healing.

Medical-record relevance: Granulation and epithelialization are useful objective wound descriptors.

Related terminology: granulation; angiogenesis; epithelialization

Related anatomy: Skin; connective tissue

Source: StatPearls — Physiology, Wound Healing

Remodeling phase of wound healingIntegumentary / connective tissue · A&P LINK

Normal function anchor: Collagen organization provides tissue strength.

Etiology / risk factors: Maturation after wound closure.

Pathophysiologic mechanism: Collagen is reorganized and tensile strength gradually increases.

Progression: Can continue for months to years.

Clinical manifestations: Scar maturation and reduced vascularity.

Diagnostics / labs / imaging: Clinical exam; scar assessment.

Complications: Contracture, weak scar, hypertrophic scar.

Treatment categories: Scar management or surgical treatment when indicated.

Medical-record relevance: Explains why a healed wound can continue changing after epithelial closure.

Related terminology: remodeling; maturation

Related anatomy: Dermis; collagen

Source: StatPearls — Physiology, Wound Healing

Chronic woundIntegumentary / vascular / metabolic · NEW

Normal function anchor: Normal wounds progress through coordinated healing phases.

Etiology / risk factors: Poor perfusion, diabetes, infection, pressure, malnutrition, immune dysfunction, repeated trauma.

Pathophysiologic mechanism: Wound becomes stalled, commonly in a prolonged inflammatory state, with impaired granulation or epithelialization.

Progression: Persists beyond expected healing timeframe.

Clinical manifestations: Nonhealing ulcer, drainage, pain, tissue breakdown.

Diagnostics / labs / imaging: Serial measurements; vascular assessment; glucose testing; culture when indicated; imaging for deep infection.

Complications: Cellulitis, osteomyelitis, tissue loss, amputation risk.

Treatment categories: Pressure relief, perfusion optimization, infection management, debridement, metabolic/nutritional support as indicated.

Medical-record relevance: Etiology, site, depth, stage/grade, infection status, and healing progress drive documentation specificity.

Related terminology: chronic wound; ulcer

Related anatomy: Skin; vasculature

Source: StatPearls — Physiology, Wound Healing

Delayed wound healingIntegumentary · CROSS-LINK

Normal function anchor: Wounds transition through hemostasis, inflammation, proliferation, remodeling.

Etiology / risk factors: Hypoxia, infection, poor nutrition, diabetes, smoking, medications, immune suppression, vascular disease.

Pathophysiologic mechanism: Repair phases are prolonged or disrupted, reducing collagen deposition, angiogenesis, epithelialization, or immune clearance.

Progression: Healing slows and may become chronic.

Clinical manifestations: Persistent open wound, poor granulation, drainage.

Diagnostics / labs / imaging: Wound exam; vascular/metabolic/nutritional assessment.

Complications: Infection, dehiscence, chronic ulcer.

Treatment categories: Correct barriers and provide wound-specific care.

Medical-record relevance: Document contributing conditions separately from the wound itself.

Related terminology: delayed healing

Related anatomy: Skin; connective tissue

Source: StatPearls — Physiology, Wound Healing

Wound dehiscenceIntegumentary / surgical · MED TERM LINK

Normal function anchor: Healing wound edges remain approximated while tensile strength develops.

Etiology / risk factors: Infection, poor perfusion, mechanical stress, impaired healing, surgical factors.

Pathophysiologic mechanism: Partial or complete separation occurs before adequate tissue strength is established.

Progression: May remain superficial or extend into deeper layers.

Clinical manifestations: Wound separation, drainage, pain.

Diagnostics / labs / imaging: Clinical wound exam; imaging if deep complication suspected.

Complications: Infection, evisceration in severe cases, delayed healing.

Treatment categories: Wound support; surgical management depending on depth and severity.

Medical-record relevance: Depth and involvement of fascia/organ space are important operative/documentation details.

Related terminology: dehiscence

Related anatomy: Skin; fascia

Source: StatPearls — Physiology, Wound Healing

Hypertrophic scarIntegumentary / connective tissue · NEW

Normal function anchor: Remodeling balances collagen synthesis and degradation.

Etiology / risk factors: Excessive localized repair signaling after injury.

Pathophysiologic mechanism: Excess collagen remains within original wound boundaries.

Progression: May thicken during maturation and sometimes regress partially.

Clinical manifestations: Raised, firm scar; pruritus or discomfort.

Diagnostics / labs / imaging: Clinical exam.

Complications: Contracture or functional limitation depending on location.

Treatment categories: Scar therapy; injections, laser or surgery in selected cases.

Medical-record relevance: Distinguish from keloid because distribution and behavior differ.

Related terminology: hypertrophic scar

Related anatomy: Dermis; collagen

Source: StatPearls — Physiology, Wound Healing

KeloidIntegumentary / connective tissue · MED TERM LINK

Normal function anchor: Scar formation normally remains within wound boundaries.

Etiology / risk factors: Predisposition plus dysregulated wound-healing response.

Pathophysiologic mechanism: Persistent inflammation and excess extracellular-matrix deposition produce scar growth beyond the original injury.

Progression: Can continue enlarging and recur after treatment.

Clinical manifestations: Raised scar extending beyond original wound; pain or pruritus.

Diagnostics / labs / imaging: Clinical exam; biopsy if diagnosis uncertain.

Complications: Cosmetic or functional impairment; recurrence.

Treatment categories: Scar-directed therapies including injections, surgery, radiation or other modalities in selected cases.

Medical-record relevance: Accurate distinction from hypertrophic scar affects treatment and documentation.

Related terminology: keloid

Related anatomy: Dermis; collagen

Source: StatPearls — Physiology, Wound Healing

FibrosisMultisystem / connective tissue · CROSS-LINK

Normal function anchor: Repair restores structure while limiting excessive scar deposition.

Etiology / risk factors: Chronic inflammation, repetitive injury, autoimmune disease, toxins, persistent infection.

Pathophysiologic mechanism: Activated fibroblasts deposit excess extracellular matrix and collagen, replacing functional tissue.

Progression: Progressive scarring can distort architecture and reduce organ function.

Clinical manifestations: Organ-specific dysfunction.

Diagnostics / labs / imaging: Imaging; organ-function tests; biomarkers; biopsy when needed.

Complications: Cirrhosis, pulmonary fibrosis, cardiac remodeling, strictures or other organ failure depending on site.

Treatment categories: Treat cause; antifibrotic therapy in selected diseases; supportive care.

Medical-record relevance: Fibrosis is a structural consequence and should be distinguished from the initiating disease.

Related terminology: fibrosis; scar

Related anatomy: Connective tissue; organ stroma

Source: StatPearls — Chronic Inflammation

Inflammation-related tissue damageImmune / multisystem · NEW

Normal function anchor: Immune responses eliminate threats while preserving host tissue.

Etiology / risk factors: Excessive, misdirected, or prolonged inflammation.

Pathophysiologic mechanism: Reactive species, proteases, cytokines, and immune-cell activity injure nearby tissue.

Progression: Repeated injury can lead to necrosis, remodeling, or fibrosis.

Clinical manifestations: Organ-specific pain and dysfunction.

Diagnostics / labs / imaging: Inflammatory markers; imaging; biopsy; organ-function testing.

Complications: Chronic organ damage and loss of function.

Treatment categories: Control underlying inflammatory driver and treat organ complications.

Medical-record relevance: Provides the mechanism connecting chronic inflammation to structural disease.

Related terminology: tissue injury; inflammatory damage

Related anatomy: Immune cells; tissues

Source: StatPearls — Chronic Inflammation

Pathophysiology section 5

Immune Dysfunction

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Immune dysfunctionImmune · NEW

Normal function anchor: Innate and adaptive responses defend against pathogens while limiting self-injury.

Etiology / risk factors: Genetic defects, acquired disease, drugs, malignancy, malnutrition, dysregulated immune signaling.

Pathophysiologic mechanism: One or more immune components are absent, overactive, misdirected, or poorly regulated.

Progression: May present as recurrent infection, allergy, inflammation, autoimmunity, or malignancy risk.

Clinical manifestations: Pattern varies by affected immune pathway.

Diagnostics / labs / imaging: CBC/differential; immunoglobulins; lymphocyte subsets; complement; disease-specific tests.

Complications: Severe infection, organ injury, autoimmunity, lymphoproliferation.

Treatment categories: Cause-specific immune, anti-infective, replacement, or targeted therapy.

Medical-record relevance: Umbrella concept; record should identify the specific immune disorder when established.

Related terminology: immune dysfunction

Related anatomy: Lymphoid organs; leukocytes

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Primary immunodeficiency / inborn error of immunityImmune / genetic · NEW

Normal function anchor: Immune development produces functional innate and adaptive components.

Etiology / risk factors: Pathogenic germline variants affecting immune development or function.

Pathophysiologic mechanism: Inherited defects impair antibody, T-cell, phagocyte, complement, or regulatory pathways.

Progression: Often begins with recurrent, severe, unusual, or opportunistic infection; some present with autoimmunity.

Clinical manifestations: Recurrent infections, failure to thrive, inflammatory or autoimmune findings.

Diagnostics / labs / imaging: Immunologic testing; genetic testing; infection history.

Complications: Chronic infection, bronchiectasis, autoimmunity, malignancy.

Treatment categories: Immunoglobulin replacement, prophylaxis, transplant or targeted therapy by disorder.

Medical-record relevance: Distinguish confirmed genetic immune disorder from nonspecific recurrent infections.

Related terminology: inborn error of immunity; primary immunodeficiency

Related anatomy: Bone marrow; thymus; lymph nodes

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Secondary immunodeficiencyImmune · NEW

Normal function anchor: Normal immune function is maintained without acquired suppression.

Etiology / risk factors: Infection, immunosuppressive drugs, malignancy, malnutrition, metabolic disease, age-related factors.

Pathophysiologic mechanism: An acquired condition suppresses previously developed immune function.

Progression: May be temporary, reversible, or persistent depending on cause.

Clinical manifestations: Recurrent or severe infections; poor vaccine response; disease-specific findings.

Diagnostics / labs / imaging: CBC; immunoglobulins; lymphocyte subsets; HIV testing or other cause-specific evaluation.

Complications: Opportunistic infection, poor wound healing, malignancy-related risk.

Treatment categories: Treat cause; infection prevention; immune replacement in selected cases.

Medical-record relevance: Underlying cause should be documented separately from immune deficiency.

Related terminology: secondary immunodeficiency

Related anatomy: Leukocytes; lymphoid organs

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Antibody deficiencyAdaptive immune / B cell · CROSS-LINK

Normal function anchor: B cells differentiate into plasma cells and generate antigen-specific immunoglobulins.

Etiology / risk factors: B-cell defects, immunoglobulin production defects, acquired depletion.

Pathophysiologic mechanism: Reduced quantity or function of antibodies impairs neutralization and opsonization.

Progression: Repeated sinopulmonary or encapsulated bacterial infections may accumulate over time.

Clinical manifestations: Recurrent respiratory infections; poor vaccine response.

Diagnostics / labs / imaging: IgG/IgA/IgM; vaccine titers; B-cell counts.

Complications: Bronchiectasis, chronic infection.

Treatment categories: Immunoglobulin replacement, vaccines/prophylaxis where appropriate.

Medical-record relevance: Low immunoglobulin level alone should be interpreted with clinical context and specific diagnosis.

Related terminology: hypogammaglobulinemia; antibody deficiency

Related anatomy: B cells; plasma cells

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

T-cell deficiencyAdaptive immune / cellular · CROSS-LINK

Normal function anchor: T cells coordinate cellular immunity and support B-cell responses.

Etiology / risk factors: Genetic T-cell defects, HIV, immunosuppression, marrow/thymic disorders.

Pathophysiologic mechanism: Reduced T-cell number or function weakens defense against intracellular pathogens and immune coordination.

Progression: Can lead to opportunistic infection and impaired humoral responses.

Clinical manifestations: Viral/fungal/opportunistic infections; chronic diarrhea; failure to thrive in severe cases.

Diagnostics / labs / imaging: Lymphocyte subsets; CD4/CD8 counts; functional assays.

Complications: Severe opportunistic infection, malignancy.

Treatment categories: Cause-specific immune restoration, prophylaxis, transplant in selected disorders.

Medical-record relevance: T-cell counts and cause are key record distinctions.

Related terminology: cellular immunodeficiency; CD4

Related anatomy: Thymus; T lymphocytes

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Combined immunodeficiencyAdaptive immune · NEW

Normal function anchor: B- and T-cell systems cooperate for effective adaptive immunity.

Etiology / risk factors: Genetic defects or acquired conditions impairing multiple lymphocyte pathways.

Pathophysiologic mechanism: Both cellular and humoral immunity are compromised.

Progression: Often severe and early when congenital; acquired forms vary.

Clinical manifestations: Severe recurrent infections across pathogen classes.

Diagnostics / labs / imaging: Lymphocyte subsets; immunoglobulins; genetic/functional testing.

Complications: Life-threatening infection, growth failure, organ damage.

Treatment categories: Transplant, gene/targeted therapy, prophylaxis, immune replacement depending on disorder.

Medical-record relevance: Combined defects carry broader infectious patterns than isolated antibody deficiency.

Related terminology: combined immunodeficiency

Related anatomy: B cells; T cells; marrow; thymus

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Complement deficiencyInnate / humoral · CROSS-LINK

Normal function anchor: Complement promotes opsonization, inflammation, and membrane attack.

Etiology / risk factors: Inherited complement defects or acquired consumption.

Pathophysiologic mechanism: Loss of specific components impairs microbial clearance or immune-complex handling.

Progression: Risk pattern depends on component affected.

Clinical manifestations: Recurrent bacterial infection or autoimmune-like manifestations.

Diagnostics / labs / imaging: CH50/AH50; individual complement levels.

Complications: Sepsis, recurrent meningococcal infection, immune-complex disease.

Treatment categories: Vaccination, prophylaxis, cause-specific management.

Medical-record relevance: Component and pathway matter for accurate interpretation.

Related terminology: complement deficiency

Related anatomy: Complement proteins; plasma

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Phagocyte dysfunctionInnate immune · NEW

Normal function anchor: Neutrophils and macrophages migrate, engulf, and kill microbes.

Etiology / risk factors: Genetic oxidative-burst defects, neutropenia, acquired marrow/drug effects.

Pathophysiologic mechanism: Reduced number or killing function impairs containment of bacteria and fungi.

Progression: Recurrent deep infections or abscesses may occur.

Clinical manifestations: Skin/deep infections, poor pus formation in some disorders.

Diagnostics / labs / imaging: CBC; neutrophil count; oxidative-burst testing; cultures.

Complications: Abscess, invasive infection.

Treatment categories: Antimicrobial prophylaxis/treatment; growth factors or transplant in selected conditions.

Medical-record relevance: Differentiate quantitative neutropenia from functional phagocyte defects.

Related terminology: phagocyte; neutrophil dysfunction

Related anatomy: Neutrophils; macrophages

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Immune dysregulationImmune · NEW

Normal function anchor: Activation and tolerance are balanced to eliminate threats without self-attack.

Etiology / risk factors: Genetic regulatory defects, chronic immune activation, acquired disease.

Pathophysiologic mechanism: Feedback controls fail, allowing excessive inflammation, autoimmunity, or lymphoproliferation.

Progression: May alternate between infection susceptibility and autoimmune/inflammatory disease.

Clinical manifestations: Fever, lymphadenopathy, cytopenias, organ-specific inflammation.

Diagnostics / labs / imaging: CBC; inflammatory markers; autoantibodies; immune phenotyping; genetic tests.

Complications: Organ damage, malignancy, chronic inflammation.

Treatment categories: Targeted immunomodulation; treat complications.

Medical-record relevance: Important when immune deficiency coexists with autoimmunity.

Related terminology: immune dysregulation

Related anatomy: Lymphocytes; cytokine networks

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Loss of self-toleranceAdaptive immune · NEW

Normal function anchor: Central and peripheral tolerance suppress autoreactive lymphocytes.

Etiology / risk factors: Genetic susceptibility, environmental triggers, hormonal factors, infections.

Pathophysiologic mechanism: Autoreactive T or B cells escape control and target self-antigens.

Progression: Can evolve from subclinical autoimmunity to organ-specific or systemic disease.

Clinical manifestations: Disease-specific inflammatory manifestations.

Diagnostics / labs / imaging: Autoantibodies; organ-specific labs; clinical criteria.

Complications: Chronic tissue injury, fibrosis, organ dysfunction.

Treatment categories: Immunomodulatory therapy by disease.

Medical-record relevance: Autoantibody positivity alone does not always equal active autoimmune disease.

Related terminology: self-tolerance; autoreactivity

Related anatomy: Thymus; lymphocytes

Source: StatPearls — Biochemistry, Autoimmunity

Autoimmune diseaseImmune / multisystem · CROSS-LINK

Normal function anchor: Immune recognition distinguishes self from non-self.

Etiology / risk factors: Multifactorial genetic, hormonal, and environmental factors.

Pathophysiologic mechanism: Sustained autoreactive immune responses damage self tissues through antibodies, T cells, cytokines, or complexes.

Progression: May relapse/remit or become chronically active.

Clinical manifestations: Systemic or organ-specific symptoms.

Diagnostics / labs / imaging: Disease-specific antibodies, inflammatory markers, imaging/biopsy as needed.

Complications: Permanent organ damage; treatment-related immunosuppression.

Treatment categories: Disease-specific immunomodulation.

Medical-record relevance: Documentation should name established autoimmune diagnosis and affected organs.

Related terminology: autoimmunity

Related anatomy: Immune system; target organs

Source: StatPearls — Biochemistry, Autoimmunity

Type I hypersensitivityAllergic / immune · NEW

Normal function anchor: IgE participates in defense but is tightly controlled.

Etiology / risk factors: Allergen sensitization and re-exposure.

Pathophysiologic mechanism: Allergen cross-links mast-cell/basophil-bound IgE, releasing histamine and other mediators.

Progression: Occurs rapidly after exposure; can remain local or become systemic.

Clinical manifestations: Rhinitis, urticaria, wheeze, angioedema, anaphylaxis.

Diagnostics / labs / imaging: Clinical history; specific IgE/skin testing in selected cases; tryptase after severe reactions.

Complications: Airway compromise, shock.

Treatment categories: Avoidance, antihistamine or other allergy therapy; epinephrine for anaphylaxis.

Medical-record relevance: Allergy, adverse reaction, and anaphylaxis should not be conflated.

Related terminology: immediate hypersensitivity; IgE

Related anatomy: Mast cells; basophils

Source: StatPearls — Type I Hypersensitivity Reaction

Type II hypersensitivityImmune / hematologic / organ-specific · NEW

Normal function anchor: Antibodies normally target foreign antigens.

Etiology / risk factors: Autoantibodies, transfusion mismatch, drug-associated antibodies.

Pathophysiologic mechanism: IgG/IgM binds cell-surface or matrix antigens, causing complement/Fc-mediated injury or receptor dysfunction.

Progression: Can produce cytopenia or organ-specific dysfunction.

Clinical manifestations: Anemia, thrombocytopenia, renal, skin, neuromuscular, or endocrine manifestations.

Diagnostics / labs / imaging: Coombs testing, blood smear, hemolysis labs, disease-specific antibodies.

Complications: Bleeding, hemolysis, organ failure.

Treatment categories: Remove trigger; immunosuppression, IVIG, plasmapheresis depending on disorder.

Medical-record relevance: Mechanism helps distinguish immune cytopenia from production failure.

Related terminology: antibody-mediated cytotoxicity

Related anatomy: Blood cells; extracellular matrix

Source: StatPearls — Type II Hypersensitivity Reaction

Type III hypersensitivityImmune / vascular · NEW

Normal function anchor: Immune complexes are normally cleared from circulation.

Etiology / risk factors: Persistent antigen exposure, infection, autoimmunity.

Pathophysiologic mechanism: Soluble antigen-antibody complexes deposit in tissues and activate complement/inflammation.

Progression: Inflammation develops where complexes accumulate.

Clinical manifestations: Vasculitis, arthritis, nephritic findings, rash depending on site.

Diagnostics / labs / imaging: Complement levels; inflammatory markers; urinalysis; biopsy; disease-specific antibodies.

Complications: Glomerulonephritis, vasculitis, tissue injury.

Treatment categories: Treat underlying cause and immune inflammation.

Medical-record relevance: Supports distinction between immune-complex mechanism and direct antibody-mediated injury.

Related terminology: immune complex

Related anatomy: Vessels; glomeruli; joints

Source: StatPearls — Type III Hypersensitivity Reaction

Type IV hypersensitivityCell-mediated immune · NEW

Normal function anchor: T cells coordinate delayed cellular responses to intracellular threats.

Etiology / risk factors: Prior sensitization to antigen, drug, contact allergen, pathogen.

Pathophysiologic mechanism: Sensitized T cells release cytokines or directly injure target cells rather than relying on antibodies.

Progression: Typically delayed after exposure.

Clinical manifestations: Contact dermatitis, granulomatous inflammation, drug reactions, test-site reactions.

Diagnostics / labs / imaging: Clinical history; patch testing or tissue evaluation in selected cases.

Complications: Persistent tissue injury, severe drug reactions.

Treatment categories: Avoid trigger; anti-inflammatory/immunosuppressive treatment when indicated.

Medical-record relevance: Delayed timing and T-cell mechanism differentiate it from immediate allergy.

Related terminology: delayed hypersensitivity

Related anatomy: T cells; macrophages

Source: StatPearls — Type IV Hypersensitivity Reaction

AnaphylaxisAllergic / systemic · NEW

Normal function anchor: Immune mediator release is normally localized and controlled.

Etiology / risk factors: Food, medication, venom, latex, other triggers in sensitized individuals.

Pathophysiologic mechanism: Systemic mast-cell/basophil mediator release causes vasodilation, capillary leak, bronchoconstriction, and mucosal edema.

Progression: Can progress within minutes to respiratory/circulatory collapse.

Clinical manifestations: Hives, wheeze, swelling, hypotension, GI symptoms.

Diagnostics / labs / imaging: Primarily clinical; serum tryptase may support diagnosis.

Complications: Shock, hypoxic injury, death.

Treatment categories: Immediate epinephrine and emergency supportive care.

Medical-record relevance: Document trigger, systemic features, treatment, and whether criteria for anaphylaxis were met.

Related terminology: anaphylaxis

Related anatomy: Airway; vasculature; mast cells

Source: StatPearls — Type I Hypersensitivity Reaction

Allergic inflammationAllergic / respiratory / skin · CROSS-LINK

Normal function anchor: Barrier and immune responses tolerate harmless environmental exposures.

Etiology / risk factors: Ongoing allergen exposure in sensitized individuals.

Pathophysiologic mechanism: Repeated IgE-mediated and cytokine responses recruit eosinophils and sustain local inflammation.

Progression: Can shift from episodic reactions to chronic inflammatory disease.

Clinical manifestations: Rhinitis, asthma symptoms, dermatitis, pruritus.

Diagnostics / labs / imaging: History; eosinophils; IgE testing; organ-specific studies.

Complications: Airway remodeling, chronic dermatitis, recurrent flares.

Treatment categories: Allergen control and disease-specific anti-inflammatory therapy.

Medical-record relevance: Distinguish allergic trigger from infectious inflammation.

Related terminology: allergy; eosinophilia

Related anatomy: Airway; skin; mucosa

Source: StatPearls — Type I Hypersensitivity Reaction

Immune-mediated cytopeniaImmune / hematologic · CROSS-LINK

Normal function anchor: Blood-cell production and survival maintain normal counts.

Etiology / risk factors: Autoantibodies, drugs, immune dysregulation.

Pathophysiologic mechanism: Antibodies or immune effector cells accelerate destruction of red cells, platelets, or neutrophils.

Progression: Counts fall and symptoms reflect cell type affected.

Clinical manifestations: Fatigue/jaundice, bleeding, infection susceptibility.

Diagnostics / labs / imaging: CBC; smear; hemolysis labs; antiglobulin/antibody testing.

Complications: Severe anemia, hemorrhage, infection.

Treatment categories: Immunosuppression, IVIG, transfusion/supportive care as appropriate.

Medical-record relevance: Record should distinguish immune destruction from marrow production failure.

Related terminology: immune hemolysis; immune thrombocytopenia

Related anatomy: Blood cells; spleen

Source: StatPearls — Type II Hypersensitivity Reaction

Opportunistic infection susceptibilityImmune / infectious · CROSS-LINK

Normal function anchor: Intact immunity suppresses organisms of low pathogenicity.

Etiology / risk factors: T-cell deficiency, neutropenia, transplant, immunosuppressive therapy, advanced immune disease.

Pathophysiologic mechanism: Loss of specific host-defense pathways permits unusual organisms or disseminated infection.

Progression: Risk rises with depth/duration of immunosuppression.

Clinical manifestations: Pathogen-specific; may be atypical or severe.

Diagnostics / labs / imaging: Cultures/PCR, imaging, antigen testing, immune evaluation.

Complications: Dissemination, organ failure.

Treatment categories: Targeted antimicrobials plus immune restoration/prophylaxis where possible.

Medical-record relevance: Opportunistic infection often signals clinically significant immune impairment.

Related terminology: opportunistic infection

Related anatomy: Immune system; affected organs

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Immune reconstitution / restorationImmune · NEW

Normal function anchor: Functional immune compartments maintain host defense.

Etiology / risk factors: Recovery after treating underlying cause, stopping suppression, transplant, or targeted replacement.

Pathophysiologic mechanism: Cell counts or immune function recover, changing infection and inflammatory risk.

Progression: Improvement may be gradual and can occasionally unmask inflammation.

Clinical manifestations: Fewer infections; changing inflammatory symptoms.

Diagnostics / labs / imaging: Serial CBC, lymphocyte subsets, immunoglobulins, disease-specific monitoring.

Complications: Inflammatory rebound or incomplete recovery.

Treatment categories: Cause-directed restoration; prophylaxis adjusted to immune status.

Medical-record relevance: Serial immune measures may change problem-list status and prophylaxis needs.

Related terminology: immune reconstitution

Related anatomy: Bone marrow; lymphocytes

Source: StatPearls — Immunodeficiency Disorders (Primary and Secondary)

Pathophysiology section 6

Infection & Host Defense

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Host defense barrier failureInfectious / integumentary / mucosal · CROSS-LINK

Normal function anchor: Skin and mucosa block microbial entry.

Etiology / risk factors: Trauma, burns, ulcers, procedures, devices, aging, mucosal injury.

Pathophysiologic mechanism: Barrier disruption creates a portal of entry for colonizing or environmental organisms.

Progression: Local contamination may progress to invasion depending on pathogen and host factors.

Clinical manifestations: Local redness, drainage, pain, or no symptoms initially.

Diagnostics / labs / imaging: Clinical exam; culture if infection suspected.

Complications: Local infection, bacteremia, deep-tissue spread.

Treatment categories: Barrier care, source control, antimicrobial therapy when infection established.

Medical-record relevance: Document portal/source separately from systemic spread.

Related terminology: portal of entry; barrier defense

Related anatomy: Skin; mucosa

Source: StatPearls — Bacteremia

ColonizationInfectious · MED TERM LINK

Normal function anchor: Normal flora may inhabit body surfaces without tissue invasion.

Etiology / risk factors: Exposure, altered microbiome, devices, healthcare setting.

Pathophysiologic mechanism: Microorganisms are present and may multiply without causing host tissue damage.

Progression: May remain stable or precede infection if barriers/host defenses fail.

Clinical manifestations: Usually asymptomatic.

Diagnostics / labs / imaging: Culture or screening assay depending on organism/site.

Complications: Potential transmission or later infection in high-risk hosts.

Treatment categories: Usually no disease treatment unless specific decolonization indication exists.

Medical-record relevance: Positive culture does not automatically equal infection.

Related terminology: colonization

Related anatomy: Skin; mucosa

Source: StatPearls — Bacteremia

Local infectionInfectious · NEW

Normal function anchor: Innate defenses contain pathogens at entry sites.

Etiology / risk factors: Microbial invasion plus inadequate local clearance.

Pathophysiologic mechanism: Pathogen replication triggers localized inflammation and tissue injury.

Progression: May resolve, form abscess, or spread through lymph/blood.

Clinical manifestations: Pain, erythema, swelling, purulence, fever sometimes.

Diagnostics / labs / imaging: Exam; culture; CBC; imaging if deep infection suspected.

Complications: Abscess, cellulitis, bacteremia.

Treatment categories: Source control and organism-directed antimicrobials.

Medical-record relevance: Site and depth are key record distinctions.

Related terminology: infection; localized infection

Related anatomy: Affected tissue

Source: StatPearls — Bacteremia

BacteremiaInfectious / bloodstream · NEW

Normal function anchor: Blood is normally sterile.

Etiology / risk factors: Local infection, device, procedure, barrier disruption.

Pathophysiologic mechanism: Viable bacteria enter circulation; host defenses may clear them or systemic disease may follow.

Progression: Can be transient, persistent, or progress to sepsis.

Clinical manifestations: Fever, rigors, or no symptoms.

Diagnostics / labs / imaging: Blood cultures; source-directed cultures.

Complications: Sepsis, metastatic infection, endocarditis.

Treatment categories: Antibiotics and source control as indicated.

Medical-record relevance: Bacteremia is not synonymous with sepsis.

Related terminology: bacteremia

Related anatomy: Bloodstream

Source: StatPearls — Bacteremia

ViremiaInfectious / systemic · NEW

Normal function anchor: Viruses are normally contained at entry/replication sites.

Etiology / risk factors: Viral infection with systemic dissemination.

Pathophysiologic mechanism: Virus enters bloodstream and reaches distant tissues.

Progression: May be transient or sustained depending on virus and immunity.

Clinical manifestations: Virus-specific systemic symptoms.

Diagnostics / labs / imaging: PCR/NAAT; antigen/serology depending on virus.

Complications: Organ involvement, transmission, severe disease in immunocompromised hosts.

Treatment categories: Virus-specific antiviral/supportive care.

Medical-record relevance: Differentiate viral detection from documented disease syndrome.

Related terminology: viremia

Related anatomy: Bloodstream; target organs

Source: StatPearls — Physiology, Immune Response

Pathogen recognitionInnate immune · NEW

Normal function anchor: Pattern-recognition receptors identify danger signals.

Etiology / risk factors: Microbial invasion or tissue damage.

Pathophysiologic mechanism: Host receptors detect pathogen-associated patterns and initiate cytokine, complement, and leukocyte responses.

Progression: Appropriate activation promotes clearance; excessive activation can injure host tissue.

Clinical manifestations: Inflammatory signs.

Diagnostics / labs / imaging: Inflammatory markers; pathogen testing.

Complications: Dysregulated inflammation, sepsis.

Treatment categories: Treat infection and organ dysfunction as appropriate.

Medical-record relevance: Mechanistic link between infection and inflammatory response.

Related terminology: PAMP; innate recognition

Related anatomy: Innate immune cells

Source: StatPearls — Laboratory Evaluation of Sepsis

Neutrophil antimicrobial responseInnate immune · CROSS-LINK

Normal function anchor: Neutrophils rapidly kill extracellular microbes.

Etiology / risk factors: Bacterial/fungal invasion.

Pathophysiologic mechanism: Chemotaxis, phagocytosis, oxidative burst, granule enzymes, and extracellular traps attack pathogens.

Progression: Effective response contains infection; excess activation contributes to tissue injury.

Clinical manifestations: Neutrophilia, purulence.

Diagnostics / labs / imaging: CBC differential; tissue/fluid microscopy.

Complications: Collateral tissue damage, systemic inflammation.

Treatment categories: Treat underlying infection.

Medical-record relevance: Neutrophil count supports but does not define infection.

Related terminology: neutrophilia; oxidative burst

Related anatomy: Neutrophils

Source: StatPearls — Laboratory Evaluation of Sepsis

Complement activation in infectionInnate immune · CROSS-LINK

Normal function anchor: Complement opsonizes pathogens and supports lysis/inflammation.

Etiology / risk factors: Microbial surfaces and immune complexes.

Pathophysiologic mechanism: Cascade activation enhances phagocytosis, chemotaxis, and membrane attack.

Progression: Usually localized; widespread activation can amplify systemic inflammation.

Clinical manifestations: Inflammatory manifestations.

Diagnostics / labs / imaging: Complement testing mainly when deficiency/dysregulation suspected.

Complications: Tissue injury if excessive; recurrent infection if deficient.

Treatment categories: Treat infection; address complement disorder if present.

Medical-record relevance: Useful bridge between innate defense and immune-complex disease.

Related terminology: complement activation

Related anatomy: Plasma proteins

Source: StatPearls — Physiology, Immune Response

Fever response to infectionSystemic / immune / neurologic · CROSS-LINK

Normal function anchor: Hypothalamic thermoregulation maintains core temperature.

Etiology / risk factors: Cytokines released during infection/inflammation.

Pathophysiologic mechanism: Pyrogenic cytokines increase prostaglandin signaling and raise the hypothalamic set point.

Progression: Persists while inflammatory signaling continues.

Clinical manifestations: Fever, chills, malaise.

Diagnostics / labs / imaging: Temperature trend; CBC; cultures and source evaluation.

Complications: Dehydration, metabolic stress; high fever can worsen illness.

Treatment categories: Treat cause; supportive antipyretic measures as appropriate.

Medical-record relevance: Fever is nonspecific and can be infectious or noninfectious.

Related terminology: fever; pyrogen

Related anatomy: Hypothalamus; immune system

Source: StatPearls — Laboratory Evaluation of Sepsis

Systemic inflammatory response to infectionInfectious / systemic · NEW

Normal function anchor: Inflammation is normally proportional and localized.

Etiology / risk factors: High pathogen burden, virulence, vulnerable host, delayed source control.

Pathophysiologic mechanism: Widespread cytokine, leukocyte, endothelial, complement, and coagulation activation affects multiple organs.

Progression: Can progress from infection to organ dysfunction.

Clinical manifestations: Fever/hypothermia, tachycardia, tachypnea, altered mental status.

Diagnostics / labs / imaging: CBC; lactate; metabolic/organ-function labs; cultures.

Complications: Sepsis, shock, organ failure.

Treatment categories: Rapid infection treatment, source control, organ support.

Medical-record relevance: Systemic inflammatory signs alone do not establish sepsis.

Related terminology: systemic inflammation

Related anatomy: Vasculature; immune system

Source: StatPearls — Laboratory Evaluation of Sepsis

SepsisInfectious / multisystem · NEW

Normal function anchor: Host response eliminates infection while preserving organ function.

Etiology / risk factors: Infection plus dysregulated host response.

Pathophysiologic mechanism: Maladaptive inflammatory, endothelial, metabolic, and coagulation changes cause acute organ dysfunction.

Progression: May progress rapidly to shock and multiorgan failure.

Clinical manifestations: Altered mentation, hypotension, tachypnea, oliguria, hypoxemia, other organ-specific signs.

Diagnostics / labs / imaging: Cultures, lactate, CBC, CMP, coagulation, organ-function studies; clinical severity assessment.

Complications: Shock, DIC, AKI, respiratory failure, death.

Treatment categories: Urgent antimicrobials, source control, fluids/vasopressors and organ support as indicated.

Medical-record relevance: Sepsis requires infection-associated organ dysfunction, not just bacteremia or fever.

Related terminology: sepsis

Related anatomy: Multisystem

Source: StatPearls — Laboratory Evaluation of Sepsis

Septic shockInfectious / circulatory · NEW

Normal function anchor: Circulation maintains adequate perfusion pressure and oxygen delivery.

Etiology / risk factors: Sepsis with profound circulatory/metabolic dysfunction.

Pathophysiologic mechanism: Vasodilation, capillary leak, myocardial effects, and microcirculatory dysfunction produce persistent hypotension and impaired perfusion.

Progression: Represents severe sepsis physiology with high risk of organ failure.

Clinical manifestations: Hypotension, altered mentation, oliguria, elevated lactate.

Diagnostics / labs / imaging: Hemodynamics, lactate, organ-function labs.

Complications: Multiorgan failure, death.

Treatment categories: Vasopressors, fluids, antimicrobials, source control, critical care support.

Medical-record relevance: Shock should be documented distinctly from uncomplicated infection/sepsis.

Related terminology: septic shock

Related anatomy: Vasculature; heart

Source: StatPearls — Laboratory Evaluation of Sepsis

Infection-associated endothelial dysfunctionInfectious / vascular · NEW

Normal function anchor: Endothelium regulates tone, permeability, and coagulation.

Etiology / risk factors: Severe systemic infection and inflammatory mediators.

Pathophysiologic mechanism: Endothelial activation increases permeability, vasodilation, leukocyte adhesion, and procoagulant signaling.

Progression: Can impair microcirculatory flow and tissue oxygen delivery.

Clinical manifestations: Edema, hypotension, organ dysfunction.

Diagnostics / labs / imaging: Lactate, hemodynamic and organ-function assessment.

Complications: Shock, microthrombosis, organ failure.

Treatment categories: Treat infection and support perfusion.

Medical-record relevance: Mechanism connects sepsis to capillary leak and organ injury.

Related terminology: endothelial dysfunction

Related anatomy: Microvasculature

Source: StatPearls — Laboratory Evaluation of Sepsis

Disseminated infectionInfectious / multisystem · NEW

Normal function anchor: Host defenses contain pathogens at the primary site.

Etiology / risk factors: Immunosuppression, virulent pathogen, high burden, delayed treatment.

Pathophysiologic mechanism: Pathogen spreads hematogenously or through lymphatics to distant tissues.

Progression: Multiple secondary sites may develop.

Clinical manifestations: Multifocal organ-specific symptoms.

Diagnostics / labs / imaging: Blood cultures/PCR; imaging; site-specific cultures.

Complications: Abscesses, endocarditis, CNS infection, organ failure.

Treatment categories: Systemic pathogen-directed therapy and source control.

Medical-record relevance: Primary site and metastatic sites should be distinguished in the record.

Related terminology: dissemination; metastatic infection

Related anatomy: Blood; lymphatics; organs

Source: StatPearls — Bacteremia

Opportunistic infectionInfectious / immune · CROSS-LINK

Normal function anchor: Intact immunity suppresses low-virulence organisms.

Etiology / risk factors: Immunodeficiency, transplant, chemotherapy, steroids, advanced immune disease.

Pathophysiologic mechanism: Loss of specific immune defenses allows pathogens that rarely cause disease in healthy hosts.

Progression: May be atypical, severe, recurrent, or disseminated.

Clinical manifestations: Organism-specific and often atypical.

Diagnostics / labs / imaging: PCR/antigen/culture; imaging; immune-status testing.

Complications: Dissemination, organ failure.

Treatment categories: Targeted antimicrobials plus immune restoration/prophylaxis where possible.

Medical-record relevance: Opportunistic infection often supports an underlying immunocompromised state.

Related terminology: opportunistic infection

Related anatomy: Affected organs; immune system

Source: StatPearls — Physiology, Immune Response

Source controlInfectious / procedural · NEW

Normal function anchor: Immune and antimicrobial defenses work best when pathogen burden is limited.

Etiology / risk factors: Abscess, infected device, obstruction, necrotic tissue.

Pathophysiologic mechanism: Persistent nidus sustains microbial growth despite systemic therapy.

Progression: Failure of source control can prolong bacteremia/sepsis.

Clinical manifestations: Persistent fever, drainage, localized findings.

Diagnostics / labs / imaging: Imaging; cultures; procedural findings.

Complications: Recurrent infection, sepsis.

Treatment categories: Drainage, debridement, device removal, surgery when indicated.

Medical-record relevance: Procedure documentation often explains infection improvement/failure.

Related terminology: source control

Related anatomy: Site-specific

Source: StatPearls — Laboratory Evaluation of Sepsis

Blood culture interpretationInfectious / diagnostic · CROSS-LINK

Normal function anchor: Blood is normally sterile.

Etiology / risk factors: Suspected bloodstream infection; contamination during collection is possible.

Pathophysiologic mechanism: Growth of organisms may represent true bacteremia or contamination depending on organism, number of sets, and clinical context.

Progression: Serial positivity can suggest persistent bloodstream infection.

Clinical manifestations: No manifestation inherent to the test.

Diagnostics / labs / imaging: Paired blood-culture sets; repeat cultures when indicated.

Complications: Misclassification can lead to under- or overtreatment.

Treatment categories: Interpret with clinical context and source evaluation.

Medical-record relevance: Positive blood culture is a finding, not automatically sepsis.

Related terminology: blood culture; contamination

Related anatomy: Bloodstream

Source: StatPearls — Bacteremia

Infection-related leukocytosis / leukopeniaHematologic / infectious · CROSS-LINK

Normal function anchor: WBC production and trafficking respond to immune demand.

Etiology / risk factors: Acute infection, marrow reserve, severe systemic illness, drugs.

Pathophysiologic mechanism: Cytokines alter marrow release and peripheral distribution; severe illness may deplete or suppress counts.

Progression: Counts can rise or fall with disease severity and host factors.

Clinical manifestations: Often accompanies infection symptoms.

Diagnostics / labs / imaging: CBC with differential; trend over time.

Complications: Severe leukopenia can impair host defense.

Treatment categories: Treat cause; supportive hematologic management if needed.

Medical-record relevance: WBC abnormalities support context but are not specific for infection.

Related terminology: leukocytosis; leukopenia

Related anatomy: Bone marrow; blood

Source: StatPearls — Laboratory Evaluation of Sepsis

Lactate elevation in severe infectionMetabolic / circulatory · CROSS-LINK

Normal function anchor: Aerobic metabolism and perfusion normally keep lactate controlled.

Etiology / risk factors: Hypoperfusion, adrenergic stress, impaired clearance, severe systemic infection.

Pathophysiologic mechanism: Increased production and/or reduced clearance raises serum lactate.

Progression: Persistent elevation may track ongoing physiologic stress or poor perfusion.

Clinical manifestations: May accompany hypotension, tachypnea, altered mental status.

Diagnostics / labs / imaging: Serum lactate serial measurements.

Complications: Organ dysfunction, shock.

Treatment categories: Treat infection and restore perfusion; reassess trend.

Medical-record relevance: Elevated lactate is a severity marker, not a diagnosis by itself.

Related terminology: lactate

Related anatomy: Circulation; liver; muscle

Source: StatPearls — Laboratory Evaluation of Sepsis

Clinical indicators versus documented infection diagnosisInfectious / medical record · NEW

Normal function anchor: Diagnosis integrates symptoms, exam, tests, and clinician assessment.

Etiology / risk factors: Abnormal labs/imaging/cultures may be nonspecific or incidental.

Pathophysiologic mechanism: Indicators increase or decrease diagnostic probability but do not substitute for provider-established disease when documentation rules require diagnosis.

Progression: Evidence may evolve during evaluation.

Clinical manifestations: Varies.

Diagnostics / labs / imaging: Cultures, imaging, CBC, biomarkers, site-specific tests.

Complications: Coding/clinical ambiguity if findings are treated as diagnoses without documentation.

Treatment categories: Clarify diagnosis and treat based on clinical assessment.

Medical-record relevance: Foundational bridge into documentation, coding, CDI, and RCM.

Related terminology: clinical indicator; diagnosis

Related anatomy: Medical record

Source: StatPearls — Laboratory Evaluation of Sepsis

Pathophysiology section 7

Stress & Disease

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Physiologic stress responseNeuroendocrine / autonomic · NEW

Normal function anchor: Homeostasis is maintained through coordinated neural, endocrine, and immune regulation.

Etiology / risk factors: Physical or psychological stressor.

Pathophysiologic mechanism: Sympathetic-adrenomedullary and HPA systems mobilize energy and cardiovascular resources.

Progression: Adaptive when time-limited; repeated/prolonged activation can become maladaptive.

Clinical manifestations: Tachycardia, alertness, sweating, appetite/sleep changes depending on context.

Diagnostics / labs / imaging: Vital signs; clinical history; targeted labs when endocrine disease is suspected.

Complications: Chronic cardiometabolic, immune, and behavioral effects.

Treatment categories: Remove/manage stressor and treat resulting disease where present.

Medical-record relevance: Stress response is a mechanism, not itself proof of a psychiatric or endocrine diagnosis.

Related terminology: stress response

Related anatomy: Hypothalamus; pituitary; adrenals; autonomic nerves

Source: StatPearls — Physiology, Stress Reaction

Sympathetic-adrenomedullary activationAutonomic / cardiovascular · A&P LINK

Normal function anchor: Autonomic tone adjusts heart rate, vascular tone, and metabolism.

Etiology / risk factors: Acute stress, pain, fear, illness, trauma.

Pathophysiologic mechanism: Sympathetic nerves and adrenal medulla release catecholamines, raising cardiac output and substrate availability.

Progression: Rapid onset and usually short duration.

Clinical manifestations: Tachycardia, increased BP, tremor, sweating.

Diagnostics / labs / imaging: Vital signs; catecholamine testing only for selected disorders.

Complications: Arrhythmia or ischemia in vulnerable patients.

Treatment categories: Treat underlying stressor/disease; supportive management.

Medical-record relevance: Explains acute stress-related vital-sign changes.

Related terminology: SAM axis; catecholamine

Related anatomy: Sympathetic nervous system; adrenal medulla

Source: StatPearls — Physiology, Stress Reaction

HPA-axis activationNeuroendocrine · A&P LINK

Normal function anchor: Hypothalamic CRH, pituitary ACTH, and adrenal cortisol form a regulated axis.

Etiology / risk factors: Stress signals from CNS and inflammatory pathways.

Pathophysiologic mechanism: CRH stimulates ACTH, which increases cortisol to support energy availability and modulate immunity.

Progression: Normally self-limited by negative feedback; chronic activation can alter axis regulation.

Clinical manifestations: Metabolic, sleep, mood, immune, and cardiovascular effects.

Diagnostics / labs / imaging: Cortisol/ACTH testing when endocrine disease suspected; clinical context otherwise.

Complications: Metabolic dysfunction, immune changes, sleep disturbance.

Treatment categories: Treat underlying stressor or endocrine disorder.

Medical-record relevance: Do not infer cortisol disease from nonspecific stress symptoms alone.

Related terminology: HPA axis; cortisol

Related anatomy: Hypothalamus; pituitary; adrenal cortex

Source: StatPearls — Physiology, Stress Reaction

Cortisol-mediated stress effectsEndocrine / metabolic · CROSS-LINK

Normal function anchor: Cortisol supports glucose regulation, vascular tone, and immune modulation.

Etiology / risk factors: Acute/chronic stress or exogenous glucocorticoids.

Pathophysiologic mechanism: Cortisol increases gluconeogenic substrate availability and modifies inflammatory signaling.

Progression: Short-term effects are adaptive; chronic excess resembles glucocorticoid overexposure.

Clinical manifestations: Hyperglycemia, sleep/mood changes, muscle catabolism when prolonged.

Diagnostics / labs / imaging: Glucose; cortisol testing if pathologic excess suspected.

Complications: Insulin resistance, infection risk, muscle/bone effects with prolonged excess.

Treatment categories: Address cause; endocrine management if true hypercortisolism.

Medical-record relevance: Differentiate physiologic stress response from Cushing syndrome or steroid adverse effects.

Related terminology: cortisol; glucocorticoid

Related anatomy: Adrenal cortex

Source: StatPearls — Physiology, Stress Reaction

Acute stress responseNeuroendocrine / autonomic · NEW

Normal function anchor: Rapid adaptation supports survival during short-lived threats.

Etiology / risk factors: Trauma, surgery, pain, fear, acute illness.

Pathophysiologic mechanism: SAM and HPA activation increase perfusion, alertness, glucose availability, and inflammatory coordination.

Progression: Usually resolves after threat removal.

Clinical manifestations: Transient tachycardia, BP elevation, hyperglycemia, vigilance.

Diagnostics / labs / imaging: Clinical observation; vitals; labs based on illness.

Complications: Decompensation in patients with limited cardiac/metabolic reserve.

Treatment categories: Treat underlying acute illness/stressor.

Medical-record relevance: Acute physiologic stress should be separated from chronic stress disorders.

Related terminology: acute stress

Related anatomy: Autonomic nervous system; HPA axis

Source: StatPearls — Physiology, Stress Reaction

Chronic stress physiologyNeuroendocrine / multisystem · NEW

Normal function anchor: Stress systems normally deactivate after recovery.

Etiology / risk factors: Persistent or repeated stress exposure.

Pathophysiologic mechanism: Repeated neuroendocrine/autonomic activation alters metabolic, immune, cardiovascular, and sleep regulation.

Progression: Cumulative effects can persist after individual stress episodes.

Clinical manifestations: Sleep disturbance, fatigue, BP/glucose changes, mood/cognitive symptoms.

Diagnostics / labs / imaging: History; disease-specific labs/vitals rather than a single stress biomarker.

Complications: Hypertension, metabolic disease, immune dysregulation, functional decline.

Treatment categories: Stress reduction plus treatment of resulting conditions.

Medical-record relevance: Document established conditions rather than attributing all abnormalities to stress alone.

Related terminology: chronic stress

Related anatomy: Multisystem

Source: StatPearls — Physiology, Stress Reaction

Allostatic loadMultisystem · NEW

Normal function anchor: Adaptive systems return toward baseline after challenge.

Etiology / risk factors: Frequent or prolonged physiologic demands.

Pathophysiologic mechanism: Cumulative wear from repeated adaptation affects cardiovascular, metabolic, neuroendocrine, and immune systems.

Progression: Burden increases when recovery is incomplete.

Clinical manifestations: No single specific symptom; manifests through multiple chronic conditions.

Diagnostics / labs / imaging: No single routine diagnostic test; assessed through clinical risk factors/biomarkers in research contexts.

Complications: Chronic disease burden and reduced reserve.

Treatment categories: Risk-factor and disease-specific management.

Medical-record relevance: Useful conceptual framework; not a routine standalone clinical diagnosis.

Related terminology: allostasis; allostatic load

Related anatomy: Multisystem

Source: StatPearls — Physiology, Stress Reaction

Stress-induced hyperglycemiaEndocrine / metabolic · CROSS-LINK

Normal function anchor: Insulin and counter-regulatory hormones maintain glucose.

Etiology / risk factors: Acute severe illness, trauma, surgery, catecholamine/cortisol surge.

Pathophysiologic mechanism: Counter-regulatory hormones increase hepatic glucose output and insulin resistance.

Progression: May resolve with recovery or reveal underlying dysglycemia.

Clinical manifestations: Elevated glucose; often asymptomatic.

Diagnostics / labs / imaging: Serum glucose; HbA1c helps distinguish chronic baseline elevation.

Complications: Infection risk, osmotic diuresis, worse outcomes in severe illness.

Treatment categories: Glycemic management appropriate to clinical context.

Medical-record relevance: Differentiate transient stress hyperglycemia from established diabetes.

Related terminology: stress hyperglycemia

Related anatomy: Liver; pancreas; adrenal glands

Source: StatPearls — Physiology, Stress Reaction

Stress-related insulin resistanceMetabolic / endocrine · CROSS-LINK

Normal function anchor: Insulin promotes glucose uptake and storage.

Etiology / risk factors: Catecholamines, cortisol, inflammatory cytokines, chronic stress.

Pathophysiologic mechanism: Stress hormones reduce insulin sensitivity and increase hepatic glucose production.

Progression: Can be transient or contribute to chronic metabolic dysfunction.

Clinical manifestations: Hyperglycemia, metabolic syndrome features.

Diagnostics / labs / imaging: Glucose; HbA1c; disease-specific metabolic evaluation.

Complications: Type 2 diabetes risk, vascular disease.

Treatment categories: Lifestyle and disease-specific metabolic management.

Medical-record relevance: Mechanism may explain glucose elevation without replacing a diabetes diagnosis.

Related terminology: insulin resistance

Related anatomy: Pancreas; liver; skeletal muscle

Source: StatPearls — Physiology, Stress Reaction

Stress and immune modulationNeuroendocrine / immune · CROSS-LINK

Normal function anchor: Neural, endocrine, and immune systems communicate bidirectionally.

Etiology / risk factors: Acute or chronic stress.

Pathophysiologic mechanism: Catecholamines and glucocorticoids alter cytokine production, leukocyte trafficking, and immune activity.

Progression: Acute effects may be adaptive; chronic exposure can impair or dysregulate immunity.

Clinical manifestations: Variable infection/inflammatory patterns.

Diagnostics / labs / imaging: CBC/inflammatory markers only as clinically indicated.

Complications: Infection susceptibility or inflammatory dysregulation.

Treatment categories: Treat underlying disease and reduce prolonged stress exposure where relevant.

Medical-record relevance: Stress is a modifier, not a substitute for a specific immune diagnosis.

Related terminology: psychoneuroimmunology

Related anatomy: Immune system; HPA axis

Source: StatPearls — Physiology, Stress Reaction

Stress and inflammatory signalingNeuroendocrine / immune · NEW

Normal function anchor: Inflammation normally resolves after threat removal.

Etiology / risk factors: Repeated stress plus inflammatory or behavioral risk factors.

Pathophysiologic mechanism: Chronic stress can alter cytokine regulation and glucocorticoid responsiveness.

Progression: Low-grade inflammatory patterns may persist in some contexts.

Clinical manifestations: Nonspecific fatigue/pain or disease-specific manifestations.

Diagnostics / labs / imaging: CRP/ESR are nonspecific and interpreted within disease context.

Complications: Cardiometabolic and inflammatory disease associations.

Treatment categories: Treat established disease and contributing risk factors.

Medical-record relevance: Avoid coding inflammation solely from stress without clinical diagnosis.

Related terminology: stress inflammation

Related anatomy: Cytokine networks

Source: StatPearls — Physiology, Stress Reaction

Stress-related cardiovascular loadCardiovascular / autonomic · CROSS-LINK

Normal function anchor: Cardiac output and vascular tone match normal demand.

Etiology / risk factors: Repeated sympathetic activation, chronic stress, poor recovery.

Pathophysiologic mechanism: Heart rate, BP, vascular tone, and metabolic demand rise repeatedly.

Progression: Can exacerbate hypertension or ischemia in predisposed patients.

Clinical manifestations: Palpitations, BP elevation, chest discomfort in some individuals.

Diagnostics / labs / imaging: Vitals; ECG; cardiac testing based on symptoms/risk.

Complications: Arrhythmia, hypertension, ischemic events in vulnerable patients.

Treatment categories: Treat cardiovascular disease and stress-related triggers.

Medical-record relevance: Cardiovascular diagnoses require standard clinical evidence beyond stress exposure.

Related terminology: sympathetic load

Related anatomy: Heart; vessels

Source: StatPearls — Physiology, Stress Reaction

Stress and sleep disruptionNeurologic / endocrine · CROSS-LINK

Normal function anchor: Circadian and sleep systems support restoration and hormonal regulation.

Etiology / risk factors: Psychological stress, illness, hyperarousal, irregular schedule.

Pathophysiologic mechanism: Heightened arousal and altered HPA/autonomic signaling interfere with sleep initiation and maintenance.

Progression: Sleep loss can further amplify stress signaling.

Clinical manifestations: Insomnia, nonrestorative sleep, daytime fatigue.

Diagnostics / labs / imaging: Sleep history; formal sleep study when another sleep disorder suspected.

Complications: Cognitive impairment, metabolic and mood effects.

Treatment categories: Sleep hygiene and disorder-specific management.

Medical-record relevance: Document insomnia or sleep disorder when clinically established, not simply stress exposure.

Related terminology: hyperarousal; insomnia

Related anatomy: Brain; circadian system

Source: StatPearls — Physiology, Stress Reaction

Stress and gastrointestinal functionGI / autonomic · CROSS-LINK

Normal function anchor: Autonomic and enteric systems coordinate motility, secretion, and visceral sensation.

Etiology / risk factors: Acute/chronic stress, anxiety, illness.

Pathophysiologic mechanism: Autonomic and HPA changes alter motility, permeability, secretion, and visceral sensitivity.

Progression: Symptoms may fluctuate with stress but still require evaluation for organic disease.

Clinical manifestations: Nausea, bowel changes, abdominal discomfort.

Diagnostics / labs / imaging: History; labs/endoscopy/imaging based on red flags.

Complications: Dehydration, nutrition impact, delayed recognition of organic disease.

Treatment categories: Symptom- and disease-specific management.

Medical-record relevance: Stress association should not replace evaluation/documentation of GI diagnoses.

Related terminology: brain-gut axis

Related anatomy: GI tract; enteric nervous system

Source: StatPearls — Physiology, Stress Reaction

Stress and pain amplificationNeurologic / sensory · NEW

Normal function anchor: Pain signaling is modulated by descending neural and endocrine systems.

Etiology / risk factors: Persistent stress, injury, chronic pain conditions.

Pathophysiologic mechanism: Stress-related arousal and central modulation can increase pain sensitivity and vigilance.

Progression: Can create feedback between pain, sleep loss, and stress.

Clinical manifestations: Heightened pain sensitivity or broader symptom burden.

Diagnostics / labs / imaging: Clinical pain assessment; condition-specific imaging/tests.

Complications: Functional impairment, chronic pain persistence.

Treatment categories: Multimodal pain and stress management.

Medical-record relevance: Pain severity and stress association are distinct documentation elements.

Related terminology: hyperalgesia; pain sensitization

Related anatomy: CNS; sensory pathways

Source: StatPearls — Physiology, Stress Reaction

Stress response in surgery and traumaSystemic / metabolic · NEW

Normal function anchor: Homeostasis responds to injury with controlled neuroendocrine and inflammatory changes.

Etiology / risk factors: Surgery, trauma, burns.

Pathophysiologic mechanism: Catecholamines, cortisol, inflammatory mediators, fluid shifts, and catabolism support immediate survival.

Progression: Magnitude tracks injury severity and complications.

Clinical manifestations: Tachycardia, hyperglycemia, catabolism, fluid/electrolyte changes.

Diagnostics / labs / imaging: Vitals, glucose, CBC, metabolic panels, injury-specific studies.

Complications: Infection, muscle loss, metabolic complications in prolonged critical illness.

Treatment categories: Resuscitation, analgesia, nutrition, complication management.

Medical-record relevance: Expected stress physiology should be distinguished from separately reportable complications.

Related terminology: surgical stress; trauma response

Related anatomy: Multisystem

Source: StatPearls — Physiology, Stress Reaction

Maladaptive stress responseNeuroendocrine / multisystem · NEW

Normal function anchor: Stress systems activate then terminate after challenge.

Etiology / risk factors: Prolonged, repetitive, or disproportionate activation; impaired recovery.

Pathophysiologic mechanism: Regulatory systems remain activated or become dysregulated, producing physiologic cost.

Progression: Can contribute to chronic disease or functional decline.

Clinical manifestations: Persistent sleep, autonomic, metabolic, cognitive, or inflammatory symptoms.

Diagnostics / labs / imaging: Clinical assessment; disease-specific evaluation.

Complications: Chronic disease burden and reduced resilience.

Treatment categories: Treat diagnosed disorders and contributing stressors.

Medical-record relevance: Use as mechanism/context; avoid replacing specific diagnoses with a broad label.

Related terminology: maladaptation

Related anatomy: Multisystem

Source: StatPearls — Physiology, Stress Reaction

Stress recovery / negative feedbackNeuroendocrine · A&P LINK

Normal function anchor: Cortisol and neural feedback shut down stress activation after threat resolves.

Etiology / risk factors: Resolution of stressor and intact feedback systems.

Pathophysiologic mechanism: HPA/autonomic output declines, restoring baseline metabolic and immune regulation.

Progression: Recovery time depends on stress intensity, duration, and health status.

Clinical manifestations: Normalization of vitals, sleep, appetite, and energy.

Diagnostics / labs / imaging: Trend clinical parameters; endocrine testing only if pathology suspected.

Complications: Delayed recovery can prolong physiologic strain.

Treatment categories: Support recovery and treat underlying conditions.

Medical-record relevance: Serial improvement helps distinguish transient stress physiology from persistent disease.

Related terminology: negative feedback; recovery

Related anatomy: HPA axis; autonomic system

Source: StatPearls — Physiology, Stress Reaction

Stress as disease modifierMultisystem · NEW

Normal function anchor: Established diseases have their own primary pathophysiology.

Etiology / risk factors: Stress exposure superimposed on chronic disease.

Pathophysiologic mechanism: Stress-related autonomic, endocrine, behavioral, and immune changes can alter symptom burden or disease control.

Progression: May trigger flares or worsen control without being the primary disease cause.

Clinical manifestations: Disease-specific exacerbation patterns.

Diagnostics / labs / imaging: Condition-specific measures plus stress history.

Complications: More frequent exacerbations, treatment burden.

Treatment categories: Manage primary disease and modifiable stress contributors.

Medical-record relevance: Record stress as a contributing factor only when clinically supported.

Related terminology: disease modifier

Related anatomy: Multisystem

Source: StatPearls — Physiology, Stress Reaction

Clinical stress findings versus diagnosisMedical record / neuroendocrine · NEW

Normal function anchor: Symptoms and physiologic findings require diagnostic synthesis.

Etiology / risk factors: Nonspecific symptoms such as tachycardia, fatigue, insomnia, hyperglycemia.

Pathophysiologic mechanism: Stress physiology can explain findings but does not establish a psychiatric, endocrine, or other disorder by itself.

Progression: Diagnosis depends on duration, context, criteria, and exclusion of alternatives.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: History, exam, validated criteria, targeted labs/tests.

Complications: Misclassification and missed medical causes.

Treatment categories: Evaluate underlying causes and document confirmed diagnoses.

Medical-record relevance: Direct bridge to documentation discipline: mechanism, symptom, and diagnosis are separate layers.

Related terminology: clinical indicator; stressor

Related anatomy: Medical record

Source: StatPearls — Physiology, Stress Reaction

Pathophysiology section 8

Fluid & Electrolyte Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Fluid volume depletionRenal / circulatory · CROSS-LINK

Normal function anchor: Total-body water and effective circulating volume support perfusion.

Etiology / risk factors: GI losses, renal losses, hemorrhage, poor intake, third spacing.

Pathophysiologic mechanism: Loss of extracellular fluid reduces venous return and tissue perfusion.

Progression: May progress from compensated volume loss to hypotension and organ hypoperfusion.

Clinical manifestations: Thirst, orthostasis, tachycardia, dry mucosa, low urine output.

Diagnostics / labs / imaging: Vitals; BMP; BUN/creatinine; urine studies; clinical volume assessment.

Complications: AKI, shock, electrolyte abnormalities.

Treatment categories: Replace volume and treat cause.

Medical-record relevance: Distinguish volume depletion from hypernatremia; they may coexist but are not identical.

Related terminology: hypovolemia; dehydration

Related anatomy: Extracellular fluid; vasculature

Source: StatPearls — Physiology, Body Fluids

DehydrationFluid balance · MED TERM LINK

Normal function anchor: Water intake and renal conservation maintain total-body water.

Etiology / risk factors: Poor intake, GI/renal/insensible losses, impaired access to water.

Pathophysiologic mechanism: Net water loss raises osmolality and can reduce extracellular volume.

Progression: Severity depends on amount/rate of loss and sodium balance.

Clinical manifestations: Thirst, weakness, dry mucosa, altered mentation in severe cases.

Diagnostics / labs / imaging: Serum sodium/osmolality; BUN/creatinine; urine concentration; exam.

Complications: AKI, shock, hypernatremia, delirium.

Treatment categories: Oral/IV fluid replacement based on severity and cause.

Medical-record relevance: Document dehydration separately from specific sodium disorder when both are present.

Related terminology: dehydration

Related anatomy: Total body water

Source: StatPearls — Physiology, Body Fluids

Fluid volume overloadRenal / cardiovascular · CROSS-LINK

Normal function anchor: Kidneys and hormones regulate sodium/water excretion.

Etiology / risk factors: Heart failure, kidney failure, cirrhosis, excessive IV fluids, sodium retention.

Pathophysiologic mechanism: Sodium and water accumulate in vascular/interstitial compartments.

Progression: Can progress to peripheral or pulmonary edema.

Clinical manifestations: Weight gain, edema, dyspnea, elevated venous pressure.

Diagnostics / labs / imaging: Weights; exam; BMP; BNP and imaging when cardiac cause suspected.

Complications: Pulmonary edema, impaired oxygenation, skin breakdown.

Treatment categories: Treat cause; diuresis/fluid-sodium management when indicated.

Medical-record relevance: Volume overload is a state; underlying cardiac/renal/hepatic cause should be specified.

Related terminology: hypervolemia; fluid overload

Related anatomy: Vasculature; interstitium

Source: StatPearls — Physiology, Body Fluids

EdemaInterstitial fluid balance · CROSS-LINK

Normal function anchor: Starling forces and lymphatics limit interstitial fluid accumulation.

Etiology / risk factors: Raised hydrostatic pressure, low oncotic pressure, increased permeability, lymphatic obstruction, sodium/water retention.

Pathophysiologic mechanism: Net filtration exceeds lymphatic return, expanding interstitial fluid.

Progression: Localized or generalized depending on cause.

Clinical manifestations: Swelling, pitting, weight gain; organ-specific effects such as dyspnea.

Diagnostics / labs / imaging: Exam; weights; albumin; renal/cardiac/hepatic tests; imaging as indicated.

Complications: Skin breakdown, impaired mobility, pulmonary compromise.

Treatment categories: Treat underlying cause; fluid/sodium/diuretic strategies when appropriate.

Medical-record relevance: Distribution and cause are key documentation elements.

Related terminology: edema; anasarca

Related anatomy: Interstitium; capillaries; lymphatics

Source: StatPearls — Physiology, Edema

Hydrostatic edemaCardiovascular / fluid · NEW

Normal function anchor: Capillary pressure is balanced against oncotic and interstitial forces.

Etiology / risk factors: Heart failure, venous obstruction, volume expansion.

Pathophysiologic mechanism: Elevated capillary hydrostatic pressure pushes fluid into interstitial spaces.

Progression: Persists while venous pressure/volume remains high.

Clinical manifestations: Dependent edema, pulmonary edema depending on site.

Diagnostics / labs / imaging: Exam; echo/BNP or venous studies based on cause.

Complications: Skin changes, pulmonary congestion, impaired mobility.

Treatment categories: Treat cardiac/venous/volume cause.

Medical-record relevance: Mechanism helps connect edema pattern to underlying diagnosis.

Related terminology: hydrostatic pressure

Related anatomy: Capillaries; veins

Source: StatPearls — Physiology, Edema

Low-oncotic-pressure edemaHepatic / renal / nutritional · CROSS-LINK

Normal function anchor: Plasma proteins, especially albumin, retain water intravascularly.

Etiology / risk factors: Cirrhosis, nephrotic protein loss, severe malnutrition, protein-losing states.

Pathophysiologic mechanism: Reduced plasma oncotic pressure favors fluid movement into interstitium.

Progression: May become generalized with ascites/anasarca.

Clinical manifestations: Peripheral edema, ascites, weight gain.

Diagnostics / labs / imaging: Serum albumin; liver/renal tests; urine protein.

Complications: Skin breakdown, effusions, reduced effective circulating volume.

Treatment categories: Treat underlying protein-loss/synthesis disorder.

Medical-record relevance: Low albumin is a contributor; record should specify cause when known.

Related terminology: oncotic pressure; hypoalbuminemia

Related anatomy: Plasma; interstitium

Source: StatPearls — Physiology, Edema

Lymphatic edemaLymphatic · CROSS-LINK

Normal function anchor: Lymphatics return filtered fluid/proteins to circulation.

Etiology / risk factors: Lymph node removal, malignancy, infection, congenital lymphatic dysfunction.

Pathophysiologic mechanism: Impaired lymph drainage causes protein-rich interstitial fluid accumulation.

Progression: Often chronic and can fibrose over time.

Clinical manifestations: Persistent limb or regional swelling.

Diagnostics / labs / imaging: Clinical exam; ultrasound or lymphatic imaging in selected cases.

Complications: Fibrosis, skin infection, functional impairment.

Treatment categories: Compression, lymphatic therapy, treat cause.

Medical-record relevance: Lymphedema should be distinguished from venous or systemic edema.

Related terminology: lymphedema

Related anatomy: Lymphatic vessels/nodes

Source: StatPearls — Physiology, Edema

HyponatremiaElectrolyte / neurologic · NEW

Normal function anchor: Serum sodium reflects water balance relative to exchangeable sodium/potassium.

Etiology / risk factors: Water excess, sodium loss, impaired water excretion, SIADH, diuretics, volume disorders.

Pathophysiologic mechanism: Low serum sodium usually reflects excess water relative to sodium; hypotonicity drives water into cells.

Progression: Acute/severe drops cause more neurologic risk; chronic cases allow partial cerebral adaptation.

Clinical manifestations: Nausea, headache, confusion, seizures in severe cases.

Diagnostics / labs / imaging: Serum sodium/osmolality; urine osmolality; urine sodium; volume status; medication review.

Complications: Cerebral edema, seizures; overly rapid correction can cause osmotic demyelination.

Treatment categories: Cause- and symptom-specific correction with close monitoring.

Medical-record relevance: Document sodium value, acuity, symptoms, and underlying cause when established.

Related terminology: hyponatremia

Related anatomy: Extracellular fluid; brain

Source: StatPearls — Hyponatremia

Hypotonic hyponatremiaElectrolyte / neurologic · NEW

Normal function anchor: Plasma tonicity is maintained in a narrow range.

Etiology / risk factors: Excess free water relative to solute.

Pathophysiologic mechanism: Low effective osmolality causes water movement into cells.

Progression: Severity depends on sodium level and rate of fall.

Clinical manifestations: Neurologic symptoms if significant.

Diagnostics / labs / imaging: Serum osmolality confirms hypotonicity; urine studies classify mechanism.

Complications: Cerebral edema, seizures.

Treatment categories: Treat based on volume status, cause, and symptoms.

Medical-record relevance: Separates true hypotonic hyponatremia from isotonic/hypertonic laboratory patterns.

Related terminology: hypotonicity

Related anatomy: Plasma; brain

Source: StatPearls — Hyponatremia

SIADH patternEndocrine / renal · CROSS-LINK

Normal function anchor: ADH is suppressed when plasma is dilute.

Etiology / risk factors: CNS/pulmonary disease, medications, malignancy, other triggers.

Pathophysiologic mechanism: Inappropriately persistent ADH causes water retention with concentrated urine and dilutional hyponatremia.

Progression: Usually euvolemic clinically unless another process coexists.

Clinical manifestations: Mild symptoms to confusion/seizure depending on severity.

Diagnostics / labs / imaging: Low serum osmolality; inappropriately concentrated urine; urine sodium; exclusion of thyroid/adrenal/renal causes.

Complications: Severe hyponatremia, neurologic injury.

Treatment categories: Fluid restriction and cause-specific therapy; hypertonic saline for severe symptomatic cases.

Medical-record relevance: SIADH requires a diagnostic pattern; hyponatremia alone is insufficient.

Related terminology: SIADH; ADH

Related anatomy: Hypothalamus; kidney collecting ducts

Source: StatPearls — Hyponatremia

HypernatremiaElectrolyte / neurologic · NEW

Normal function anchor: Thirst and ADH maintain water relative to sodium.

Etiology / risk factors: Net water loss, impaired access to water, diabetes insipidus, osmotic losses, sodium gain.

Pathophysiologic mechanism: High serum sodium reflects hypertonicity, drawing water out of cells.

Progression: Neurologic risk increases with severity/rate; chronic cases partially adapt.

Clinical manifestations: Thirst, weakness, confusion, seizures in severe cases.

Diagnostics / labs / imaging: Serum sodium/osmolality; urine osmolality; volume status.

Complications: Intracranial bleeding, seizures; overly rapid correction can cause cerebral edema.

Treatment categories: Restore water and volume carefully; treat cause.

Medical-record relevance: Document cause and acute/chronic context when known.

Related terminology: hypernatremia; hypertonicity

Related anatomy: Extracellular fluid; brain

Source: StatPearls — Hypernatremia

Free-water deficitFluid / electrolyte · CROSS-LINK

Normal function anchor: Water intake and renal conservation match losses.

Etiology / risk factors: Insufficient intake, diabetes insipidus, fever, osmotic diuresis, GI losses.

Pathophysiologic mechanism: Water loss exceeds sodium loss, concentrating extracellular sodium.

Progression: Can cause hypernatremia and hypovolemia.

Clinical manifestations: Thirst, dry mucosa, neurologic changes.

Diagnostics / labs / imaging: Sodium/osmolality; urine output/osmolality; clinical volume assessment.

Complications: AKI, neurologic injury.

Treatment categories: Replace free water and treat cause.

Medical-record relevance: Useful mechanism connecting dehydration to hypernatremia.

Related terminology: free water

Related anatomy: Total body water

Source: StatPearls — Hypernatremia

HypokalemiaElectrolyte / neuromuscular / cardiac · NEW

Normal function anchor: Potassium maintains resting membrane potential and muscle/nerve function.

Etiology / risk factors: GI loss, renal loss, diuretics, low intake, intracellular shift, mineralocorticoid excess.

Pathophysiologic mechanism: Reduced extracellular potassium hyperpolarizes excitable membranes and alters cardiac repolarization.

Progression: Risk rises with severity and rapid onset.

Clinical manifestations: Weakness, cramps, constipation, palpitations; severe cases paralysis/arrhythmia.

Diagnostics / labs / imaging: Serum potassium; magnesium; ECG; urine potassium when cause unclear.

Complications: Arrhythmias, rhabdomyolysis, respiratory weakness.

Treatment categories: Potassium replacement and cause correction; magnesium correction if needed.

Medical-record relevance: Severity, ECG effects, and cause matter clinically.

Related terminology: hypokalemia

Related anatomy: Cell membranes; muscle; heart

Source: StatPearls — Hypokalemia

HyperkalemiaElectrolyte / cardiac / renal · NEW

Normal function anchor: Kidneys excrete potassium and cells buffer extracellular potassium.

Etiology / risk factors: AKI/CKD, hypoaldosteronism, medications, tissue breakdown, acidosis, excessive intake in susceptible patients.

Pathophysiologic mechanism: Excess extracellular potassium depolarizes membranes and disrupts cardiac conduction.

Progression: Can progress rapidly to life-threatening arrhythmia.

Clinical manifestations: Weakness, paresthesia, palpitations; may be asymptomatic.

Diagnostics / labs / imaging: Repeat serum potassium to exclude artifact; ECG; renal function; medication review.

Complications: Malignant arrhythmia, cardiac arrest.

Treatment categories: Cardiac membrane stabilization, intracellular shift, potassium removal, cause correction as indicated.

Medical-record relevance: Confirm true hyperkalemia and distinguish from pseudohyperkalemia.

Related terminology: hyperkalemia

Related anatomy: Kidney; myocardium

Source: StatPearls — Hyperkalemia

PseudohyperkalemiaLaboratory / electrolyte · NEW

Normal function anchor: Measured serum potassium should reflect circulating plasma concentration.

Etiology / risk factors: Hemolysis, difficult draw, extreme thrombocytosis/leukocytosis, specimen handling.

Pathophysiologic mechanism: Potassium is released from cells after or during collection, producing a falsely elevated result.

Progression: Resolves on properly collected repeat specimen.

Clinical manifestations: Usually no true hyperkalemic symptoms/ECG changes.

Diagnostics / labs / imaging: Repeat nonhemolyzed plasma/serum potassium; correlate ECG.

Complications: Unnecessary treatment if misinterpreted.

Treatment categories: Repeat/verify rather than treating artifact.

Medical-record relevance: Important clinical-indicator versus diagnosis distinction.

Related terminology: pseudohyperkalemia

Related anatomy: Blood specimen

Source: StatPearls — Hyperkalemia

Potassium shift disorderElectrolyte / metabolic · CROSS-LINK

Normal function anchor: Potassium is predominantly intracellular with regulated transcellular exchange.

Etiology / risk factors: Insulin changes, beta-adrenergic effects, acid-base changes, cell breakdown.

Pathophysiologic mechanism: Potassium moves between intracellular and extracellular compartments without equivalent change in total-body stores.

Progression: Can change rapidly as metabolic state changes.

Clinical manifestations: Weakness or arrhythmia depending on direction/severity.

Diagnostics / labs / imaging: Serum potassium; glucose; acid-base tests; ECG.

Complications: Arrhythmia; rebound abnormality after correction.

Treatment categories: Treat underlying shift and monitor replacement/removal carefully.

Medical-record relevance: Distinguish redistribution from true potassium depletion/excess.

Related terminology: transcellular shift

Related anatomy: Intracellular fluid; extracellular fluid

Source: StatPearls — Hypokalemia

Third spacingFluid balance / interstitial · NEW

Normal function anchor: Fluid is distributed between vascular and interstitial spaces while maintaining effective perfusion.

Etiology / risk factors: Inflammation, burns, pancreatitis, capillary leak, hypoalbuminemia.

Pathophysiologic mechanism: Fluid leaves effective circulating space and accumulates in interstitial or body-cavity compartments.

Progression: Patient can be edematous yet intravascularly depleted.

Clinical manifestations: Edema/ascites with tachycardia, hypotension, low urine output depending on severity.

Diagnostics / labs / imaging: Exam; weights; labs; ultrasound/imaging based on site.

Complications: Hypoperfusion, AKI, respiratory compromise.

Treatment categories: Treat underlying cause and manage intravascular volume carefully.

Medical-record relevance: Explains why visible fluid excess does not always equal adequate circulating volume.

Related terminology: third spacing

Related anatomy: Vasculature; interstitium; body cavities

Source: StatPearls — Physiology, Body Fluids

Pulmonary edemaPulmonary / cardiovascular · CROSS-LINK

Normal function anchor: Alveoli remain relatively dry to permit gas exchange.

Etiology / risk factors: Elevated pulmonary hydrostatic pressure, permeability injury, renal/volume overload.

Pathophysiologic mechanism: Fluid accumulates in lung interstitium/alveoli, increasing diffusion distance and reducing compliance.

Progression: Can rapidly impair oxygenation.

Clinical manifestations: Dyspnea, orthopnea, crackles, hypoxemia.

Diagnostics / labs / imaging: Pulse oximetry; chest imaging; cardiac/renal evaluation.

Complications: Respiratory failure.

Treatment categories: Treat underlying cardiac/renal/permeability cause; oxygen/diuresis/ventilatory support as indicated.

Medical-record relevance: Specify cardiogenic versus noncardiogenic cause when established.

Related terminology: pulmonary edema

Related anatomy: Pulmonary interstitium; alveoli

Source: StatPearls — Physiology, Body Fluids

Electrolyte disturbance and cardiac conductionCardiac / electrolyte · CROSS-LINK

Normal function anchor: Ion gradients generate myocardial action potentials.

Etiology / risk factors: Potassium, calcium, magnesium abnormalities; severe sodium/osmolality disturbances.

Pathophysiologic mechanism: Altered ion gradients change depolarization/repolarization and conduction.

Progression: Arrhythmia risk rises with severity and comorbid cardiac disease.

Clinical manifestations: Palpitations, syncope, weakness, or asymptomatic ECG changes.

Diagnostics / labs / imaging: Electrolytes; ECG; telemetry when severe.

Complications: Ventricular arrhythmia, cardiac arrest.

Treatment categories: Correct electrolyte disorder and underlying cause.

Medical-record relevance: Links lab abnormalities to medical necessity for ECG/monitoring without equating every abnormal value to arrhythmia.

Related terminology: electrolyte imbalance; conduction

Related anatomy: Myocardium

Source: StatPearls — Hyperkalemia

Volume status versus electrolyte concentrationFluid / medical record · NEW

Normal function anchor: Volume, tonicity, and electrolyte concentrations are related but distinct physiologic dimensions.

Etiology / risk factors: Renal, endocrine, GI, cardiac, hepatic, medication, and intake factors.

Pathophysiologic mechanism: A patient may have sodium/potassium abnormality with low, normal, or high extracellular volume depending on mechanism.

Progression: Classification directs diagnostic reasoning and treatment.

Clinical manifestations: Manifestations vary by combination.

Diagnostics / labs / imaging: Vitals/exam; serum electrolytes/osmolality; urine studies; weights; renal function.

Complications: Misclassification can worsen electrolyte or volume disturbance.

Treatment categories: Treat both the concentration disorder and the underlying volume/cause pattern.

Medical-record relevance: Foundational bridge for interpreting labs without collapsing findings into the wrong diagnosis.

Related terminology: volume status; tonicity; electrolyte concentration

Related anatomy: Body-fluid compartments

Source: StatPearls — Physiology, Body Fluids

Pathophysiology section 9

Acid-Base Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

AcidemiaAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Excess acid generation, reduced acid excretion, or CO2 retention

Pathophysiologic mechanism: Arterial pH falls below the physiologic range when acid load exceeds buffering and compensatory capacity.

Progression: May be acute or chronic; compensation depends on primary process.

Clinical manifestations: Neurologic, cardiovascular, respiratory manifestations vary with severity.

Diagnostics / labs / imaging: ABG/VBG, electrolytes, bicarbonate, PaCO2, anion gap.

Complications: Arrhythmia, hemodynamic instability, reduced contractility in severe states.

Treatment categories: Correct underlying disorder and support ventilation/perfusion as needed.

Medical-record relevance: Overall pH state should be distinguished from the primary acidosis process.

Related terminology: acidemia

Related anatomy: Blood; lungs; kidneys

Source: StatPearls — Physiology, Acid Base Balance

AlkalemiaAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Loss of acid, gain of base, or excessive CO2 elimination

Pathophysiologic mechanism: Arterial pH rises when alkalinizing forces exceed buffering and compensation.

Progression: May be acute or chronic; compensation is incomplete.

Clinical manifestations: Paresthesia, cramps, lightheadedness, arrhythmia with severe disturbance.

Diagnostics / labs / imaging: ABG/VBG, electrolytes, bicarbonate, PaCO2.

Complications: Arrhythmia, reduced ionized calcium effects, neurologic symptoms.

Treatment categories: Treat underlying cause and correct volume/electrolyte abnormalities when indicated.

Medical-record relevance: Overall pH state is not synonymous with a single primary alkalosis process.

Related terminology: alkalemia

Related anatomy: Blood; lungs; kidneys

Source: StatPearls — Physiology, Acid Base Balance

Metabolic acidosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Acid accumulation or bicarbonate loss

Pathophysiologic mechanism: Primary fall in bicarbonate lowers pH; lungs compensate by lowering PaCO2.

Progression: Severity and compensation depend on cause and renal/respiratory reserve.

Clinical manifestations: Tachypnea, fatigue, altered mental status in severe cases.

Diagnostics / labs / imaging: Electrolytes, bicarbonate, anion gap, blood gas, lactate/ketones/renal tests.

Complications: Shock, arrhythmia, bone/mineral effects if chronic.

Treatment categories: Treat cause; bicarbonate only in selected severe contexts.

Medical-record relevance: Document underlying cause such as DKA, lactic acidosis, renal failure, or bicarbonate loss when known.

Related terminology: metabolic acidosis

Related anatomy: Kidneys; blood

Source: StatPearls — Physiology, Acid Base Balance

High-anion-gap metabolic acidosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Accumulation of unmeasured acids such as lactate, ketones, toxins, renal acids

Pathophysiologic mechanism: Unmeasured anions increase as bicarbonate buffers excess acid.

Progression: Gap may evolve with treatment and mixed disorders.

Clinical manifestations: Cause-specific symptoms plus compensatory tachypnea.

Diagnostics / labs / imaging: Electrolytes, calculated anion gap, lactate, ketones, renal function, toxicology as indicated.

Complications: Severe acidemia and organ dysfunction.

Treatment categories: Cause-directed therapy and supportive care.

Medical-record relevance: Anion gap is a calculation supporting etiology, not a standalone disease.

Related terminology: anion gap

Related anatomy: Plasma

Source: StatPearls — Physiology, Acid Base Balance

Normal-anion-gap metabolic acidosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Bicarbonate loss or impaired acid excretion with chloride retention

Pathophysiologic mechanism: Bicarbonate falls while chloride rises, keeping anion gap near normal.

Progression: Can persist with GI loss or renal tubular disorders.

Clinical manifestations: Weakness, tachypnea, cause-specific symptoms.

Diagnostics / labs / imaging: Electrolytes, blood gas, urine studies, renal function.

Complications: Volume depletion, potassium abnormalities.

Treatment categories: Treat underlying GI/renal cause and replace deficits as indicated.

Medical-record relevance: Hyperchloremic acidosis should be distinguished from high-gap acidosis.

Related terminology: hyperchloremic acidosis

Related anatomy: Kidneys; GI tract

Source: StatPearls — Physiology, Acid Base Balance

Lactic acidosisAcid-base / multisystem · CROSS-LINK

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Tissue hypoperfusion, severe illness, hypoxia, drugs, impaired clearance

Pathophysiologic mechanism: Lactate production exceeds utilization/clearance, consuming bicarbonate.

Progression: May resolve with restored perfusion or persist with ongoing disease.

Clinical manifestations: Tachypnea, hypotension, altered mentation depending on cause.

Diagnostics / labs / imaging: Serum lactate, blood gas, hemodynamics, organ-function tests.

Complications: Shock, multiorgan failure.

Treatment categories: Restore perfusion/oxygenation and treat underlying cause.

Medical-record relevance: Lactate is a severity/etiology indicator and must be interpreted in context.

Related terminology: lactic acidosis

Related anatomy: Muscle; liver; circulation

Source: StatPearls — Arterial Blood Gas Analysis

KetoacidosisAcid-base / multisystem · CROSS-LINK

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Insulin deficiency/starvation/alcohol-related metabolic shift

Pathophysiologic mechanism: Excess ketone production generates organic acids and depletes bicarbonate.

Progression: Can progress rapidly in diabetic ketoacidosis.

Clinical manifestations: Polyuria, dehydration, nausea, abdominal pain, Kussmaul breathing.

Diagnostics / labs / imaging: Glucose, beta-hydroxybutyrate/ketones, electrolytes, anion gap, blood gas.

Complications: Potassium shifts, cerebral edema in selected patients, shock.

Treatment categories: Fluids, insulin and electrolyte management for DKA; cause-specific therapy otherwise.

Medical-record relevance: Distinguish ketosis from ketoacidosis and identify subtype.

Related terminology: ketoacidosis

Related anatomy: Liver; adipose; blood

Source: StatPearls — Type 2 Diabetes

Renal acid retentionAcid-base / multisystem · CROSS-LINK

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Reduced nephron function or tubular acid excretion defects

Pathophysiologic mechanism: Hydrogen ion excretion and bicarbonate regeneration become inadequate.

Progression: May accompany CKD or renal tubular acidosis.

Clinical manifestations: Often nonspecific until advanced.

Diagnostics / labs / imaging: Bicarbonate, creatinine/eGFR, urine pH and urine electrolytes when indicated.

Complications: Bone disease, muscle effects, progression of chronic metabolic complications.

Treatment categories: Treat renal cause; alkali therapy in selected patients.

Medical-record relevance: Link acidosis to renal diagnosis when clinically established.

Related terminology: renal acidosis

Related anatomy: Kidneys

Source: StatPearls — Physiology, Acid Base Balance

Bicarbonate lossAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Diarrhea, fistula, pancreatic/intestinal losses, renal tubular defects

Pathophysiologic mechanism: Loss of bicarbonate lowers buffering capacity and produces hyperchloremic acidosis.

Progression: Continues while losses persist.

Clinical manifestations: GI symptoms, dehydration, weakness.

Diagnostics / labs / imaging: Electrolytes, bicarbonate, blood gas, urine studies if renal cause suspected.

Complications: Volume and potassium depletion.

Treatment categories: Replace fluids/electrolytes and treat source.

Medical-record relevance: Record source of loss when known.

Related terminology: bicarbonate loss

Related anatomy: GI tract; kidneys

Source: StatPearls — Physiology, Acid Base Balance

Respiratory acidosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Alveolar hypoventilation

Pathophysiologic mechanism: CO2 retention increases carbonic acid and lowers pH.

Progression: Acute cases have limited renal compensation; chronic cases increase bicarbonate retention.

Clinical manifestations: Dyspnea, somnolence, headache, confusion in severe hypercapnia.

Diagnostics / labs / imaging: Blood gas, pulse oximetry, respiratory evaluation.

Complications: CO2 narcosis, respiratory failure, arrhythmia.

Treatment categories: Restore adequate ventilation and treat cause.

Medical-record relevance: Hypercapnia plus low pH supports acute respiratory acidosis; chronic compensation changes bicarbonate.

Related terminology: hypercapnia; respiratory acidosis

Related anatomy: Lungs; brainstem; kidneys

Source: StatPearls — Respiratory Acidosis

Acute respiratory acidosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Sudden ventilatory failure from CNS depression, neuromuscular weakness, airway/lung disease

Pathophysiologic mechanism: Rapid CO2 accumulation lowers pH before kidneys can significantly retain bicarbonate.

Progression: Can deteriorate quickly if ventilation is not restored.

Clinical manifestations: Altered mental status, dyspnea, hypoxemia.

Diagnostics / labs / imaging: ABG/VBG, respiratory mechanics, toxicology/imaging as indicated.

Complications: Respiratory arrest, severe acidemia.

Treatment categories: Urgent ventilation support and reversal/treatment of cause.

Medical-record relevance: Acute versus chronic status affects expected bicarbonate compensation.

Related terminology: acute hypercapnia

Related anatomy: Lungs

Source: StatPearls — Respiratory Acidosis

Chronic respiratory acidosisAcid-base / multisystem · CROSS-LINK

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Long-standing hypoventilation such as COPD or neuromuscular/chest-wall disease

Pathophysiologic mechanism: Persistent CO2 retention triggers renal bicarbonate retention over days.

Progression: pH may approach normal despite elevated PaCO2.

Clinical manifestations: Morning headache, somnolence, chronic respiratory symptoms.

Diagnostics / labs / imaging: Blood gas, bicarbonate, spirometry/sleep/neuromuscular evaluation as indicated.

Complications: Pulmonary hypertension, acute-on-chronic respiratory failure.

Treatment categories: Treat chronic ventilatory disorder; oxygen/ventilation strategies as indicated.

Medical-record relevance: Compensated values should not be mistaken for absence of chronic respiratory disease.

Related terminology: chronic hypercapnia

Related anatomy: Lungs; kidneys

Source: StatPearls — Respiratory Acidosis

Respiratory alkalosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Excess alveolar ventilation

Pathophysiologic mechanism: CO2 falls, shifting carbonic acid equilibrium and raising pH.

Progression: Kidneys lower bicarbonate in chronic cases.

Clinical manifestations: Lightheadedness, paresthesia, chest discomfort, tetany.

Diagnostics / labs / imaging: Blood gas plus evaluation for hypoxemia, pain, sepsis, pregnancy, CNS/drug causes.

Complications: Arrhythmia, reduced cerebral blood flow when severe.

Treatment categories: Treat driver of hyperventilation.

Medical-record relevance: Do not attribute all low PaCO2 to anxiety; evaluate underlying cause.

Related terminology: hypocapnia; respiratory alkalosis

Related anatomy: Lungs; CNS

Source: StatPearls — Physiology, Acid Base Balance

Metabolic alkalosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Hydrogen loss, bicarbonate retention, chloride/volume depletion, mineralocorticoid excess

Pathophysiologic mechanism: Elevated bicarbonate raises pH; hypoventilation provides limited compensation.

Progression: Often maintained by volume/chloride/potassium depletion or reduced renal bicarbonate excretion.

Clinical manifestations: Weakness, cramps, arrhythmia, hypoventilation.

Diagnostics / labs / imaging: Electrolytes, urine chloride, blood gas, medication history.

Complications: Hypokalemia, arrhythmia, reduced ventilation.

Treatment categories: Correct cause, chloride/volume/potassium deficits as appropriate.

Medical-record relevance: Urine chloride can help classify mechanism.

Related terminology: metabolic alkalosis

Related anatomy: Kidneys; GI tract

Source: StatPearls — Physiology, Acid Base Balance

CompensationAcid-base / multisystem · A&P LINK

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Primary acid-base disorder with intact opposing organ response

Pathophysiologic mechanism: Lungs alter CO2 rapidly; kidneys alter bicarbonate more slowly.

Progression: Compensation reduces but usually does not fully normalize pH.

Clinical manifestations: Usually reflects the primary disorder rather than separate symptoms.

Diagnostics / labs / imaging: Blood gas and expected-compensation calculations.

Complications: Unexpected values may reveal a mixed disorder.

Treatment categories: Treat primary disorder.

Medical-record relevance: Compensation should not be coded as a second primary disorder without evidence.

Related terminology: acid-base compensation

Related anatomy: Lungs; kidneys

Source: StatPearls — Physiology, Acid Base Balance

Mixed acid-base disorderAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Two or more simultaneous primary acid-base processes

Pathophysiologic mechanism: Observed pH, PaCO2 and bicarbonate do not fit expected compensation for a single disorder.

Progression: Can mask pH abnormality or produce severe derangement.

Clinical manifestations: Depends on combined causes.

Diagnostics / labs / imaging: Blood gas, electrolytes, anion gap, expected compensation/delta analysis.

Complications: Diagnostic error if only one process is recognized.

Treatment categories: Treat each contributing cause.

Medical-record relevance: Normal pH does not exclude serious mixed disorders.

Related terminology: mixed acid-base disorder

Related anatomy: Blood; lungs; kidneys

Source: StatPearls — Arterial Blood Gas Analysis

Anion gapAcid-base / multisystem · CROSS-LINK

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Altered concentrations of measured versus unmeasured ions

Pathophysiologic mechanism: Calculated sodium minus chloride and bicarbonate estimates unmeasured anion burden.

Progression: Changes with albumin and acid accumulation.

Clinical manifestations: No direct symptoms.

Diagnostics / labs / imaging: BMP/CMP; albumin correction may be relevant.

Complications: Misclassification of metabolic acidosis etiology.

Treatment categories: Use as diagnostic tool, not treatment target.

Medical-record relevance: A calculated indicator, not a diagnosis.

Related terminology: anion gap

Related anatomy: Plasma electrolytes

Source: StatPearls — Arterial Blood Gas Analysis

Delta gap / delta ratioAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: High-anion-gap metabolic acidosis

Pathophysiologic mechanism: Comparison of gap increase with bicarbonate decrease helps detect a second metabolic process.

Progression: Applied after identifying elevated anion gap.

Clinical manifestations: No direct symptoms.

Diagnostics / labs / imaging: Calculated from electrolytes.

Complications: Missed mixed metabolic disorder if ignored.

Treatment categories: Treat underlying disorders.

Medical-record relevance: Interpretation aid rather than standalone condition.

Related terminology: delta gap; delta ratio

Related anatomy: Plasma

Source: StatPearls — Arterial Blood Gas Analysis

Blood-gas interpretationAcid-base / multisystem · CROSS-LINK

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Suspected respiratory/metabolic disease

Pathophysiologic mechanism: pH, PaCO2 and bicarbonate are integrated to identify primary process and compensation.

Progression: Serial gases can show response to treatment.

Clinical manifestations: No direct manifestation.

Diagnostics / labs / imaging: ABG/VBG with clinical context and oxygenation data.

Complications: Misdiagnosis if isolated values are read without context.

Treatment categories: Treat underlying disease.

Medical-record relevance: Blood gas values are clinical indicators that support diagnosis.

Related terminology: ABG; VBG

Related anatomy: Blood; lungs

Source: StatPearls — Arterial Blood Gas Analysis

Acid-base clinical indicator versus diagnosisAcid-base / multisystem · NEW

Normal function anchor: Lungs regulate CO2 while kidneys and buffers regulate bicarbonate and hydrogen ion concentration.

Etiology / risk factors: Abnormal pH, CO2, bicarbonate, or anion gap

Pathophysiologic mechanism: Laboratory abnormalities narrow mechanisms but require synthesis with disease cause and documentation.

Progression: Diagnosis may change as underlying cause is clarified.

Clinical manifestations: Cause-specific.

Diagnostics / labs / imaging: Serial labs, blood gas, renal/respiratory/metabolic workup.

Complications: Documentation/coding ambiguity.

Treatment categories: Clarify and document confirmed disorder and cause.

Medical-record relevance: Direct bridge into CDI/coding: lab values do not replace provider diagnosis.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Arterial Blood Gas Analysis

Pathophysiology section 10

Cancer Biology & Progression

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

CarcinogenesisOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Genetic, epigenetic, environmental and inflammatory exposures

Pathophysiologic mechanism: Sequential molecular alterations confer growth and survival advantages.

Progression: Progresses through initiation, clonal expansion and malignant evolution.

Clinical manifestations: Often clinically silent until tumor burden or organ disruption develops.

Diagnostics / labs / imaging: Histopathology, imaging, molecular testing.

Complications: Local invasion, metastasis, organ dysfunction.

Treatment categories: Prevention/risk reduction, surgery, radiation, systemic/targeted therapy by cancer type.

Medical-record relevance: Mechanism is distinct from a specific cancer diagnosis.

Related terminology: carcinogenesis

Related anatomy: Cells; DNA

Source: StatPearls — Carcinogenesis

Genomic instabilityOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Defects in DNA repair/checkpoints or mutagen exposure

Pathophysiologic mechanism: Increased mutation rate accelerates acquisition of oncogenic changes.

Progression: Promotes tumor heterogeneity and progression.

Clinical manifestations: Cancer-specific manifestations.

Diagnostics / labs / imaging: Molecular profiling; cytogenetics.

Complications: Treatment resistance, aggressive evolution.

Treatment categories: Targeted treatment when actionable; cancer-specific therapy.

Medical-record relevance: Genomic findings may affect classification and therapy.

Related terminology: genomic instability

Related anatomy: DNA; chromosomes

Source: StatPearls — Carcinogenesis

Oncogene activationOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Gain-of-function mutation, amplification, translocation or dysregulated signaling

Pathophysiologic mechanism: Growth-promoting genes become constitutively active.

Progression: Drives proliferation and survival.

Clinical manifestations: Cancer-specific.

Diagnostics / labs / imaging: Tumor sequencing, FISH/IHC depending on target.

Complications: Progression and targeted-therapy resistance.

Treatment categories: Targeted inhibitors when available.

Medical-record relevance: Actionable alteration should be separated from histologic diagnosis.

Related terminology: oncogene

Related anatomy: Genes; signaling pathways

Source: StatPearls — Carcinogenesis

Tumor suppressor lossOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Mutation, deletion, epigenetic silencing

Pathophysiologic mechanism: Loss of growth restraints/checkpoints permits abnormal proliferation.

Progression: Cooperates with other alterations to promote malignancy.

Clinical manifestations: Cancer-specific.

Diagnostics / labs / imaging: Tumor molecular testing; IHC in selected cancers.

Complications: Genomic instability, progression.

Treatment categories: Cancer-specific therapy; some pathways guide hereditary evaluation.

Medical-record relevance: Loss-of-function finding may carry prognostic/hereditary relevance.

Related terminology: tumor suppressor

Related anatomy: Genes; nucleus

Source: StatPearls — Carcinogenesis

Evasion of apoptosisOncology / multisystem · CROSS-LINK

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Altered survival signaling

Pathophysiologic mechanism: Cancer cells resist programmed cell death despite damage or stress.

Progression: Allows persistence of abnormal clones.

Clinical manifestations: Cancer-specific.

Diagnostics / labs / imaging: Pathology/molecular assays.

Complications: Therapy resistance.

Treatment categories: Systemic/targeted therapies aimed at survival pathways in selected cancers.

Medical-record relevance: Mechanistic hallmark, not independent diagnosis.

Related terminology: apoptosis resistance

Related anatomy: Cells

Source: StatPearls — Carcinogenesis

Sustained proliferative signalingOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Growth-factor/receptor/pathway activation

Pathophysiologic mechanism: Mitogenic signaling remains active independent of normal controls.

Progression: Produces progressive clonal expansion.

Clinical manifestations: Mass effect or organ-specific symptoms.

Diagnostics / labs / imaging: Histology; molecular profiling.

Complications: Tumor growth, recurrence.

Treatment categories: Targeted or cytotoxic therapy depending on tumor.

Medical-record relevance: Can explain targeted-therapy selection.

Related terminology: proliferative signaling

Related anatomy: Cells; receptors

Source: StatPearls — Carcinogenesis

AngiogenesisOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Tumor hypoxia and proangiogenic signaling

Pathophysiologic mechanism: Tumor stimulates new vessel formation to support growth.

Progression: Enables enlargement and dissemination.

Clinical manifestations: Usually indirect.

Diagnostics / labs / imaging: Imaging/pathology; molecular markers in selected settings.

Complications: Bleeding, metastasis, rapid growth.

Treatment categories: Antiangiogenic therapy in selected cancers.

Medical-record relevance: Vascular tumor features may influence prognosis/treatment.

Related terminology: angiogenesis

Related anatomy: Tumor vasculature

Source: StatPearls — Carcinogenesis

Local invasionOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Loss of adhesion, matrix degradation, motility changes

Pathophysiologic mechanism: Malignant cells breach basement membranes and infiltrate adjacent tissue.

Progression: Extends primary tumor beyond tissue boundaries.

Clinical manifestations: Pain, obstruction, bleeding, organ dysfunction.

Diagnostics / labs / imaging: Imaging, surgery, histopathology.

Complications: Local destruction, unresectability.

Treatment categories: Surgery/radiation/systemic therapy based on stage.

Medical-record relevance: Invasion is central to malignant staging/pathology.

Related terminology: invasion

Related anatomy: Basement membrane; adjacent tissue

Source: StatPearls — Carcinogenesis

MetastasisOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Invasion, intravasation, survival in circulation, extravasation, colonization

Pathophysiologic mechanism: Cancer spreads to noncontiguous distant sites.

Progression: May occur early or late depending on tumor biology.

Clinical manifestations: Site-specific systemic symptoms.

Diagnostics / labs / imaging: Staging imaging; biopsy; molecular comparison when needed.

Complications: Organ failure, advanced-stage disease.

Treatment categories: Systemic therapy, site-directed therapy, palliation as appropriate.

Medical-record relevance: Metastatic site and primary origin are separate record elements.

Related terminology: metastasis

Related anatomy: Blood; lymphatics; distant organs

Source: StatPearls — Carcinogenesis

Lymphatic spreadOncology / multisystem · CROSS-LINK

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Tumor access to lymphatic channels

Pathophysiologic mechanism: Malignant cells travel through draining lymphatics to regional nodes.

Progression: Often precedes or accompanies distant dissemination.

Clinical manifestations: Enlarged nodes or no symptoms.

Diagnostics / labs / imaging: Imaging, sentinel-node biopsy, nodal pathology.

Complications: Upstaging and recurrence risk.

Treatment categories: Surgery/radiation/systemic therapy by stage.

Medical-record relevance: Regional nodal status is a major staging variable.

Related terminology: nodal metastasis

Related anatomy: Lymphatics; lymph nodes

Source: StatPearls — Carcinogenesis

Hematogenous spreadOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Tumor invasion of blood vessels

Pathophysiologic mechanism: Circulating tumor cells seed distant organs.

Progression: Common routes vary by primary tumor.

Clinical manifestations: Distant-organ symptoms.

Diagnostics / labs / imaging: Imaging; biopsy; circulating markers in selected contexts.

Complications: Metastatic organ failure.

Treatment categories: Systemic therapy and site-directed management.

Medical-record relevance: Distant metastasis changes stage and treatment intent.

Related terminology: hematogenous metastasis

Related anatomy: Vasculature

Source: StatPearls — Carcinogenesis

Tumor microenvironmentOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Cancer cells plus stromal, immune, vascular and extracellular components

Pathophysiologic mechanism: Reciprocal signaling supports growth, immune evasion and invasion.

Progression: Changes with therapy and progression.

Clinical manifestations: Indirect.

Diagnostics / labs / imaging: Pathology/molecular profiling.

Complications: Resistance, metastasis.

Treatment categories: Immunotherapy/targeted approaches may exploit microenvironment biology.

Medical-record relevance: Explains why tumor behavior is not determined by malignant cells alone.

Related terminology: tumor microenvironment

Related anatomy: Stroma; immune cells; vessels

Source: StatPearls — Carcinogenesis

Tumor-promoting inflammationOncology / multisystem · CROSS-LINK

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Chronic inflammatory signaling

Pathophysiologic mechanism: Cytokines and immune-cell interactions can support mutation, growth, angiogenesis and invasion.

Progression: May sustain progression.

Clinical manifestations: Cancer- and inflammation-specific symptoms.

Diagnostics / labs / imaging: Inflammatory markers are nonspecific; pathology/molecular context required.

Complications: Progression, cachexia.

Treatment categories: Cancer-specific treatment; treat inflammatory drivers where relevant.

Medical-record relevance: Inflammation alone does not establish malignancy.

Related terminology: cancer inflammation

Related anatomy: Immune system; tumor stroma

Source: StatPearls — Carcinogenesis

Cancer metabolism reprogrammingOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Oncogenic signaling and hypoxic adaptation

Pathophysiologic mechanism: Tumor cells alter nutrient uptake and energy pathways to support rapid growth.

Progression: Can create metabolic dependencies.

Clinical manifestations: Weight loss or systemic effects in advanced disease.

Diagnostics / labs / imaging: Metabolic imaging such as FDG-PET; molecular assays.

Complications: Cachexia, treatment resistance.

Treatment categories: Cancer-specific systemic/targeted therapy.

Medical-record relevance: Metabolic imaging findings require correlation with diagnosis.

Related terminology: tumor metabolism

Related anatomy: Cells; mitochondria

Source: StatPearls — Carcinogenesis

Immune evasionOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Checkpoint signaling, antigen loss, suppressive microenvironment

Pathophysiologic mechanism: Tumor reduces effective antitumor immune recognition or function.

Progression: Permits persistence and progression.

Clinical manifestations: Indirect.

Diagnostics / labs / imaging: IHC/molecular biomarkers such as PD-L1 in selected cancers.

Complications: Progression, resistance.

Treatment categories: Checkpoint inhibitors and other immunotherapies in eligible cancers.

Medical-record relevance: Biomarkers may determine treatment eligibility.

Related terminology: immune evasion

Related anatomy: Immune cells; tumor cells

Source: StatPearls — Carcinogenesis

Tumor heterogeneityOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Clonal evolution and variable molecular alterations

Pathophysiologic mechanism: Subclones differ in genotype, phenotype and treatment sensitivity.

Progression: Diversity can increase during progression/therapy.

Clinical manifestations: Variable tumor behavior.

Diagnostics / labs / imaging: Multiregion or serial molecular testing in selected cases.

Complications: Resistance, recurrence.

Treatment categories: Combination/next-line therapies based on evolving biology.

Medical-record relevance: One biopsy may not capture all tumor clones.

Related terminology: clonal heterogeneity

Related anatomy: Tumor tissue

Source: StatPearls — Carcinogenesis

Dysplasia-to-carcinoma progressionOncology / multisystem · CROSS-LINK

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Persistent proliferative injury and accumulating alterations

Pathophysiologic mechanism: Preinvasive atypia acquires sufficient changes for malignant invasion.

Progression: Not all dysplasia progresses; grade and site influence risk.

Clinical manifestations: Often screen-detected.

Diagnostics / labs / imaging: Cytology, biopsy, endoscopy/imaging depending on organ.

Complications: Invasive cancer.

Treatment categories: Surveillance or excision/ablation by lesion type.

Medical-record relevance: Dysplasia and invasive carcinoma must be documented distinctly.

Related terminology: dysplasia; carcinoma in situ

Related anatomy: Epithelium

Source: StatPearls — Carcinogenesis

Cancer stagingOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Tumor size/local extent, nodal status, metastasis and disease-specific factors

Pathophysiologic mechanism: Staging summarizes anatomic disease burden and sometimes biologic features.

Progression: Stage may change with new evidence.

Clinical manifestations: No direct symptom.

Diagnostics / labs / imaging: Imaging, pathology, operative findings.

Complications: Prognostic and treatment implications.

Treatment categories: Treatment based on stage and tumor type.

Medical-record relevance: Stage is not interchangeable with grade.

Related terminology: TNM; stage

Related anatomy: Primary tumor; nodes; metastases

Source: StatPearls — Carcinogenesis

Tumor gradeOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Degree of differentiation/proliferation on pathology

Pathophysiologic mechanism: Poor differentiation and high proliferative activity often indicate more aggressive biology.

Progression: Grade may remain stable or evolve.

Clinical manifestations: No direct symptom.

Diagnostics / labs / imaging: Histopathology; mitotic/proliferation markers.

Complications: Recurrence/progression risk.

Treatment categories: Guides risk stratification and treatment in selected cancers.

Medical-record relevance: Grade and stage should be recorded separately.

Related terminology: tumor grade

Related anatomy: Tumor histology

Source: StatPearls — Carcinogenesis

Cancer clinical indicators versus diagnosisOncology / multisystem · NEW

Normal function anchor: Normal cells coordinate proliferation, DNA repair, differentiation, apoptosis, immune surveillance, and tissue boundaries.

Etiology / risk factors: Abnormal imaging, tumor marker, cytology or molecular finding

Pathophysiologic mechanism: Indicators can raise suspicion but diagnosis usually requires integrated clinical/pathologic confirmation.

Progression: Workup may refine primary site, histology and stage.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Imaging, biopsy, pathology, molecular testing.

Complications: Misclassification if suspicious findings are treated as confirmed cancer.

Treatment categories: Complete diagnostic workup and document confirmed malignancy.

Medical-record relevance: Direct bridge into CDI/coding and oncology abstraction.

Related terminology: clinical indicator; malignancy

Related anatomy: Medical record

Source: StatPearls — Carcinogenesis

Pathophysiology section 11

Neurologic Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Ischemic strokeNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Arterial thrombosis or embolism

Pathophysiologic mechanism: Abrupt loss of cerebral blood flow produces infarction if perfusion is not restored.

Progression: Core infarct can expand into salvageable penumbra over time.

Clinical manifestations: Sudden focal neurologic deficit.

Diagnostics / labs / imaging: Noncontrast CT, CTA/MRA, MRI, glucose and vascular/cardiac evaluation.

Complications: Disability, edema, hemorrhagic transformation.

Treatment categories: Rapid reperfusion in eligible patients plus secondary prevention.

Medical-record relevance: Time of onset/last-known-well, vessel, deficit and imaging drive treatment and documentation.

Related terminology: ischemic stroke

Related anatomy: Brain; cerebral arteries

Source: StatPearls — Ischemic Stroke

Intracerebral hemorrhageNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Hypertension, vascular malformation, anticoagulation, amyloid angiopathy

Pathophysiologic mechanism: Vessel rupture causes bleeding into brain parenchyma with mass effect and tissue injury.

Progression: Expansion may worsen early neurologic injury.

Clinical manifestations: Headache, focal deficit, altered consciousness.

Diagnostics / labs / imaging: Noncontrast CT; CTA/MRI as indicated; coagulation studies.

Complications: Herniation, hydrocephalus, death.

Treatment categories: Blood-pressure control, reversal of anticoagulation, neurosurgical management when indicated.

Medical-record relevance: Hemorrhagic stroke must be distinguished from ischemic stroke.

Related terminology: intracerebral hemorrhage

Related anatomy: Brain parenchyma; vessels

Source: StatPearls — Acute Stroke: Evaluation and Management

Subarachnoid hemorrhageNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Ruptured aneurysm or other vascular lesion

Pathophysiologic mechanism: Blood enters subarachnoid space, raising intracranial pressure and irritating meninges/vessels.

Progression: Risk of rebleeding, vasospasm and hydrocephalus.

Clinical manifestations: Sudden severe headache, neck stiffness, altered consciousness.

Diagnostics / labs / imaging: CT, CTA; lumbar puncture in selected CT-negative cases.

Complications: Vasospasm, hydrocephalus, rebleeding.

Treatment categories: Aneurysm securing and neurocritical care.

Medical-record relevance: Etiology and hemorrhage type should be specifically documented.

Related terminology: subarachnoid hemorrhage

Related anatomy: Subarachnoid space; cerebral arteries

Source: StatPearls — Acute Stroke: Evaluation and Management

Transient ischemic attackNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Transient focal cerebral ischemia without established infarction

Pathophysiologic mechanism: Temporary perfusion failure produces reversible neurologic dysfunction.

Progression: Signals elevated near-term stroke risk.

Clinical manifestations: Brief focal weakness, speech/vision change.

Diagnostics / labs / imaging: Clinical assessment; brain/vascular imaging; cardiac evaluation.

Complications: Subsequent ischemic stroke.

Treatment categories: Rapid secondary-prevention evaluation and treatment.

Medical-record relevance: TIA requires clinical synthesis; resolved symptoms do not make event trivial.

Related terminology: TIA

Related anatomy: Brain; vessels

Source: StatPearls — Acute Stroke: Evaluation and Management

Cerebral edemaNeurologic · CROSS-LINK

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Stroke, trauma, tumor, infection, metabolic injury

Pathophysiologic mechanism: Cellular or vasogenic fluid accumulation increases brain volume.

Progression: Can raise intracranial pressure and worsen perfusion.

Clinical manifestations: Headache, vomiting, altered consciousness, focal deficit.

Diagnostics / labs / imaging: CT/MRI; intracranial pressure assessment in selected cases.

Complications: Herniation, ischemia.

Treatment categories: Treat cause and control intracranial pressure.

Medical-record relevance: Edema may be a complication rather than the primary neurologic diagnosis.

Related terminology: cerebral edema

Related anatomy: Brain

Source: StatPearls — Acute Stroke: Evaluation and Management

Raised intracranial pressureNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Mass lesion, edema, hemorrhage, hydrocephalus

Pathophysiologic mechanism: Intracranial volume increase exceeds compensatory reserve, reducing cerebral perfusion.

Progression: Can progress rapidly to herniation.

Clinical manifestations: Headache, vomiting, papilledema, altered consciousness.

Diagnostics / labs / imaging: Imaging; ICP monitoring in selected critical cases.

Complications: Herniation, brain ischemia.

Treatment categories: Urgent cause-specific neurocritical management.

Medical-record relevance: Document cause and neurologic consequences.

Related terminology: intracranial pressure

Related anatomy: Skull; brain; CSF

Source: StatPearls — Acute Stroke: Evaluation and Management

SeizureNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Abnormal synchronized cortical neuronal firing

Pathophysiologic mechanism: Transient network hyperexcitability produces motor, sensory, autonomic or awareness changes.

Progression: May be isolated, recurrent, or provoked by acute brain disease.

Clinical manifestations: Convulsions or nonconvulsive focal/generalized symptoms.

Diagnostics / labs / imaging: EEG, metabolic labs, neuroimaging based on presentation.

Complications: Status epilepticus, injury, aspiration.

Treatment categories: Antiseizure treatment depending on cause/recurrence risk.

Medical-record relevance: A seizure event and epilepsy diagnosis are not synonymous.

Related terminology: seizure

Related anatomy: Cerebral cortex

Source: StatPearls — Acute Stroke: Evaluation and Management

Status epilepticusNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Prolonged or recurrent seizures without adequate recovery

Pathophysiologic mechanism: Persistent neuronal firing becomes self-sustaining and injurious.

Progression: Neurologic injury risk rises with duration.

Clinical manifestations: Ongoing convulsions or altered mental status.

Diagnostics / labs / imaging: Clinical recognition, EEG, labs, imaging.

Complications: Hypoxia, rhabdomyolysis, neuronal injury.

Treatment categories: Emergency antiseizure therapy and cause correction.

Medical-record relevance: Time course and EEG evidence may be critical.

Related terminology: status epilepticus

Related anatomy: Brain

Source: StatPearls — Acute Stroke: Evaluation and Management

EpilepsyNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Predisposition to recurrent unprovoked seizures

Pathophysiologic mechanism: Network excitability and structural/genetic causes create ongoing seizure susceptibility.

Progression: Course varies by syndrome and control.

Clinical manifestations: Recurrent seizures.

Diagnostics / labs / imaging: EEG, MRI, clinical criteria.

Complications: Injury, status epilepticus, psychosocial impact.

Treatment categories: Antiseizure medication; surgery/device therapy in selected refractory cases.

Medical-record relevance: Requires established diagnostic criteria beyond a single provoked seizure.

Related terminology: epilepsy

Related anatomy: Brain networks

Source: StatPearls — Acute Stroke: Evaluation and Management

DemyelinationNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Autoimmune, infectious, metabolic or genetic injury to myelin

Pathophysiologic mechanism: Loss of myelin slows or blocks axonal conduction.

Progression: Episodes or progression depend on cause.

Clinical manifestations: Weakness, sensory change, vision or coordination problems.

Diagnostics / labs / imaging: MRI; CSF and antibody testing in selected conditions.

Complications: Persistent neurologic disability.

Treatment categories: Immunotherapy or cause-specific treatment.

Medical-record relevance: Demyelinating lesion pattern can support but not alone establish a named disorder.

Related terminology: demyelination

Related anatomy: CNS/PNS myelin

Source: StatPearls — Acute Stroke: Evaluation and Management

NeurodegenerationNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Protein aggregation, genetic susceptibility, aging and cellular stress

Pathophysiologic mechanism: Progressive neuronal dysfunction and loss affect specific neural networks.

Progression: Gradual progression is common.

Clinical manifestations: Cognitive, motor or behavioral decline depending on disease.

Diagnostics / labs / imaging: Clinical testing, MRI, biomarkers/genetic testing in selected disorders.

Complications: Progressive disability.

Treatment categories: Disease-specific symptomatic and disease-modifying therapy where available.

Medical-record relevance: Document specific neurodegenerative diagnosis when established.

Related terminology: neurodegeneration

Related anatomy: Brain; neurons

Source: StatPearls — Acute Stroke: Evaluation and Management

Peripheral neuropathyNeurologic · CROSS-LINK

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Diabetes, toxins, nutritional deficiency, immune or hereditary disease

Pathophysiologic mechanism: Axonal or myelin injury disrupts peripheral nerve signaling.

Progression: May be length-dependent and progressive.

Clinical manifestations: Numbness, burning pain, weakness, reduced reflexes.

Diagnostics / labs / imaging: Neurologic exam, EMG/NCS, labs for cause.

Complications: Falls, ulcers, weakness.

Treatment categories: Treat cause plus symptom/rehabilitation management.

Medical-record relevance: Cause and distribution improve diagnostic specificity.

Related terminology: neuropathy

Related anatomy: Peripheral nerves

Source: StatPearls — Type 2 Diabetes

Autonomic dysfunctionNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Neuropathy, neurodegenerative disease, autoimmune or other causes

Pathophysiologic mechanism: Autonomic control of cardiovascular, GI, urinary and sudomotor function becomes impaired.

Progression: May affect multiple organ systems.

Clinical manifestations: Orthostasis, GI dysmotility, bladder dysfunction, sweating changes.

Diagnostics / labs / imaging: Orthostatic vitals; autonomic testing; cause-specific evaluation.

Complications: Syncope, falls, urinary complications.

Treatment categories: Cause-directed and symptom-specific management.

Medical-record relevance: Document organ manifestations and underlying neurologic cause when known.

Related terminology: dysautonomia

Related anatomy: Autonomic nervous system

Source: StatPearls — Acute Stroke: Evaluation and Management

NeuroinflammationNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Infection, autoimmunity, injury or degeneration

Pathophysiologic mechanism: Activated glia and immune mediators alter neuronal function and can produce tissue injury.

Progression: May resolve or become chronic.

Clinical manifestations: Disease-specific neurologic symptoms.

Diagnostics / labs / imaging: CSF, MRI, inflammatory/infectious testing.

Complications: Edema, neuronal injury.

Treatment categories: Treat underlying immune/infectious cause.

Medical-record relevance: Mechanistic finding should be tied to a clinical diagnosis when possible.

Related terminology: neuroinflammation

Related anatomy: CNS; glia

Source: StatPearls — Acute Stroke: Evaluation and Management

Blood-brain barrier disruptionNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Inflammation, ischemia, trauma, tumor

Pathophysiologic mechanism: Endothelial barrier permeability increases, allowing fluid/proteins/cells into CNS tissue.

Progression: Promotes vasogenic edema and inflammatory injury.

Clinical manifestations: Neurologic symptoms depend on cause.

Diagnostics / labs / imaging: MRI/CT; disease-specific tests.

Complications: Edema, secondary brain injury.

Treatment categories: Treat underlying cause.

Medical-record relevance: Supports mechanism for edema but is not usually a standalone diagnosis.

Related terminology: blood-brain barrier

Related anatomy: Cerebral microvasculature

Source: StatPearls — Acute Stroke: Evaluation and Management

AphasiaNeurologic · CROSS-LINK

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Dominant-hemisphere language network injury

Pathophysiologic mechanism: Damage disrupts language production, comprehension, naming or repetition.

Progression: May improve with recovery/rehabilitation or persist.

Clinical manifestations: Speech/language impairment.

Diagnostics / labs / imaging: Neurologic exam; imaging; speech-language evaluation.

Complications: Communication disability.

Treatment categories: Treat cause and provide rehabilitation.

Medical-record relevance: Aphasia is a neurologic deficit that can support stroke localization.

Related terminology: aphasia

Related anatomy: Dominant cerebral hemisphere

Source: StatPearls — Acute Stroke: Evaluation and Management

HemiparesisNeurologic · CROSS-LINK

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Contralateral corticospinal tract injury

Pathophysiologic mechanism: Motor pathway disruption causes unilateral weakness.

Progression: Recovery depends on lesion and rehabilitation.

Clinical manifestations: Weakness of face/arm/leg on one side.

Diagnostics / labs / imaging: Neurologic exam; imaging; functional assessment.

Complications: Falls, contractures, disability.

Treatment categories: Treat cause plus PT/OT rehabilitation.

Medical-record relevance: Laterality is important in medical documentation.

Related terminology: hemiparesis

Related anatomy: Motor cortex; corticospinal tract

Source: StatPearls — Acute Stroke: Evaluation and Management

Altered mental statusNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Metabolic, toxic, infectious, structural, seizure or psychiatric causes

Pathophysiologic mechanism: Global cerebral function is disrupted by one or more acute processes.

Progression: May fluctuate or progress to coma.

Clinical manifestations: Confusion, reduced attention or consciousness.

Diagnostics / labs / imaging: Glucose, CBC/CMP, toxicology, imaging, EEG, infection workup as indicated.

Complications: Aspiration, injury, missed critical diagnosis.

Treatment categories: Treat underlying cause and protect airway/safety.

Medical-record relevance: A symptom/indicator requiring etiology rather than a final diagnosis by itself.

Related terminology: altered mental status

Related anatomy: Brain

Source: StatPearls — Acute Stroke: Evaluation and Management

Neurologic deficit versus lesionNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Structural or functional nervous-system disorder

Pathophysiologic mechanism: Observed deficits reflect affected pathways but do not always specify etiology.

Progression: Localization guides further testing.

Clinical manifestations: Weakness, sensory loss, speech/vision/coordination changes.

Diagnostics / labs / imaging: Focused exam plus imaging/electrodiagnostics.

Complications: Misdiagnosis if deficit is coded as a cause without confirmation.

Treatment categories: Investigate and treat underlying diagnosis.

Medical-record relevance: Deficit, lesion and disease diagnosis are separate record layers.

Related terminology: focal neurologic deficit

Related anatomy: Nervous system

Source: StatPearls — Acute Stroke: Evaluation and Management

Neurologic clinical indicator versus diagnosisNeurologic · NEW

Normal function anchor: Neural tissue maintains perfusion, electrical signaling, network connectivity, myelin integrity, and regulated intracranial homeostasis.

Etiology / risk factors: Abnormal exam, imaging, EEG or biomarker

Pathophysiologic mechanism: Indicators support probability and localization but require clinical synthesis.

Progression: Diagnosis may evolve after imaging/lab confirmation.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Neurologic exam, imaging, EEG, CSF and labs as appropriate.

Complications: Documentation/coding ambiguity.

Treatment categories: Clarify confirmed diagnosis, acuity and sequelae.

Medical-record relevance: Direct CDI/coding bridge for stroke and other neurologic disorders.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Acute Stroke: Evaluation and Management

Pathophysiology section 12

Endocrine & Metabolic Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Insulin resistanceEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Obesity, genetics, inactivity, ectopic fat, inflammation

Pathophysiologic mechanism: Target tissues respond less effectively to insulin, increasing insulin requirements.

Progression: Compensatory hyperinsulinemia may precede overt hyperglycemia.

Clinical manifestations: Often asymptomatic; may coexist with metabolic syndrome.

Diagnostics / labs / imaging: Glucose, HbA1c, lipids; insulin assays not routinely required for diagnosis.

Complications: Type 2 diabetes, cardiovascular disease.

Treatment categories: Lifestyle and disease-specific metabolic therapy.

Medical-record relevance: Mechanism is not equivalent to a diabetes diagnosis.

Related terminology: insulin resistance

Related anatomy: Liver; muscle; adipose

Source: StatPearls — Type 2 Diabetes

Type 2 diabetes mellitusEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Insulin resistance plus progressive beta-cell dysfunction

Pathophysiologic mechanism: Persistent hyperglycemia develops when insulin supply no longer matches metabolic demand.

Progression: Usually chronic and progressive without treatment.

Clinical manifestations: Polyuria, polydipsia, fatigue or asymptomatic.

Diagnostics / labs / imaging: HbA1c, fasting/random plasma glucose using diagnostic criteria.

Complications: Retinopathy, nephropathy, neuropathy, ASCVD.

Treatment categories: Lifestyle and glucose-lowering therapy individualized to comorbidity.

Medical-record relevance: Type, control status and complications should be separately documented.

Related terminology: type 2 diabetes

Related anatomy: Pancreas; liver; muscle

Source: StatPearls — Type 2 Diabetes

Chronic hyperglycemiaEndocrine / metabolic · CROSS-LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Diabetes and other glucose-regulation disorders

Pathophysiologic mechanism: Excess glucose causes osmotic, glycation, oxidative and vascular injury.

Progression: Damage accumulates over time.

Clinical manifestations: May be asymptomatic until complications develop.

Diagnostics / labs / imaging: HbA1c, glucose trends.

Complications: Microvascular and macrovascular disease.

Treatment categories: Improve glycemic control and treat complications.

Medical-record relevance: Hyperglycemia may be a finding or part of a defined diabetes diagnosis.

Related terminology: hyperglycemia

Related anatomy: Blood; vessels

Source: StatPearls — Type 2 Diabetes

Diabetic microvascular injuryEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Chronic hyperglycemia

Pathophysiologic mechanism: Basement membrane, endothelial and metabolic changes damage small vessels.

Progression: Progresses with duration and poor control.

Clinical manifestations: Vision, renal or sensory symptoms depending on organ.

Diagnostics / labs / imaging: Eye exam, urine albumin/eGFR, neurologic exam.

Complications: Retinopathy, nephropathy, neuropathy.

Treatment categories: Glycemic/BP risk reduction and organ-specific care.

Medical-record relevance: Specific complication should be documented rather than only ‘diabetes’.

Related terminology: microangiopathy

Related anatomy: Retina; glomeruli; nerves

Source: StatPearls — Type 2 Diabetes

Diabetic macrovascular diseaseEndocrine / metabolic · CROSS-LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Diabetes plus dyslipidemia, hypertension, inflammation and endothelial dysfunction

Pathophysiologic mechanism: Atherosclerotic risk is accelerated.

Progression: Leads to coronary, cerebral or peripheral arterial disease.

Clinical manifestations: Angina, claudication, stroke symptoms or asymptomatic disease.

Diagnostics / labs / imaging: Risk assessment; ECG/imaging/vascular studies as indicated.

Complications: MI, stroke, limb ischemia.

Treatment categories: Aggressive risk-factor and ASCVD management.

Medical-record relevance: ASCVD diagnosis is distinct from diabetes though related.

Related terminology: macrovascular disease

Related anatomy: Arteries

Source: StatPearls — Type 2 Diabetes

Diabetic nephropathyEndocrine / metabolic · CROSS-LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Chronic hyperglycemia and glomerular hemodynamic stress

Pathophysiologic mechanism: Glomerular injury causes albuminuria and progressive nephron loss.

Progression: May progress to CKD.

Clinical manifestations: Often asymptomatic early.

Diagnostics / labs / imaging: Urine albumin-creatinine ratio; eGFR.

Complications: CKD, ESRD, cardiovascular risk.

Treatment categories: Glycemic/BP/renal-protective therapy.

Medical-record relevance: Albuminuria and CKD stage are important documentation elements.

Related terminology: diabetic kidney disease

Related anatomy: Kidney glomeruli

Source: StatPearls — Type 2 Diabetes

Diabetic neuropathyEndocrine / metabolic · CROSS-LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Chronic metabolic and microvascular nerve injury

Pathophysiologic mechanism: Axonal dysfunction/loss affects sensory, motor and autonomic nerves.

Progression: Often length-dependent and progressive.

Clinical manifestations: Burning, numbness, loss of protective sensation.

Diagnostics / labs / imaging: Clinical exam; monofilament; EMG/NCS when atypical.

Complications: Ulcers, falls, autonomic dysfunction.

Treatment categories: Glycemic control and symptom/foot-care management.

Medical-record relevance: Specify neuropathy type when established.

Related terminology: diabetic neuropathy

Related anatomy: Peripheral nerves

Source: StatPearls — Type 2 Diabetes

Diabetic retinopathyEndocrine / metabolic · CROSS-LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Chronic retinal microvascular injury

Pathophysiologic mechanism: Capillary leakage, ischemia and neovascular signaling damage retina.

Progression: Nonproliferative disease may progress to proliferative disease/macular edema.

Clinical manifestations: Often asymptomatic until advanced.

Diagnostics / labs / imaging: Dilated retinal exam; retinal imaging.

Complications: Vision loss.

Treatment categories: Glycemic/BP control and ophthalmic therapy.

Medical-record relevance: Stage and macular edema status affect severity documentation.

Related terminology: diabetic retinopathy

Related anatomy: Retina

Source: StatPearls — Type 2 Diabetes

Diabetic ketoacidosisEndocrine / metabolic · CROSS-LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Marked insulin deficiency with counter-regulatory hormone excess

Pathophysiologic mechanism: Lipolysis and hepatic ketogenesis produce high-gap metabolic acidosis and osmotic diuresis.

Progression: Can progress rapidly to shock and electrolyte instability.

Clinical manifestations: Polyuria, vomiting, abdominal pain, Kussmaul breathing, altered mentation.

Diagnostics / labs / imaging: Glucose, ketones/beta-hydroxybutyrate, electrolytes, anion gap, blood gas.

Complications: Cerebral edema, arrhythmia, shock.

Treatment categories: IV fluids, insulin, potassium and trigger treatment.

Medical-record relevance: DKA requires metabolic criteria; hyperglycemia alone is insufficient.

Related terminology: DKA

Related anatomy: Pancreas; liver; blood

Source: StatPearls — Type 2 Diabetes

Hyperosmolar hyperglycemic stateEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Severe insulin deficiency insufficient for ketosis suppression plus profound dehydration

Pathophysiologic mechanism: Extreme hyperglycemia causes osmotic diuresis and hyperosmolality with minimal ketosis.

Progression: Often develops over days.

Clinical manifestations: Marked dehydration, neurologic change.

Diagnostics / labs / imaging: Glucose, osmolality, electrolytes, renal function.

Complications: Shock, thrombosis, coma.

Treatment categories: Fluids, insulin, electrolyte management and trigger treatment.

Medical-record relevance: Differentiate HHS from DKA; overlap can occur.

Related terminology: HHS

Related anatomy: Blood; brain; kidneys

Source: StatPearls — Type 2 Diabetes

HypoglycemiaEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Excess glucose-lowering therapy, fasting, endocrine or organ failure

Pathophysiologic mechanism: Plasma glucose falls below supply needs, triggering autonomic and neuroglycopenic responses.

Progression: Can progress rapidly to seizure/coma.

Clinical manifestations: Sweating, tremor, confusion, seizure.

Diagnostics / labs / imaging: Capillary/plasma glucose; medication and cause evaluation.

Complications: Injury, arrhythmia, neurologic harm.

Treatment categories: Rapid glucose replacement and prevention of recurrence.

Medical-record relevance: Document clinically significant episodes and cause where known.

Related terminology: hypoglycemia

Related anatomy: Brain; liver; pancreas

Source: StatPearls — Type 2 Diabetes

Metabolic syndromeEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Central adiposity, insulin resistance, hypertension, dyslipidemia

Pathophysiologic mechanism: Clustered metabolic abnormalities amplify vascular risk.

Progression: May precede overt diabetes and ASCVD.

Clinical manifestations: Often asymptomatic.

Diagnostics / labs / imaging: Waist/BMI, BP, glucose, triglycerides, HDL.

Complications: Diabetes, ASCVD, fatty liver.

Treatment categories: Weight, activity, BP/lipid/glucose management.

Medical-record relevance: A syndrome label should follow defined criteria; document individual components.

Related terminology: metabolic syndrome

Related anatomy: Adipose; liver; vasculature

Source: StatPearls — Type 2 Diabetes

Obesity-related metabolic dysfunctionEndocrine / metabolic · CROSS-LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Energy imbalance, genetics, neuroendocrine and environmental factors

Pathophysiologic mechanism: Adipose expansion alters insulin sensitivity, inflammatory signaling and ectopic fat deposition.

Progression: Can drive multiple cardiometabolic diseases.

Clinical manifestations: Weight gain, sleep/respiratory and joint effects, metabolic abnormalities.

Diagnostics / labs / imaging: BMI/waist plus comorbidity assessment.

Complications: Diabetes, OSA, fatty liver, cardiovascular disease.

Treatment categories: Lifestyle, pharmacologic and surgical obesity treatment as indicated.

Medical-record relevance: Obesity class and comorbidities may affect risk and treatment.

Related terminology: obesity

Related anatomy: Adipose tissue

Source: StatPearls — Type 2 Diabetes

Endocrine negative-feedback failureEndocrine / metabolic · A&P LINK

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Primary gland disease, pituitary/hypothalamic disease or exogenous hormones

Pathophysiologic mechanism: Hormone concentrations no longer produce expected feedback relationships.

Progression: Patterns differ in primary versus central disorders.

Clinical manifestations: Hormone-specific symptoms.

Diagnostics / labs / imaging: Paired trophic/target hormone testing.

Complications: Multisystem hormone excess/deficiency.

Treatment categories: Treat specific endocrine cause.

Medical-record relevance: Paired hormone interpretation distinguishes gland from pituitary/hypothalamic disease.

Related terminology: negative feedback

Related anatomy: Hypothalamus; pituitary; endocrine glands

Source: StatPearls — Type 2 Diabetes

Hormone deficiencyEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Autoimmune destruction, surgery, congenital defects, pituitary disease, medications

Pathophysiologic mechanism: Insufficient hormone signaling reduces target-organ activity.

Progression: Can be gradual or acute depending on hormone.

Clinical manifestations: Hormone-specific fatigue, BP, metabolic, reproductive or growth effects.

Diagnostics / labs / imaging: Specific hormone plus regulatory-hormone testing.

Complications: Crisis states for some hormones; chronic organ dysfunction.

Treatment categories: Hormone replacement and cause treatment.

Medical-record relevance: Document named deficiency when confirmed rather than nonspecific symptoms.

Related terminology: endocrine deficiency

Related anatomy: Endocrine glands

Source: StatPearls — Type 2 Diabetes

Hormone excessEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Autonomous secretion, tumors, hyperplasia, exogenous exposure

Pathophysiologic mechanism: Excess receptor stimulation disrupts normal target-organ regulation.

Progression: Chronic excess causes tissue remodeling/metabolic effects.

Clinical manifestations: Hormone-specific symptoms.

Diagnostics / labs / imaging: Hormone assays plus imaging/functional tests.

Complications: Cardiovascular, metabolic, bone or reproductive complications.

Treatment categories: Remove source or block synthesis/action; condition-specific therapy.

Medical-record relevance: Exogenous versus endogenous cause should be distinguished.

Related terminology: endocrine excess

Related anatomy: Endocrine glands

Source: StatPearls — Type 2 Diabetes

Thyroid-axis dysfunctionEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Autoimmune, nodular, pituitary or medication-related disease

Pathophysiologic mechanism: Altered thyroid hormone signaling changes metabolic rate and organ function.

Progression: May be hypo- or hyperthyroid and subclinical or overt.

Clinical manifestations: Weight, heart-rate, temperature, bowel, mood and menstrual changes.

Diagnostics / labs / imaging: TSH and free T4; antibodies/imaging in selected cases.

Complications: Arrhythmia, bone loss, myxedema/thyroid storm in extremes.

Treatment categories: Hormone replacement or antithyroid/definitive therapy by cause.

Medical-record relevance: TSH and thyroid hormone pattern determines diagnosis.

Related terminology: thyroid dysfunction

Related anatomy: Thyroid; pituitary

Source: StatPearls — Type 2 Diabetes

Adrenal stress-hormone disorderEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Primary adrenal or pituitary disease, exogenous glucocorticoids

Pathophysiologic mechanism: Cortisol/aldosterone abnormalities disrupt vascular, metabolic and electrolyte regulation.

Progression: Can be chronic or present as acute crisis.

Clinical manifestations: BP, glucose, weight, weakness, electrolyte changes.

Diagnostics / labs / imaging: Cortisol/ACTH, aldosterone/renin and dynamic testing as indicated.

Complications: Adrenal crisis or chronic cardiometabolic complications.

Treatment categories: Hormone replacement or suppression/cause treatment.

Medical-record relevance: Differentiate physiologic stress cortisol from pathologic adrenal disease.

Related terminology: adrenal dysfunction

Related anatomy: Adrenal cortex

Source: StatPearls — Type 2 Diabetes

Pituitary hormone disorderEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Adenoma, surgery, infarction, inflammation or mass effect

Pathophysiologic mechanism: Trophic hormone excess or deficiency alters downstream endocrine glands.

Progression: Can affect multiple axes.

Clinical manifestations: Headache/visual symptoms plus endocrine changes.

Diagnostics / labs / imaging: Pituitary and target hormones; MRI.

Complications: Visual loss, adrenal insufficiency, reproductive/metabolic effects.

Treatment categories: Medical/surgical/radiation and hormone replacement as indicated.

Medical-record relevance: Multiple hormone abnormalities may share one pituitary cause.

Related terminology: pituitary disorder

Related anatomy: Pituitary gland

Source: StatPearls — Type 2 Diabetes

Endocrine clinical indicator versus diagnosisEndocrine / metabolic · NEW

Normal function anchor: Endocrine feedback systems coordinate glucose, energy, fluid, growth, stress, thyroid, adrenal, pituitary, and reproductive functions.

Etiology / risk factors: Abnormal glucose, TSH, cortisol, electrolytes or imaging

Pathophysiologic mechanism: Single laboratory abnormalities may be transient, medication-related or physiologic; diagnosis requires appropriate criteria and context.

Progression: Serial testing may confirm or refute disease.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Repeat/confirmatory tests, dynamic testing and imaging where indicated.

Complications: Misclassification and unnecessary treatment.

Treatment categories: Complete endocrine evaluation and document confirmed condition.

Medical-record relevance: Direct bridge into CDI/coding: lab values are indicators, not automatic diagnoses.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Type 2 Diabetes

Pathophysiology section 13

Hematologic Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

AnemiaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Blood loss, reduced erythropoiesis, hemolysis or nutrient deficiency

Pathophysiologic mechanism: Reduced red-cell mass lowers oxygen-carrying capacity.

Progression: Severity and tempo determine compensation.

Clinical manifestations: Fatigue, dyspnea, pallor, tachycardia.

Diagnostics / labs / imaging: CBC, indices, reticulocytes, smear, iron/B12/folate and cause-specific tests.

Complications: Ischemia, high-output cardiac stress in severe cases.

Treatment categories: Treat underlying cause and replace deficits/transfuse when indicated.

Medical-record relevance: Type and cause are more informative than low hemoglobin alone.

Related terminology: anemia

Related anatomy: RBCs; bone marrow

Source: StatPearls — Leukemia

Iron-deficiency anemiaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Chronic blood loss, low intake, malabsorption, increased demand

Pathophysiologic mechanism: Iron depletion limits hemoglobin synthesis and produces microcytosis.

Progression: Usually progressive unless losses are acute.

Clinical manifestations: Fatigue, pica, exertional symptoms.

Diagnostics / labs / imaging: CBC, ferritin, iron/TIBC, source evaluation.

Complications: Functional impairment; thrombosis association in some patients.

Treatment categories: Iron replacement and source control.

Medical-record relevance: Document iron deficiency and bleeding source when known.

Related terminology: iron deficiency

Related anatomy: RBCs; marrow

Source: StatPearls — Thrombosis

Macrocytic anemiaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: B12/folate deficiency, drugs, liver disease, marrow disorders

Pathophysiologic mechanism: Impaired DNA synthesis or other causes enlarge circulating RBCs.

Progression: May progress with neurologic effects in B12 deficiency.

Clinical manifestations: Fatigue; neuropathy may occur with B12 deficiency.

Diagnostics / labs / imaging: CBC indices, smear, B12/folate, reticulocytes, liver/thyroid tests.

Complications: Neurologic injury, cytopenias.

Treatment categories: Replace deficiency or treat cause.

Medical-record relevance: Macrocytosis is a finding; cause should be established.

Related terminology: macrocytosis

Related anatomy: RBCs; marrow

Source: StatPearls — Leukemia

Hemolytic anemiaHematologic · CROSS-LINK

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Immune, hereditary, mechanical, infectious or toxic injury

Pathophysiologic mechanism: RBC destruction exceeds marrow replacement.

Progression: May be acute or chronic.

Clinical manifestations: Jaundice, dark urine, fatigue, splenomegaly.

Diagnostics / labs / imaging: CBC, reticulocytes, bilirubin, LDH, haptoglobin, smear, antiglobulin test.

Complications: Gallstones, severe anemia.

Treatment categories: Treat cause; immune or transfusion support when indicated.

Medical-record relevance: Evidence of hemolysis should be linked to a defined cause where possible.

Related terminology: hemolysis

Related anatomy: RBCs; spleen

Source: StatPearls — Thrombocytopenia

LeukocytosisHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Infection, inflammation, stress, steroids or malignancy

Pathophysiologic mechanism: WBC production/release increases.

Progression: Transient reactive pattern or persistent clonal process.

Clinical manifestations: Often asymptomatic itself.

Diagnostics / labs / imaging: CBC differential, smear, cause-specific tests.

Complications: May signal severe infection or hematologic malignancy.

Treatment categories: Treat underlying cause.

Medical-record relevance: A high WBC count is an indicator, not automatically leukemia.

Related terminology: leukocytosis

Related anatomy: WBCs; marrow

Source: StatPearls — Leukemia

LeukopeniaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Marrow suppression, infection, autoimmune disease, drugs or nutritional deficiency

Pathophysiologic mechanism: Circulating leukocytes fall below normal reserve.

Progression: May be transient or persistent.

Clinical manifestations: Often asymptomatic until infection develops.

Diagnostics / labs / imaging: CBC differential, smear, marrow evaluation if unexplained.

Complications: Infection susceptibility.

Treatment categories: Treat cause; growth-factor support in selected cases.

Medical-record relevance: Specify neutropenia/lymphopenia when present.

Related terminology: leukopenia

Related anatomy: WBCs; marrow

Source: StatPearls — Leukemia

NeutropeniaHematologic · CROSS-LINK

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Chemotherapy, marrow disease, autoimmune/infectious causes

Pathophysiologic mechanism: Reduced neutrophil count impairs innate bacterial/fungal defense.

Progression: Risk rises with depth and duration.

Clinical manifestations: Fever may be the only sign of infection.

Diagnostics / labs / imaging: ANC, CBC, cultures if febrile.

Complications: Sepsis and opportunistic infection.

Treatment categories: Cause-specific care; febrile neutropenia requires urgent antimicrobial evaluation.

Medical-record relevance: ANC and fever status drive urgency.

Related terminology: neutropenia

Related anatomy: Neutrophils

Source: StatPearls — Leukemia

ThrombocytopeniaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Reduced production, increased destruction/consumption or splenic sequestration

Pathophysiologic mechanism: Low platelet count impairs primary hemostasis.

Progression: Severity depends on count and cause.

Clinical manifestations: Petechiae, bruising, mucosal bleeding or asymptomatic.

Diagnostics / labs / imaging: Repeat CBC, smear, HIV/HCV, liver/coagulation and marrow studies as indicated.

Complications: Major bleeding.

Treatment categories: Treat cause; platelet support in selected severe cases.

Medical-record relevance: Confirm true thrombocytopenia and mechanism.

Related terminology: thrombocytopenia

Related anatomy: Platelets; marrow; spleen

Source: StatPearls — Thrombocytopenia

Immune thrombocytopeniaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Autoantibody-mediated platelet destruction with impaired production

Pathophysiologic mechanism: Immune clearance lowers platelets.

Progression: Often isolated thrombocytopenia.

Clinical manifestations: Petechiae, bruising, mucosal bleeding.

Diagnostics / labs / imaging: CBC/smear and exclusion of secondary causes.

Complications: Severe bleeding.

Treatment categories: Steroids, IVIG and other immune-directed therapies when indicated.

Medical-record relevance: ITP is a diagnosis of exclusion, not every isolated low platelet count.

Related terminology: ITP

Related anatomy: Platelets; spleen

Source: StatPearls — Thrombocytopenia

ThrombocytosisHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Reactive inflammation/iron deficiency or clonal marrow disease

Pathophysiologic mechanism: Platelet count increases from cytokine-driven or clonal production.

Progression: May resolve with cause or persist.

Clinical manifestations: Often asymptomatic.

Diagnostics / labs / imaging: CBC trend, ferritin/inflammatory studies, molecular testing if clonal process suspected.

Complications: Thrombosis or bleeding in selected disorders.

Treatment categories: Treat cause; antiplatelet/cytoreduction in selected clonal disease.

Medical-record relevance: Reactive versus clonal thrombocytosis should be distinguished.

Related terminology: thrombocytosis

Related anatomy: Platelets; marrow

Source: StatPearls — Thrombosis

PancytopeniaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Marrow failure/infiltration, severe infection, nutritional deficiency or hypersplenism

Pathophysiologic mechanism: All major blood-cell lines fall.

Progression: May progress with marrow disease.

Clinical manifestations: Fatigue, infection, bleeding.

Diagnostics / labs / imaging: CBC, smear, reticulocytes, marrow biopsy when indicated.

Complications: Sepsis, hemorrhage, severe anemia.

Treatment categories: Treat underlying cause; supportive transfusion/growth factor as appropriate.

Medical-record relevance: Pancytopenia is a pattern requiring etiology.

Related terminology: pancytopenia

Related anatomy: Bone marrow; blood

Source: StatPearls — Leukemia

LeukemiaHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Clonal hematopoietic malignancy

Pathophysiologic mechanism: Abnormal leukocyte precursors proliferate and crowd normal marrow.

Progression: Acute forms progress rapidly; chronic forms may be indolent.

Clinical manifestations: Fatigue, infection, bleeding, lymphadenopathy or incidental leukocytosis.

Diagnostics / labs / imaging: CBC/smear, flow cytometry, marrow, cytogenetic/molecular testing.

Complications: Marrow failure, leukostasis, tumor lysis.

Treatment categories: Subtype-specific systemic therapy.

Medical-record relevance: Acute/chronic and lineage subtype determine diagnosis and treatment.

Related terminology: leukemia

Related anatomy: Bone marrow; blood

Source: StatPearls — Leukemia

Bone-marrow failureHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Aplastic, toxic, immune, malignant or infiltrative causes

Pathophysiologic mechanism: Hematopoietic production falls across one or more lineages.

Progression: Can become severe and life-threatening.

Clinical manifestations: Fatigue, infection, bleeding.

Diagnostics / labs / imaging: CBC, reticulocytes, marrow biopsy.

Complications: Pancytopenia, sepsis, hemorrhage.

Treatment categories: Cause-specific therapy, transfusion, transplant in selected cases.

Medical-record relevance: Production failure differs from peripheral destruction.

Related terminology: marrow failure

Related anatomy: Bone marrow

Source: StatPearls — Leukemia

CoagulopathyHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Factor deficiency, liver disease, anticoagulants, DIC or inherited disorders

Pathophysiologic mechanism: Secondary hemostasis is impaired.

Progression: May be acute or chronic.

Clinical manifestations: Bleeding, bruising or abnormal labs only.

Diagnostics / labs / imaging: PT/INR, aPTT, fibrinogen, factor studies.

Complications: Major hemorrhage.

Treatment categories: Reverse/treat cause and replace factors when indicated.

Medical-record relevance: Abnormal coagulation tests require clinical cause/context.

Related terminology: coagulopathy

Related anatomy: Coagulation factors

Source: StatPearls — Thrombosis

HypercoagulabilityHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Inherited or acquired prothrombotic states

Pathophysiologic mechanism: Balance shifts toward clot formation through excess procoagulant activity or reduced anticoagulant function.

Progression: May remain silent until thrombosis.

Clinical manifestations: Often asymptomatic until VTE/arterial event.

Diagnostics / labs / imaging: Cause-directed thrombophilia testing only when clinically appropriate.

Complications: DVT, PE, recurrent thrombosis.

Treatment categories: Anticoagulation and cause management.

Medical-record relevance: A risk state is distinct from an acute thrombosis diagnosis.

Related terminology: thrombophilia

Related anatomy: Coagulation system

Source: StatPearls — Thrombosis

Venous thrombosisHematologic · CROSS-LINK

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Stasis, endothelial injury and hypercoagulability

Pathophysiologic mechanism: Fibrin-rich clot forms in venous circulation.

Progression: Can propagate or embolize.

Clinical manifestations: Swelling, pain or asymptomatic.

Diagnostics / labs / imaging: Compression ultrasound and clinical risk assessment.

Complications: Pulmonary embolism, post-thrombotic syndrome.

Treatment categories: Anticoagulation; thrombectomy in selected cases.

Medical-record relevance: Site and acuity should be documented.

Related terminology: DVT

Related anatomy: Veins

Source: StatPearls — Thrombosis

Disseminated intravascular coagulationHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Sepsis, trauma, obstetric catastrophe, malignancy

Pathophysiologic mechanism: Systemic coagulation activation consumes platelets/factors and causes microthrombi plus bleeding.

Progression: Can rapidly produce multiorgan injury.

Clinical manifestations: Bleeding, thrombosis, organ dysfunction.

Diagnostics / labs / imaging: Platelets, PT/aPTT, fibrinogen, D-dimer and clinical context.

Complications: Shock, organ failure, hemorrhage.

Treatment categories: Treat trigger; targeted blood-component support.

Medical-record relevance: DIC requires a compatible clinical/lab pattern.

Related terminology: DIC

Related anatomy: Microvasculature; coagulation

Source: StatPearls — Thrombosis

HemostasisHematologic · A&P LINK

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Platelet, vessel, coagulation and fibrinolytic systems

Pathophysiologic mechanism: Coordinated clot formation limits bleeding then fibrinolysis restores flow.

Progression: Dysfunction can cause bleeding or thrombosis.

Clinical manifestations: No symptoms when normal.

Diagnostics / labs / imaging: Platelet count/function and coagulation tests when abnormal.

Complications: Hemorrhage or thrombosis.

Treatment categories: Treat specific defect.

Medical-record relevance: Foundation for interpreting bleeding and clotting disorders.

Related terminology: hemostasis

Related anatomy: Blood; vessels

Source: StatPearls — Thrombosis

CBC interpretationHematologic · CROSS-LINK

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Suspected hematologic/systemic disease

Pathophysiologic mechanism: Counts and indices summarize circulating blood-cell populations.

Progression: Trends help identify acute versus chronic patterns.

Clinical manifestations: No direct symptom.

Diagnostics / labs / imaging: CBC with differential, indices, smear when indicated.

Complications: Misclassification if values are treated as diagnoses without context.

Treatment categories: Evaluate cause of abnormalities.

Medical-record relevance: CBC findings are indicators supporting diagnosis.

Related terminology: CBC; differential

Related anatomy: Blood

Source: StatPearls — Thrombocytopenia

Hematologic indicator versus diagnosisHematologic · NEW

Normal function anchor: Bone marrow produces blood cells while coagulation and fibrinolysis maintain hemostatic balance.

Etiology / risk factors: Abnormal count, smear or coagulation result

Pathophysiologic mechanism: Laboratory patterns narrow mechanisms but require clinical synthesis.

Progression: Diagnosis evolves with confirmatory testing.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Repeat labs, smear, marrow, molecular/coagulation studies as indicated.

Complications: Documentation/coding ambiguity.

Treatment categories: Document confirmed disease and cause.

Medical-record relevance: Direct bridge into CDI/coding.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Leukemia

Pathophysiology section 14

Cardiovascular & Lymphatic Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

HypertensionCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Genetic, renal, vascular, endocrine and lifestyle factors

Pathophysiologic mechanism: Sustained arterial pressure increases vascular and myocardial load.

Progression: Chronic pressure causes remodeling and end-organ injury.

Clinical manifestations: Often asymptomatic; headache is nonspecific.

Diagnostics / labs / imaging: Repeated standardized BP; ambulatory/home monitoring when needed.

Complications: LVH, CKD, stroke, CAD.

Treatment categories: Lifestyle and antihypertensive therapy.

Medical-record relevance: Diagnosis depends on repeated measurements/clinical context.

Related terminology: hypertension

Related anatomy: Arteries; heart

Source: StatPearls — Hypertensive Heart Disease

Hypertensive heart diseaseCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Long-standing hypertension

Pathophysiologic mechanism: Pressure overload produces LV hypertrophy and diastolic/systolic dysfunction.

Progression: May progress to heart failure or arrhythmia.

Clinical manifestations: Dyspnea, exercise intolerance, edema in advanced disease.

Diagnostics / labs / imaging: BP history, ECG, echocardiography.

Complications: HF, AF, ischemia, sudden death.

Treatment categories: BP control and HF/arrhythmia care when present.

Medical-record relevance: Hypertension plus documented cardiac disease supports specific linkage.

Related terminology: hypertensive heart disease

Related anatomy: Left ventricle

Source: StatPearls — Hypertensive Heart Disease

Left ventricular hypertrophyCardiovascular / lymphatic · CROSS-LINK

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Pressure overload, athletic adaptation or other cardiac disease

Pathophysiologic mechanism: Myocytes enlarge to normalize wall stress.

Progression: May remain compensatory or progress to stiffness/failure.

Clinical manifestations: Often asymptomatic.

Diagnostics / labs / imaging: ECG and echocardiography.

Complications: Diastolic dysfunction, arrhythmia.

Treatment categories: Treat underlying cause.

Medical-record relevance: LVH is a structural finding; etiology should be documented.

Related terminology: LVH

Related anatomy: Left ventricle

Source: StatPearls — Hypertensive Heart Disease

AtherosclerosisCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Lipids, hypertension, smoking, diabetes, inflammation

Pathophysiologic mechanism: Endothelial dysfunction and lipid accumulation form plaques.

Progression: Plaques enlarge, calcify or rupture.

Clinical manifestations: Often silent until ischemia.

Diagnostics / labs / imaging: Risk assessment, vascular imaging, lipid testing.

Complications: MI, stroke, PAD.

Treatment categories: Risk-factor modification, lipid-lowering, antiplatelet/revascularization when indicated.

Medical-record relevance: Anatomic vascular disease and risk factors should be distinguished.

Related terminology: atherosclerosis

Related anatomy: Arteries

Source: StatPearls — Thrombosis

Coronary artery diseaseCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Atherosclerotic plaque in coronary arteries

Pathophysiologic mechanism: Fixed stenosis or plaque rupture reduces myocardial perfusion.

Progression: Can produce stable ischemia or acute coronary syndrome.

Clinical manifestations: Angina, dyspnea or silent ischemia.

Diagnostics / labs / imaging: ECG, troponin when acute, stress testing/CT/coronary angiography as indicated.

Complications: MI, HF, arrhythmia.

Treatment categories: Risk-factor therapy and revascularization when indicated.

Medical-record relevance: Stable CAD and acute MI are distinct diagnoses.

Related terminology: CAD

Related anatomy: Coronary arteries

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Myocardial ischemiaCardiovascular / lymphatic · CROSS-LINK

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Supply-demand mismatch or coronary obstruction

Pathophysiologic mechanism: Myocardial oxygen delivery is insufficient for demand.

Progression: May be transient or progress to infarction.

Clinical manifestations: Chest pressure, dyspnea or atypical symptoms.

Diagnostics / labs / imaging: ECG, troponin trends, imaging/stress testing.

Complications: Infarction, arrhythmia.

Treatment categories: Restore perfusion/treat cause.

Medical-record relevance: Ischemia is not automatically infarction.

Related terminology: ischemia

Related anatomy: Myocardium; coronaries

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Myocardial infarctionCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Acute coronary thrombosis or other ischemic mechanism

Pathophysiologic mechanism: Prolonged ischemia causes irreversible myocyte necrosis.

Progression: Necrosis triggers inflammation/remodeling.

Clinical manifestations: Chest pain, dyspnea, diaphoresis or atypical symptoms.

Diagnostics / labs / imaging: ECG, serial troponin, angiography.

Complications: Arrhythmia, cardiogenic shock, HF.

Treatment categories: Urgent reperfusion and guideline-directed therapy.

Medical-record relevance: Type, territory and acute status matter.

Related terminology: myocardial infarction

Related anatomy: Myocardium

Source: StatPearls — Thrombosis

Heart failureCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Ischemic, hypertensive, valvular, myocardial or other structural disease

Pathophysiologic mechanism: Heart cannot meet circulatory demand without elevated filling pressures.

Progression: May progress through symptomatic and advanced stages.

Clinical manifestations: Dyspnea, edema, fatigue, orthopnea.

Diagnostics / labs / imaging: BNP/NT-proBNP, ECG, echo, chest imaging, renal/electrolyte tests.

Complications: Pulmonary edema, renal dysfunction, arrhythmia.

Treatment categories: Guideline-directed therapy and treatment of cause.

Medical-record relevance: Document EF phenotype and acute/chronic status where established.

Related terminology: heart failure

Related anatomy: Heart; circulation

Source: StatPearls — Heart Failure (Congestive Heart Failure)

HFrEFCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Systolic myocardial dysfunction

Pathophysiologic mechanism: Reduced contractility lowers ejection fraction and forward output.

Progression: Neurohormonal activation drives remodeling.

Clinical manifestations: Dyspnea, fatigue, edema.

Diagnostics / labs / imaging: Echo LVEF, BNP, clinical assessment.

Complications: Decompensation, arrhythmia.

Treatment categories: Guideline-directed HFrEF therapy.

Medical-record relevance: Reduced EF phenotype has specific treatment/documentation relevance.

Related terminology: HFrEF

Related anatomy: Left ventricle

Source: StatPearls — Heart Failure (Congestive Heart Failure)

HFpEFCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Diastolic stiffness/relaxation abnormality often with hypertension/aging/comorbidity

Pathophysiologic mechanism: Filling pressures rise despite preserved EF.

Progression: Chronic congestion and exercise intolerance can develop.

Clinical manifestations: Dyspnea, edema, fatigue.

Diagnostics / labs / imaging: Echo, BNP, diastolic parameters and clinical context.

Complications: Decompensated HF, AF, pulmonary hypertension.

Treatment categories: Volume/comorbidity management and evidence-based HF therapy.

Medical-record relevance: Preserved EF does not exclude heart failure.

Related terminology: HFpEF

Related anatomy: Left ventricle

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Acute decompensated heart failureCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Trigger superimposed on chronic or new HF

Pathophysiologic mechanism: Filling pressures rise and congestion/perfusion worsen.

Progression: Can progress to respiratory failure/shock.

Clinical manifestations: Acute dyspnea, edema, hypoxemia.

Diagnostics / labs / imaging: BNP, ECG, troponin, chest imaging, echo, renal/electrolytes.

Complications: Pulmonary edema, cardiorenal syndrome.

Treatment categories: Diuresis, afterload/preload/perfusion management and trigger treatment.

Medical-record relevance: Acute versus chronic status should be explicit.

Related terminology: decompensated HF

Related anatomy: Heart; lungs

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Cardiogenic shockCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Severe pump failure

Pathophysiologic mechanism: Cardiac output falls enough to cause tissue hypoperfusion.

Progression: Rapidly progressive critical state.

Clinical manifestations: Hypotension, cool extremities, oliguria, altered mentation.

Diagnostics / labs / imaging: Hemodynamics, lactate, echo, ECG/troponin.

Complications: Multiorgan failure, death.

Treatment categories: Revascularization/circulatory support and cause treatment.

Medical-record relevance: Shock type should be specifically documented.

Related terminology: cardiogenic shock

Related anatomy: Heart; circulation

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Atrial fibrillationCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Atrial structural/electrical remodeling, age, hypertension, HF, valvular disease

Pathophysiologic mechanism: Chaotic atrial activation eliminates coordinated atrial contraction.

Progression: May be paroxysmal or persistent.

Clinical manifestations: Palpitations, fatigue, dyspnea or asymptomatic.

Diagnostics / labs / imaging: ECG/rhythm monitoring.

Complications: Stroke, HF exacerbation.

Treatment categories: Rate/rhythm control and anticoagulation based on risk.

Medical-record relevance: Rhythm type and anticoagulation indication matter.

Related terminology: atrial fibrillation

Related anatomy: Atria

Source: StatPearls — Hypertensive Heart Disease

Venous thromboembolismCardiovascular / lymphatic · CROSS-LINK

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Stasis, endothelial injury, hypercoagulability

Pathophysiologic mechanism: Venous thrombus forms and may embolize.

Progression: DVT can propagate to pulmonary embolism.

Clinical manifestations: Limb swelling or cardiopulmonary symptoms if embolization occurs.

Diagnostics / labs / imaging: Ultrasound, CT pulmonary angiography/VQ testing depending on presentation.

Complications: PE, post-thrombotic syndrome.

Treatment categories: Anticoagulation; intervention in selected high-risk cases.

Medical-record relevance: DVT and PE should be separately documented by site/acuity.

Related terminology: VTE

Related anatomy: Veins; pulmonary arteries

Source: StatPearls — Thrombosis

Peripheral arterial diseaseCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Atherosclerosis in limb arteries

Pathophysiologic mechanism: Flow limitation causes exertional or critical limb ischemia.

Progression: Can progress from claudication to tissue loss.

Clinical manifestations: Claudication, rest pain, ulcers.

Diagnostics / labs / imaging: ABI, duplex, CTA/MRA.

Complications: Ulceration, amputation.

Treatment categories: Risk-factor therapy and revascularization when indicated.

Medical-record relevance: Laterality/site and ulcer status matter.

Related terminology: PAD

Related anatomy: Peripheral arteries

Source: StatPearls — Thrombosis

Chronic venous insufficiencyCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Valve failure/venous obstruction

Pathophysiologic mechanism: Venous hypertension causes edema and skin/tissue changes.

Progression: Can progress to venous ulceration.

Clinical manifestations: Leg swelling, varicosities, stasis skin changes.

Diagnostics / labs / imaging: Clinical exam, venous duplex.

Complications: Ulcers, dermatitis.

Treatment categories: Compression and venous intervention when indicated.

Medical-record relevance: Differentiate venous from arterial/lymphatic edema.

Related terminology: venous insufficiency

Related anatomy: Leg veins

Source: StatPearls — Thrombosis

LymphedemaCardiovascular / lymphatic · CROSS-LINK

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Lymphatic obstruction or developmental dysfunction

Pathophysiologic mechanism: Protein-rich interstitial fluid accumulates when lymph drainage is impaired.

Progression: Chronic swelling can produce fibrosis.

Clinical manifestations: Persistent limb swelling.

Diagnostics / labs / imaging: Clinical exam; imaging in selected cases.

Complications: Cellulitis, fibrosis, functional limitation.

Treatment categories: Compression/lymphatic therapy and cause treatment.

Medical-record relevance: Lymphedema is distinct from venous edema.

Related terminology: lymphedema

Related anatomy: Lymphatic vessels

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Endothelial dysfunctionCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Hypertension, diabetes, smoking, inflammation, dyslipidemia

Pathophysiologic mechanism: Reduced vasodilatory and antithrombotic endothelial function promotes vascular disease.

Progression: Contributes to atherosclerosis and thrombosis.

Clinical manifestations: Usually asymptomatic.

Diagnostics / labs / imaging: Risk-factor assessment; specialized endothelial tests uncommon clinically.

Complications: ASCVD, thrombosis.

Treatment categories: Risk-factor modification.

Medical-record relevance: Mechanistic concept rather than routine standalone diagnosis.

Related terminology: endothelial dysfunction

Related anatomy: Vascular endothelium

Source: StatPearls — Hypertensive Heart Disease

Cardiac biomarker interpretationCardiovascular / lymphatic · CROSS-LINK

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Myocardial injury, stretch, renal dysfunction and systemic illness

Pathophysiologic mechanism: Troponin reflects myocardial injury; natriuretic peptides reflect wall stress but are not perfectly disease-specific.

Progression: Trends and clinical context determine significance.

Clinical manifestations: No direct symptom.

Diagnostics / labs / imaging: Serial troponin; BNP/NT-proBNP; ECG/imaging.

Complications: Misdiagnosis if biomarker is equated with a specific syndrome.

Treatment categories: Treat confirmed underlying condition.

Medical-record relevance: Elevated troponin is not automatically acute MI; BNP is not independently HF.

Related terminology: troponin; BNP

Related anatomy: Heart; blood

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Cardiovascular indicator versus diagnosisCardiovascular / lymphatic · NEW

Normal function anchor: Heart, vessels and lymphatics maintain perfusion, pressure, fluid return, and oxygen delivery.

Etiology / risk factors: Abnormal ECG, biomarker, BP or imaging

Pathophysiologic mechanism: Findings support diagnostic probability but require synthesis with symptoms and criteria.

Progression: Diagnosis evolves with serial testing.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: ECG, echo, biomarkers, vascular imaging, hemodynamics.

Complications: Documentation/coding ambiguity.

Treatment categories: Clarify confirmed disease, acuity and causal links.

Medical-record relevance: Direct CDI/coding bridge.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Heart Failure (Congestive Heart Failure)

Pathophysiology section 15

Pulmonary Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

AsthmaPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Genetic/atopic susceptibility and environmental triggers

Pathophysiologic mechanism: Airway inflammation, hyperresponsiveness and reversible bronchoconstriction cause variable airflow limitation.

Progression: Episodic symptoms may progress with poor control/remodeling.

Clinical manifestations: Wheeze, cough, dyspnea, chest tightness.

Diagnostics / labs / imaging: Spirometry showing variable expiratory obstruction/bronchodilator response.

Complications: Severe exacerbation, respiratory failure.

Treatment categories: Controller/reliever therapy and trigger management.

Medical-record relevance: Diagnosis requires symptom pattern plus variable airflow limitation.

Related terminology: asthma

Related anatomy: Bronchi

Source: StatPearls — Asthma

Asthma exacerbationPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Infection, allergens, irritants, poor adherence

Pathophysiologic mechanism: Acute inflammation and smooth-muscle constriction narrow airways.

Progression: May progress rapidly.

Clinical manifestations: Wheeze, dyspnea, tachypnea, reduced peak flow.

Diagnostics / labs / imaging: Clinical severity, pulse oximetry, peak flow/spirometry when feasible.

Complications: Status asthmaticus, respiratory failure.

Treatment categories: Rapid bronchodilation, corticosteroids, oxygen/support as indicated.

Medical-record relevance: Acute exacerbation should be distinguished from baseline asthma.

Related terminology: asthma exacerbation

Related anatomy: Airways

Source: StatPearls — Asthma

COPDPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Tobacco/biomass exposure, genetics, recurrent injury

Pathophysiologic mechanism: Small-airway disease and emphysema produce persistent airflow obstruction.

Progression: Progressive with exacerbations.

Clinical manifestations: Chronic dyspnea, cough, sputum.

Diagnostics / labs / imaging: Post-bronchodilator spirometry.

Complications: Respiratory failure, pulmonary hypertension, cachexia.

Treatment categories: Smoking cessation, inhaled therapy, rehab, oxygen in eligible patients.

Medical-record relevance: Spirometric confirmation and exacerbation history matter.

Related terminology: COPD

Related anatomy: Bronchi; alveoli

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

COPD exacerbationPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Infection, pollutants or other triggers

Pathophysiologic mechanism: Acute increase in airway inflammation and gas-exchange impairment.

Progression: Can require hospitalization/ventilatory support.

Clinical manifestations: Worsened dyspnea, cough, sputum.

Diagnostics / labs / imaging: Clinical assessment, oximetry, blood gas/imaging when severe.

Complications: Acute respiratory failure.

Treatment categories: Bronchodilators, steroids, antibiotics when indicated, oxygen/ventilation support.

Medical-record relevance: Acute exacerbation status changes acuity documentation.

Related terminology: AECOPD

Related anatomy: Airways; alveoli

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

EmphysemaPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Smoking, alpha-1 antitrypsin deficiency, chronic injury

Pathophysiologic mechanism: Alveolar wall destruction reduces elastic recoil and gas-exchange surface.

Progression: Progressive air trapping and hyperinflation.

Clinical manifestations: Dyspnea, reduced exercise tolerance.

Diagnostics / labs / imaging: CT, spirometry, DLCO.

Complications: Respiratory failure, pneumothorax.

Treatment categories: COPD-directed therapy; selected surgical interventions.

Medical-record relevance: Emphysema can coexist with chronic bronchitic phenotype.

Related terminology: emphysema

Related anatomy: Alveoli

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Chronic bronchitis phenotypePulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Smoking/irritant exposure

Pathophysiologic mechanism: Mucus-gland enlargement and airway inflammation increase sputum and obstruction.

Progression: Chronic productive cough with COPD physiology.

Clinical manifestations: Cough, sputum, dyspnea.

Diagnostics / labs / imaging: Clinical history plus spirometry for COPD.

Complications: Infection/exacerbations, hypoxemia.

Treatment categories: COPD-directed treatment.

Medical-record relevance: Phenotype description should not replace objective COPD confirmation.

Related terminology: chronic bronchitis

Related anatomy: Bronchi

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Airflow obstructionPulmonary · CROSS-LINK

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Asthma, COPD, bronchiectasis or airway lesion

Pathophysiologic mechanism: Expiratory flow is limited by narrowed/collapsible airways.

Progression: May be reversible or fixed.

Clinical manifestations: Wheeze, dyspnea.

Diagnostics / labs / imaging: Spirometry FEV1/FVC pattern.

Complications: Air trapping, respiratory failure.

Treatment categories: Treat underlying airway disorder.

Medical-record relevance: A spirometric pattern is not itself a specific diagnosis.

Related terminology: obstruction

Related anatomy: Airways

Source: StatPearls — Asthma

HypoxemiaPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: V/Q mismatch, shunt, diffusion impairment, hypoventilation or low inspired oxygen

Pathophysiologic mechanism: Arterial oxygen falls below normal.

Progression: Severity and chronicity determine physiologic response.

Clinical manifestations: Dyspnea, cyanosis, confusion if severe.

Diagnostics / labs / imaging: Pulse oximetry, ABG, imaging/PFTs as indicated.

Complications: Tissue hypoxia, arrhythmia, organ dysfunction.

Treatment categories: Oxygen/support and cause treatment.

Medical-record relevance: Low saturation is an indicator; cause should be documented.

Related terminology: hypoxemia

Related anatomy: Lungs; blood

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

HypercapniaPulmonary · CROSS-LINK

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Alveolar hypoventilation or severe V/Q inefficiency

Pathophysiologic mechanism: CO2 elimination becomes inadequate.

Progression: Can be acute, chronic or acute-on-chronic.

Clinical manifestations: Headache, somnolence, confusion.

Diagnostics / labs / imaging: Blood gas and ventilatory evaluation.

Complications: Respiratory acidosis, CO2 narcosis.

Treatment categories: Restore ventilation and treat cause.

Medical-record relevance: Differentiate chronic compensation from acute respiratory failure.

Related terminology: hypercapnia

Related anatomy: Lungs

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Acute respiratory failurePulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Severe oxygenation and/or ventilation failure

Pathophysiologic mechanism: Gas exchange cannot meet physiologic needs.

Progression: May progress rapidly to multiorgan injury.

Clinical manifestations: Severe dyspnea, hypoxemia/hypercapnia, altered mentation.

Diagnostics / labs / imaging: ABG, oximetry, imaging, respiratory mechanics.

Complications: Cardiac arrest, organ failure.

Treatment categories: Oxygen, noninvasive/invasive ventilation and cause treatment.

Medical-record relevance: Type (hypoxemic/hypercapnic) and acute/chronic status matter.

Related terminology: respiratory failure

Related anatomy: Lungs

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Chronic respiratory failurePulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Advanced COPD, restrictive/neuromuscular/chest-wall disease

Pathophysiologic mechanism: Long-term gas-exchange impairment persists despite compensation.

Progression: May worsen during acute illness.

Clinical manifestations: Chronic hypoxemia/hypercapnia, exertional limitation.

Diagnostics / labs / imaging: Blood gas, oximetry, PFTs, sleep testing as indicated.

Complications: Pulmonary hypertension, cor pulmonale.

Treatment categories: Long-term oxygen/ventilation strategies when indicated.

Medical-record relevance: Chronic baseline should be distinguished from acute decompensation.

Related terminology: chronic respiratory failure

Related anatomy: Lungs

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Ventilation-perfusion mismatchPulmonary · A&P LINK

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Airway, alveolar or vascular lung disease

Pathophysiologic mechanism: Ventilation and perfusion become unevenly matched, lowering gas-exchange efficiency.

Progression: Common mechanism of hypoxemia.

Clinical manifestations: Dyspnea/hypoxemia.

Diagnostics / labs / imaging: ABG, imaging, PFTs and cause-specific tests.

Complications: Respiratory failure.

Treatment categories: Treat underlying airway/alveolar/vascular disease.

Medical-record relevance: Mechanism supports interpretation but is not a standalone diagnosis.

Related terminology: V/Q mismatch

Related anatomy: Alveoli; pulmonary vessels

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Diffusion impairmentPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Interstitial/alveolar-capillary disease

Pathophysiologic mechanism: Gas transfer across alveolar-capillary membrane becomes inefficient.

Progression: Often worse with exertion.

Clinical manifestations: Exertional dyspnea/hypoxemia.

Diagnostics / labs / imaging: DLCO, oximetry, HRCT when indicated.

Complications: Chronic hypoxemia.

Treatment categories: Treat underlying interstitial/alveolar disease.

Medical-record relevance: Low DLCO is a functional finding requiring context.

Related terminology: diffusion capacity

Related anatomy: Alveolar-capillary membrane

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Air trappingPulmonary · CROSS-LINK

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Obstructive airway disease

Pathophysiologic mechanism: Incomplete exhalation increases residual volume and hyperinflation.

Progression: Worsens with tachypnea/exacerbation.

Clinical manifestations: Dyspnea, prolonged expiration.

Diagnostics / labs / imaging: PFT lung volumes; imaging.

Complications: Dynamic hyperinflation, ventilatory failure.

Treatment categories: Bronchodilation and obstructive-lung treatment.

Medical-record relevance: Air trapping supports obstructive physiology.

Related terminology: air trapping

Related anatomy: Small airways; lungs

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Bronchial hyperresponsivenessPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Asthma and related airway inflammation

Pathophysiologic mechanism: Airways constrict excessively to stimuli.

Progression: Variable over time.

Clinical manifestations: Trigger-associated wheeze/cough.

Diagnostics / labs / imaging: Bronchodilator or bronchoprovocation testing in selected cases.

Complications: Severe bronchospasm.

Treatment categories: Asthma-directed therapy.

Medical-record relevance: Supports asthma mechanism but is not always diagnostic alone.

Related terminology: bronchial hyperresponsiveness

Related anatomy: Bronchi

Source: StatPearls — Asthma

Mucus hypersecretionPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Asthma, COPD/chronic bronchitis, infection

Pathophysiologic mechanism: Goblet-cell/gland activity increases airway secretions.

Progression: Can obstruct small airways and impair clearance.

Clinical manifestations: Productive cough, wheeze.

Diagnostics / labs / imaging: Clinical assessment; imaging if complications suspected.

Complications: Atelectasis, infection, airflow obstruction.

Treatment categories: Airway clearance and disease-specific therapy.

Medical-record relevance: Sputum change may signal exacerbation but is nonspecific.

Related terminology: mucus hypersecretion

Related anatomy: Airways

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary hypertension from lung diseasePulmonary · CROSS-LINK

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Chronic hypoxemia and vascular remodeling

Pathophysiologic mechanism: Pulmonary vascular resistance rises.

Progression: May progress to right-heart strain.

Clinical manifestations: Dyspnea, fatigue, edema in advanced disease.

Diagnostics / labs / imaging: Echo; right-heart catheterization for confirmation when indicated.

Complications: Cor pulmonale, right HF.

Treatment categories: Treat lung disease/hypoxemia; PH-specific therapy only in selected groups.

Medical-record relevance: Cause/group classification matters.

Related terminology: pulmonary hypertension

Related anatomy: Pulmonary arteries

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Cor pulmonalePulmonary · CROSS-LINK

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Chronic pulmonary hypertension from lung disease

Pathophysiologic mechanism: Right ventricle hypertrophies/dilates under increased pulmonary pressure.

Progression: Can progress to right-sided failure.

Clinical manifestations: Peripheral edema, JVD, hepatomegaly.

Diagnostics / labs / imaging: Echo, ECG, chest imaging.

Complications: Right HF.

Treatment categories: Treat lung disease/hypoxemia and volume status.

Medical-record relevance: Cor pulmonale links cardiac findings to pulmonary cause.

Related terminology: cor pulmonale

Related anatomy: Right ventricle; pulmonary arteries

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Spirometry interpretationPulmonary · CROSS-LINK

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Suspected obstructive lung disease

Pathophysiologic mechanism: FEV1, FVC and ratio quantify expiratory airflow.

Progression: Pre/post-bronchodilator values help characterize reversibility.

Clinical manifestations: No direct symptom.

Diagnostics / labs / imaging: Quality-controlled spirometry.

Complications: Misclassification if poor-quality effort or wrong reference interpretation.

Treatment categories: Use to support diagnosis and severity.

Medical-record relevance: Spirometric pattern must be integrated with clinical diagnosis.

Related terminology: FEV1; FVC

Related anatomy: Lungs

Source: StatPearls — Asthma

Pulmonary indicator versus diagnosisPulmonary · NEW

Normal function anchor: Airways, alveoli, pulmonary vessels and respiratory muscles maintain ventilation and gas exchange.

Etiology / risk factors: Dyspnea, wheeze, hypoxemia or abnormal PFT/imaging

Pathophysiologic mechanism: Symptoms and tests narrow mechanism but do not automatically establish a specific lung disease.

Progression: Diagnosis may evolve after testing.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: PFTs, imaging, blood gas, oximetry and clinical history.

Complications: Documentation/coding ambiguity.

Treatment categories: Document confirmed disease, acuity and respiratory-failure status.

Medical-record relevance: Direct CDI/coding bridge.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Chronic Obstructive Pulmonary Disease (COPD)

Pathophysiology section 16

Renal & Urologic Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Acute kidney injuryRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Prerenal hypoperfusion, intrinsic renal injury or postrenal obstruction

Pathophysiologic mechanism: Abrupt fall in filtration causes creatinine rise and/or oliguria.

Progression: May be reversible or progress to severe renal failure.

Clinical manifestations: Reduced urine, edema, uremic symptoms or asymptomatic lab change.

Diagnostics / labs / imaging: Serial creatinine, urine output, urinalysis, electrolytes, imaging as indicated.

Complications: Hyperkalemia, acidosis, volume overload, uremia.

Treatment categories: Treat cause and complications; dialysis when indicated.

Medical-record relevance: AKI requires clinical criteria and temporal change, not a single creatinine value.

Related terminology: AKI

Related anatomy: Kidneys

Source: StatPearls — Acute Kidney Injury

Prerenal AKIRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Volume depletion, low cardiac output or altered renal perfusion

Pathophysiologic mechanism: Reduced renal blood flow lowers GFR without primary parenchymal injury initially.

Progression: Can reverse rapidly or progress to ischemic tubular injury.

Clinical manifestations: Orthostasis, low urine output, cause-specific signs.

Diagnostics / labs / imaging: Creatinine trend, urine studies, volume/hemodynamic assessment.

Complications: Ischemic ATN if prolonged.

Treatment categories: Restore perfusion and treat cause.

Medical-record relevance: Differentiate prerenal physiology from intrinsic renal damage.

Related terminology: prerenal azotemia

Related anatomy: Renal perfusion

Source: StatPearls — Acute Kidney Injury

Intrinsic AKIRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Tubular, glomerular, interstitial or vascular injury

Pathophysiologic mechanism: Renal parenchymal damage impairs filtration and tubular function.

Progression: Recovery varies by lesion and severity.

Clinical manifestations: Oliguria, hematuria/proteinuria, edema or systemic features.

Diagnostics / labs / imaging: Urinalysis/sediment, creatinine, serologies, imaging, biopsy in selected cases.

Complications: Electrolyte/acid-base disturbance, CKD.

Treatment categories: Cause-specific renal therapy and supportive care.

Medical-record relevance: Urine sediment can help identify mechanism.

Related terminology: intrinsic AKI

Related anatomy: Nephrons

Source: StatPearls — Acute Kidney Injury

Acute tubular injuryRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Ischemia, sepsis, nephrotoxins

Pathophysiologic mechanism: Tubular epithelial injury impairs reabsorption and causes obstruction/backleak.

Progression: May have oliguric then recovery phase.

Clinical manifestations: Low urine output or creatinine rise.

Diagnostics / labs / imaging: Urine sediment, creatinine, exposure/hemodynamic history.

Complications: Volume/electrolyte complications.

Treatment categories: Remove insult and support renal function.

Medical-record relevance: Common intrinsic AKI mechanism.

Related terminology: acute tubular injury

Related anatomy: Renal tubules

Source: StatPearls — Acute Kidney Injury

Postrenal AKIRenal / urologic · CROSS-LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Urinary tract obstruction

Pathophysiologic mechanism: Back pressure reduces filtration; prolonged obstruction causes inflammation/fibrosis.

Progression: May be intermittent, unilateral or bilateral; severe bilateral obstruction threatens renal function.

Clinical manifestations: Retention, flank pain, low urine or overflow symptoms.

Diagnostics / labs / imaging: Bladder scan, renal ultrasound/CT, creatinine.

Complications: Hydronephrosis, infection, irreversible nephron loss.

Treatment categories: Relieve obstruction and monitor post-obstructive diuresis.

Medical-record relevance: Obstruction site and laterality are important.

Related terminology: postrenal AKI

Related anatomy: Urinary tract

Source: StatPearls — Obstructive Uropathy

Obstructive uropathyRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: BPH, stones, malignancy, stricture, neurogenic dysfunction

Pathophysiologic mechanism: Urine flow obstruction raises upstream pressure and damages kidney/urinary tract.

Progression: Chronic obstruction causes hydronephrosis and nephron loss.

Clinical manifestations: Hesitancy, retention, flank pain or silent disease.

Diagnostics / labs / imaging: Ultrasound/CT, postvoid residual, renal function.

Complications: AKI/CKD, infection.

Treatment categories: Decompression and cause-specific intervention.

Medical-record relevance: Structural obstruction should be documented separately from renal consequences.

Related terminology: obstructive uropathy

Related anatomy: Ureters; bladder; urethra

Source: StatPearls — Obstructive Uropathy

HydronephrosisRenal / urologic · CROSS-LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Obstruction or reflux

Pathophysiologic mechanism: Renal collecting system dilates from impaired urine drainage.

Progression: Persistent pressure can thin parenchyma.

Clinical manifestations: Flank pain or asymptomatic.

Diagnostics / labs / imaging: Ultrasound/CT.

Complications: Renal impairment, infection.

Treatment categories: Treat cause of obstruction/reflux.

Medical-record relevance: Hydronephrosis is an imaging/structural finding; cause matters.

Related terminology: hydronephrosis

Related anatomy: Renal pelvis; ureter

Source: StatPearls — Obstructive Uropathy

Chronic kidney diseaseRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Diabetes, hypertension, glomerular, hereditary and other renal disease

Pathophysiologic mechanism: Persistent kidney damage or reduced GFR leads to nephron loss and maladaptive hyperfiltration.

Progression: Progressive in many patients but rate varies.

Clinical manifestations: Often asymptomatic until advanced.

Diagnostics / labs / imaging: eGFR, urine albumin, urinalysis, imaging and cause-specific tests.

Complications: Anemia, mineral-bone disease, hyperkalemia, acidosis, cardiovascular disease.

Treatment categories: Slow progression, manage complications, renal replacement planning if advanced.

Medical-record relevance: Cause, G stage and albuminuria category are key.

Related terminology: CKD

Related anatomy: Kidneys

Source: StatPearls — Chronic Kidney Disease

AlbuminuriaRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Glomerular barrier injury or increased glomerular pressure

Pathophysiologic mechanism: Albumin leaks into urine.

Progression: Can precede GFR decline.

Clinical manifestations: Usually asymptomatic.

Diagnostics / labs / imaging: Urine albumin-creatinine ratio.

Complications: CKD progression and cardiovascular risk.

Treatment categories: Treat underlying renal/metabolic disease.

Medical-record relevance: Albuminuria is a kidney-damage marker and should be quantified.

Related terminology: albuminuria

Related anatomy: Glomerulus

Source: StatPearls — Chronic Kidney Disease

ProteinuriaRenal / urologic · CROSS-LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Glomerular, tubular or overflow mechanisms

Pathophysiologic mechanism: Protein excretion exceeds normal handling.

Progression: Persistent protein loss can reflect significant renal disease.

Clinical manifestations: Foamy urine, edema in heavy proteinuria.

Diagnostics / labs / imaging: Urine protein/creatinine or albumin tests, urinalysis.

Complications: Hypoalbuminemia, CKD progression.

Treatment categories: Cause-specific therapy.

Medical-record relevance: Differentiate albuminuria from total proteinuria mechanisms.

Related terminology: proteinuria

Related anatomy: Kidneys

Source: StatPearls — Chronic Kidney Disease

Nephrotic patternRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Glomerular disease

Pathophysiologic mechanism: Heavy protein loss causes hypoalbuminemia, edema and lipid abnormalities.

Progression: May be primary or secondary.

Clinical manifestations: Edema, frothy urine.

Diagnostics / labs / imaging: Protein quantification, albumin, lipids, serologies/biopsy as indicated.

Complications: Thrombosis, infection, CKD.

Treatment categories: Treat underlying glomerular disease and complications.

Medical-record relevance: Syndrome pattern should be tied to a defined cause when possible.

Related terminology: nephrotic syndrome

Related anatomy: Glomerulus

Source: StatPearls — Chronic Kidney Disease

Nephritic patternRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Inflammatory glomerular injury

Pathophysiologic mechanism: Hematuria, reduced filtration and variable proteinuria occur from glomerular inflammation.

Progression: May be acute or progressive.

Clinical manifestations: Hematuria, edema, hypertension.

Diagnostics / labs / imaging: Urinalysis/sediment, creatinine, complement/serologies, biopsy as indicated.

Complications: AKI, hypertension, CKD.

Treatment categories: Cause-specific immunologic/infectious management.

Medical-record relevance: Urine sediment and cause determine diagnosis.

Related terminology: nephritic syndrome

Related anatomy: Glomerulus

Source: StatPearls — Acute Kidney Injury

Glomerular filtration declineRenal / urologic · A&P LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Nephron loss or acute hemodynamic/intrinsic injury

Pathophysiologic mechanism: Reduced filtration raises nitrogenous waste and alters fluid/electrolyte handling.

Progression: Acute or chronic depending on cause.

Clinical manifestations: Often asymptomatic until severe.

Diagnostics / labs / imaging: Creatinine/eGFR, cystatin C in selected cases.

Complications: Drug accumulation, electrolyte/acid-base problems.

Treatment categories: Treat cause and adjust medications.

Medical-record relevance: eGFR is an estimate and must be interpreted in context.

Related terminology: GFR

Related anatomy: Glomerulus

Source: StatPearls — Chronic Kidney Disease

UremiaRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Advanced renal failure

Pathophysiologic mechanism: Retention of uremic solutes causes systemic toxicity.

Progression: Occurs with severe kidney dysfunction.

Clinical manifestations: Nausea, pruritus, confusion, pericarditis and other systemic symptoms.

Diagnostics / labs / imaging: Renal function plus clinical syndrome.

Complications: Encephalopathy, pericarditis, bleeding.

Treatment categories: Dialysis/renal replacement when indicated.

Medical-record relevance: Uremia is a clinical syndrome, not just elevated BUN.

Related terminology: uremia

Related anatomy: Multisystem; kidneys

Source: StatPearls — Chronic Kidney Disease

Renal anemiaRenal / urologic · CROSS-LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: CKD with reduced erythropoietin plus iron/inflammatory factors

Pathophysiologic mechanism: Marrow RBC production falls.

Progression: Worsens as CKD advances.

Clinical manifestations: Fatigue, dyspnea.

Diagnostics / labs / imaging: CBC, iron studies, renal function.

Complications: Reduced quality of life, cardiac strain.

Treatment categories: Iron and erythropoiesis-stimulating therapy in selected patients.

Medical-record relevance: Link anemia to CKD only when clinically established.

Related terminology: anemia of CKD

Related anatomy: Kidney; bone marrow

Source: StatPearls — Chronic Kidney Disease

CKD mineral-bone disorderRenal / urologic · CROSS-LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Phosphate retention, reduced calcitriol, secondary hyperparathyroidism

Pathophysiologic mechanism: Disordered calcium/phosphate/PTH metabolism alters bone and vascular tissue.

Progression: Progresses with CKD severity.

Clinical manifestations: Bone pain/fracture risk or asymptomatic labs.

Diagnostics / labs / imaging: Calcium, phosphate, PTH, vitamin D, bone imaging as indicated.

Complications: Fracture, vascular calcification.

Treatment categories: Manage phosphate/PTH/vitamin D according to CKD stage.

Medical-record relevance: Specific abnormalities and CKD stage matter.

Related terminology: CKD-MBD

Related anatomy: Kidney; bone; parathyroid

Source: StatPearls — Chronic Kidney Disease

Renal hyperkalemiaRenal / urologic · CROSS-LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Reduced potassium excretion, medications, acidosis

Pathophysiologic mechanism: Potassium accumulates when renal clearance is inadequate.

Progression: May worsen rapidly with AKI or advanced CKD.

Clinical manifestations: Often asymptomatic until arrhythmia/weakness.

Diagnostics / labs / imaging: Potassium, ECG, renal function.

Complications: Cardiac arrest.

Treatment categories: Urgent potassium management when severe and treat renal cause.

Medical-record relevance: Renal cause should be documented where established.

Related terminology: hyperkalemia

Related anatomy: Kidneys; heart

Source: StatPearls — Chronic Kidney Disease

Renal metabolic acidosisRenal / urologic · CROSS-LINK

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Reduced ammonium/acid excretion and bicarbonate regeneration

Pathophysiologic mechanism: Hydrogen retention lowers serum bicarbonate.

Progression: Common in advanced CKD and some tubular disorders.

Clinical manifestations: Often subtle; fatigue/muscle effects.

Diagnostics / labs / imaging: Bicarbonate, blood gas, renal function.

Complications: Bone/muscle effects, CKD progression.

Treatment categories: Alkali therapy in selected patients and cause management.

Medical-record relevance: Link acidosis to renal disease when documented.

Related terminology: renal acidosis

Related anatomy: Kidneys

Source: StatPearls — Chronic Kidney Disease

Post-obstructive diuresisRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Relief of significant urinary obstruction

Pathophysiologic mechanism: Kidneys excrete retained salt/water and may have impaired concentrating ability after decompression.

Progression: Can be physiologic or pathologic.

Clinical manifestations: High urine output after relief.

Diagnostics / labs / imaging: Strict urine output, electrolytes, volume status.

Complications: Hypovolemia, sodium/potassium abnormalities.

Treatment categories: Fluid/electrolyte replacement and monitoring.

Medical-record relevance: A recognized complication after decompression.

Related terminology: post-obstructive diuresis

Related anatomy: Kidneys; urinary tract

Source: StatPearls — Obstructive Uropathy

Renal indicator versus diagnosisRenal / urologic · NEW

Normal function anchor: Kidneys regulate filtration, fluid, electrolytes, acid-base balance and endocrine functions while the urinary tract drains urine.

Etiology / risk factors: Creatinine, eGFR, urine findings or imaging abnormality

Pathophysiologic mechanism: Indicators support kidney injury/chronicity but require timing, baseline and clinical interpretation.

Progression: Classification may change with repeat data.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Serial creatinine, urine output, albuminuria, urinalysis, imaging.

Complications: Misclassification of AKI versus CKD or structural findings.

Treatment categories: Clarify chronicity, cause and stage.

Medical-record relevance: Direct CDI/coding bridge.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Chronic Kidney Disease

Pathophysiology section 17

Reproductive Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Ovulatory dysfunctionReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: PCOS, thyroid disease, hyperprolactinemia, hypothalamic causes, diminished reserve

Pathophysiologic mechanism: Disrupted follicular development or endocrine signaling prevents predictable ovulation.

Progression: May cause intermittent or persistent anovulation.

Clinical manifestations: Irregular/absent menses and infertility.

Diagnostics / labs / imaging: Cycle history, pregnancy test, TSH/prolactin, ovulatory and ovarian-reserve testing as indicated.

Complications: Infertility, endometrial effects with chronic anovulation.

Treatment categories: Treat underlying endocrine/reproductive cause.

Medical-record relevance: Anovulation is a mechanism and may require a named underlying diagnosis.

Related terminology: anovulation

Related anatomy: Ovary; HPO axis

Source: StatPearls — Female Infertility

Female infertilityReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Ovulatory, tubal, uterine, endometriosis, genetic, age-related or unexplained factors

Pathophysiologic mechanism: Failure at ovulation, fertilization, transport or implantation reduces probability of conception.

Progression: Workup is cause-directed and age/time dependent.

Clinical manifestations: Inability to achieve pregnancy.

Diagnostics / labs / imaging: Ovulatory labs, semen analysis partner-side, tubal/uterine imaging, ovarian-reserve tests.

Complications: Psychosocial burden; delayed fertility.

Treatment categories: Cause-specific fertility treatment/ART.

Medical-record relevance: Document identified factor when known rather than only infertility.

Related terminology: infertility

Related anatomy: Female reproductive tract

Source: StatPearls — Female Infertility

Diminished ovarian reserveReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Age, genetics, surgery, gonadotoxic therapy

Pathophysiologic mechanism: Reduced follicle pool lowers reproductive potential.

Progression: Progressive and often age-related.

Clinical manifestations: Infertility; shorter/irregular cycles sometimes.

Diagnostics / labs / imaging: AMH, antral follicle count, FSH/estradiol in context.

Complications: Reduced response to fertility treatment.

Treatment categories: Fertility counseling/ART options.

Medical-record relevance: Reserve tests estimate quantity, not guaranteed fertility.

Related terminology: ovarian reserve

Related anatomy: Ovaries

Source: StatPearls — Female Infertility

Tubal-factor infertilityReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: PID, endometriosis, surgery, adhesions

Pathophysiologic mechanism: Tubal obstruction/dysfunction impairs sperm-oocyte transport.

Progression: May be unilateral or bilateral.

Clinical manifestations: Infertility, prior pelvic disease.

Diagnostics / labs / imaging: Hysterosalpingography or other tubal evaluation.

Complications: Ectopic pregnancy risk.

Treatment categories: Surgery or IVF depending on severity.

Medical-record relevance: Cause and laterality improve specificity.

Related terminology: tubal obstruction

Related anatomy: Fallopian tubes

Source: StatPearls — Female Infertility

Uterine-factor infertilityReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Fibroids, polyps, adhesions, congenital anomalies

Pathophysiologic mechanism: Cavity distortion or endometrial disruption impairs implantation.

Progression: Severity depends on lesion.

Clinical manifestations: Infertility, bleeding symptoms may coexist.

Diagnostics / labs / imaging: Ultrasound, saline sonography, hysteroscopy.

Complications: Pregnancy loss or impaired implantation.

Treatment categories: Lesion-specific treatment.

Medical-record relevance: Structural finding and fertility effect should be clinically linked.

Related terminology: uterine factor

Related anatomy: Uterus

Source: StatPearls — Female Infertility

EndometriosisReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Multifactorial hormonal, inflammatory, genetic and immune factors

Pathophysiologic mechanism: Ectopic endometrial-like tissue drives estrogen-dependent inflammation, fibrosis and adhesions.

Progression: Chronic relapsing disease.

Clinical manifestations: Pelvic pain, dysmenorrhea, dyspareunia, infertility.

Diagnostics / labs / imaging: Clinical assessment, ultrasound/MRI; laparoscopy/histology in selected cases.

Complications: Adhesions, endometrioma, infertility.

Treatment categories: Hormonal, analgesic and surgical management based on goals/severity.

Medical-record relevance: Symptom burden may not match anatomic extent.

Related terminology: endometriosis

Related anatomy: Pelvis; ovaries; peritoneum

Source: StatPearls — Endometriosis

EndometriomaReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Ovarian endometriosis

Pathophysiologic mechanism: Repeated bleeding/inflammation forms ovarian cystic lesions.

Progression: May enlarge or recur.

Clinical manifestations: Pelvic pain or infertility; may be incidental.

Diagnostics / labs / imaging: Ultrasound/MRI.

Complications: Reduced ovarian reserve, torsion/rupture rarely.

Treatment categories: Medical/surgical management by size/symptoms/fertility plan.

Medical-record relevance: Differentiate from other ovarian cysts.

Related terminology: endometrioma

Related anatomy: Ovary

Source: StatPearls — Endometriosis

PCOS / polyendocrine metabolic ovarian syndromeReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Insulin resistance, hyperandrogenism, genetic/environmental factors

Pathophysiologic mechanism: Hormonal/metabolic dysregulation disrupts follicular maturation and ovulation.

Progression: Chronic with reproductive and metabolic effects.

Clinical manifestations: Irregular menses, hirsutism/acne, infertility.

Diagnostics / labs / imaging: Clinical criteria, androgen tests, exclusion labs, ultrasound when indicated.

Complications: Endometrial hyperplasia, diabetes, metabolic risk.

Treatment categories: Lifestyle, cycle regulation, antiandrogen/metabolic/fertility therapies.

Medical-record relevance: Diagnosis requires criteria and exclusion of mimics.

Related terminology: PCOS; PMOS

Related anatomy: Ovaries; HPO axis

Source: StatPearls — Polyendocrine Metabolic Ovarian Syndrome

HyperandrogenismReproductive · CROSS-LINK

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: PCOS, adrenal/ovarian disorders, medications

Pathophysiologic mechanism: Excess androgen production/action alters hair, skin and ovulatory function.

Progression: May be chronic or rapidly progressive depending on cause.

Clinical manifestations: Hirsutism, acne, virilization in severe cases.

Diagnostics / labs / imaging: Total/free testosterone and cause-specific endocrine testing.

Complications: Infertility, metabolic effects.

Treatment categories: Treat underlying cause and symptoms.

Medical-record relevance: Rapid virilization requires evaluation for tumor-level causes.

Related terminology: hyperandrogenism

Related anatomy: Ovaries; adrenals

Source: StatPearls — Polyendocrine Metabolic Ovarian Syndrome

Chronic anovulationReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: PCOS, hypothalamic/pituitary/thyroid causes

Pathophysiologic mechanism: Endometrium experiences prolonged unopposed estrogen in some patients.

Progression: Persistent cycles without ovulation.

Clinical manifestations: Irregular or absent bleeding.

Diagnostics / labs / imaging: Cycle/endocrine evaluation.

Complications: Endometrial hyperplasia, infertility.

Treatment categories: Restore cycles/endometrial protection and treat cause.

Medical-record relevance: A key PCOS-related mechanism but not specific to PCOS.

Related terminology: chronic anovulation

Related anatomy: Ovary; endometrium

Source: StatPearls — Polyendocrine Metabolic Ovarian Syndrome

Erectile dysfunctionReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Vascular, neurologic, endocrine, medication, psychogenic and mixed causes

Pathophysiologic mechanism: Insufficient arterial inflow, smooth-muscle relaxation or veno-occlusion prevents sustained erection.

Progression: Often chronic and associated with vascular risk.

Clinical manifestations: Inability to attain/maintain erection.

Diagnostics / labs / imaging: History, exam, glucose/lipids/testosterone as indicated; specialized testing selectively.

Complications: Relationship/QOL effects; may signal vascular disease.

Treatment categories: Risk-factor management, PDE5 inhibitors and other therapies.

Medical-record relevance: ED can be a marker of cardiometabolic disease but requires its own evaluation.

Related terminology: erectile dysfunction

Related anatomy: Penis; vasculature; nerves

Source: StatPearls — Erectile Dysfunction

Male-factor infertilityReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Spermatogenic, endocrine, obstructive, genetic, varicocele or sexual dysfunction causes

Pathophysiologic mechanism: Sperm quantity, quality or delivery is impaired.

Progression: May be reversible or persistent.

Clinical manifestations: Infertility; often no other symptoms.

Diagnostics / labs / imaging: Semen analysis, endocrine/genetic/imaging evaluation as indicated.

Complications: Reduced fertility.

Treatment categories: Cause-specific medical/surgical/ART management.

Medical-record relevance: Semen abnormality is an indicator; etiology may need further workup.

Related terminology: male infertility

Related anatomy: Testes; epididymis; vas deferens

Source: StatPearls — Erectile Dysfunction

HypogonadismReproductive · CROSS-LINK

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Testicular or hypothalamic-pituitary dysfunction

Pathophysiologic mechanism: Low sex-hormone production impairs reproductive and systemic functions.

Progression: Primary or central forms differ by gonadotropins.

Clinical manifestations: Low libido, infertility, menstrual/testicular changes, bone effects.

Diagnostics / labs / imaging: Sex hormones plus LH/FSH; cause-specific imaging/genetics.

Complications: Infertility, osteoporosis, metabolic effects.

Treatment categories: Hormone/fertility treatment by cause and reproductive goals.

Medical-record relevance: Primary versus central form should be distinguished.

Related terminology: hypogonadism

Related anatomy: Gonads; pituitary

Source: StatPearls — Female Infertility

Pelvic inflammatory sequelaeReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Prior ascending genital-tract infection

Pathophysiologic mechanism: Inflammation/scarring damages tubes and pelvic tissues.

Progression: May persist after acute infection resolves.

Clinical manifestations: Pelvic pain, infertility or ectopic pregnancy risk.

Diagnostics / labs / imaging: History, imaging/tubal testing.

Complications: Tubal infertility, chronic pain, ectopic pregnancy.

Treatment categories: Treat acute infection; manage sequelae/fertility.

Medical-record relevance: Past infection and current sequelae are separate documentation layers.

Related terminology: PID sequelae

Related anatomy: Fallopian tubes; pelvis

Source: StatPearls — Female Infertility

Ectopic pregnancy mechanismReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Tubal damage/dysmotility and reproductive risk factors

Pathophysiologic mechanism: Implantation occurs outside endometrial cavity, usually in tube.

Progression: Growth can cause rupture and hemorrhage.

Clinical manifestations: Pain, bleeding or asymptomatic early.

Diagnostics / labs / imaging: Serial hCG and transvaginal ultrasound.

Complications: Rupture, hemorrhagic shock.

Treatment categories: Medical or surgical treatment based on stability/criteria.

Medical-record relevance: Location and rupture status are critical.

Related terminology: ectopic pregnancy

Related anatomy: Fallopian tube

Source: StatPearls — Female Infertility

Abnormal uterine bleeding from ovulatory dysfunctionReproductive · CROSS-LINK

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Anovulation/endocrine disorders

Pathophysiologic mechanism: Irregular endometrial proliferation and shedding causes unpredictable bleeding.

Progression: May become chronic.

Clinical manifestations: Heavy/irregular bleeding.

Diagnostics / labs / imaging: Pregnancy test, CBC, endocrine testing, imaging/endometrial assessment based on risk.

Complications: Anemia, hyperplasia.

Treatment categories: Treat cause and control bleeding.

Medical-record relevance: Bleeding pattern does not itself identify etiology.

Related terminology: AUB-O

Related anatomy: Endometrium

Source: StatPearls — Polyendocrine Metabolic Ovarian Syndrome

Endometrial hyperplasia risk from chronic anovulationReproductive · CROSS-LINK

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Prolonged unopposed estrogen exposure

Pathophysiologic mechanism: Persistent endometrial proliferation without cyclic progesterone increases hyperplasia risk.

Progression: May progress through atypia to carcinoma in selected cases.

Clinical manifestations: Abnormal bleeding.

Diagnostics / labs / imaging: Endometrial sampling when indicated.

Complications: Atypical hyperplasia/cancer.

Treatment categories: Progestin/endometrial management based on pathology.

Medical-record relevance: Hyperplasia requires pathology/clinical confirmation.

Related terminology: endometrial hyperplasia

Related anatomy: Endometrium

Source: StatPearls — Polyendocrine Metabolic Ovarian Syndrome

Reproductive endocrine axis dysfunctionReproductive · A&P LINK

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Hypothalamic, pituitary, gonadal or metabolic disease

Pathophysiologic mechanism: Altered GnRH/LH/FSH/sex-hormone signaling disrupts cycles and gametogenesis.

Progression: Pattern depends on level of axis involved.

Clinical manifestations: Irregular cycles, infertility, sexual dysfunction.

Diagnostics / labs / imaging: Paired gonadotropin/sex-hormone tests and cause evaluation.

Complications: Infertility, bone effects.

Treatment categories: Cause-specific endocrine/reproductive management.

Medical-record relevance: Hormone pattern helps localize the disorder.

Related terminology: HPO/HPT axis

Related anatomy: Hypothalamus; pituitary; gonads

Source: StatPearls — Female Infertility

Reproductive imaging finding versus diagnosisReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Cyst, fibroid, follicle pattern or lesion on imaging

Pathophysiologic mechanism: Structural findings may be incidental or clinically meaningful depending on symptoms and criteria.

Progression: May remain stable or require follow-up.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Ultrasound/MRI plus clinical correlation.

Complications: Overdiagnosis if imaging alone is treated as syndrome.

Treatment categories: Manage confirmed condition.

Medical-record relevance: Imaging features should not substitute for full diagnostic criteria.

Related terminology: imaging finding

Related anatomy: Reproductive organs

Source: StatPearls — Polyendocrine Metabolic Ovarian Syndrome

Reproductive clinical indicator versus diagnosisReproductive · NEW

Normal function anchor: The reproductive system coordinates gamete production, endocrine cycling, fertilization, implantation, sexual function, and reproductive tract integrity.

Etiology / risk factors: Hormone abnormality, bleeding pattern, semen finding or imaging result

Pathophysiologic mechanism: Indicators narrow the mechanism but require integrated clinical criteria.

Progression: Diagnosis may change with repeat testing.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Cause-specific endocrine, imaging and fertility testing.

Complications: Documentation/coding ambiguity.

Treatment categories: Document established disorder and causal links.

Medical-record relevance: Direct CDI/coding bridge.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Female Infertility

Pathophysiology section 18

Digestive Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

GERDDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Lower-esophageal sphincter dysfunction, hiatal hernia, obesity and other risk factors

Pathophysiologic mechanism: Retrograde gastric contents injure esophageal/extraesophageal mucosa.

Progression: May be intermittent or chronic.

Clinical manifestations: Heartburn, regurgitation, chest discomfort.

Diagnostics / labs / imaging: Clinical diagnosis; endoscopy/pH testing when indicated.

Complications: Esophagitis, stricture, Barrett esophagus.

Treatment categories: Lifestyle and acid-suppressive therapy; procedural options selectively.

Medical-record relevance: Symptoms alone may overlap cardiac and other GI causes.

Related terminology: GERD

Related anatomy: Esophagus; stomach

Source: StatPearls — Gastroesophageal Reflux Disease (GERD)

Reflux esophagitisDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Repeated acid/pepsin exposure

Pathophysiologic mechanism: Mucosal inflammation/erosion develops from reflux.

Progression: Severity ranges from microscopic inflammation to erosive disease.

Clinical manifestations: Heartburn, odynophagia or dysphagia.

Diagnostics / labs / imaging: Endoscopy.

Complications: Bleeding, stricture.

Treatment categories: Acid suppression and reflux management.

Medical-record relevance: Endoscopic esophagitis is a complication/manifestation of GERD.

Related terminology: esophagitis

Related anatomy: Esophagus

Source: StatPearls — Gastroesophageal Reflux Disease (GERD)

Barrett esophagus mechanismDigestive / hepatobiliary · CROSS-LINK

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Chronic reflux exposure

Pathophysiologic mechanism: Distal esophageal squamous epithelium undergoes intestinal metaplasia.

Progression: Can remain stable or develop dysplasia.

Clinical manifestations: Usually asymptomatic beyond GERD symptoms.

Diagnostics / labs / imaging: Endoscopy with biopsy.

Complications: Esophageal adenocarcinoma risk.

Treatment categories: Surveillance and reflux management; ablation for selected dysplasia.

Medical-record relevance: Barrett, dysplasia and cancer are distinct pathologic diagnoses.

Related terminology: Barrett esophagus

Related anatomy: Distal esophagus

Source: StatPearls — Gastroesophageal Reflux Disease (GERD)

Inflammatory bowel diseaseDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Genetic susceptibility, immune dysregulation and microbiome/environment interactions

Pathophysiologic mechanism: Abnormal immune response drives chronic intestinal inflammation.

Progression: Relapsing/remitting or progressive.

Clinical manifestations: Diarrhea, abdominal pain, bleeding, weight loss.

Diagnostics / labs / imaging: Endoscopy/biopsy, inflammatory markers, imaging.

Complications: Strictures, fistulas, malnutrition, cancer risk.

Treatment categories: Anti-inflammatory, immune/biologic and surgical therapy by subtype.

Medical-record relevance: Crohn disease and ulcerative colitis must be distinguished when possible.

Related terminology: IBD

Related anatomy: GI tract

Source: StatPearls — Inflammatory Bowel Disease

Crohn disease patternDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Immune-mediated IBD

Pathophysiologic mechanism: Transmural, discontinuous inflammation can affect any GI segment.

Progression: May produce inflammatory, stricturing or penetrating disease.

Clinical manifestations: Pain, diarrhea, weight loss, perianal disease.

Diagnostics / labs / imaging: Endoscopy/biopsy, cross-sectional imaging.

Complications: Fistula, abscess, stricture, malnutrition.

Treatment categories: Medical biologic/immune therapy and surgery for complications.

Medical-record relevance: Location and phenotype affect documentation and treatment.

Related terminology: Crohn disease

Related anatomy: GI tract; terminal ileum/colon

Source: StatPearls — Inflammatory Bowel Disease

Ulcerative colitis patternDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Immune-mediated IBD

Pathophysiologic mechanism: Continuous mucosal inflammation begins in rectum and extends proximally in colon.

Progression: Extent ranges from proctitis to pancolitis.

Clinical manifestations: Bloody diarrhea, urgency, pain.

Diagnostics / labs / imaging: Colonoscopy/biopsy.

Complications: Toxic megacolon, bleeding, colorectal cancer risk.

Treatment categories: Anti-inflammatory/immune therapy; colectomy can be definitive.

Medical-record relevance: Extent/severity should be documented.

Related terminology: ulcerative colitis

Related anatomy: Colon; rectum

Source: StatPearls — Inflammatory Bowel Disease

GI inflammation marker interpretationDigestive / hepatobiliary · CROSS-LINK

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: IBD, infection and other inflammatory conditions

Pathophysiologic mechanism: Inflammatory biomarkers reflect mucosal/systemic activity but are nonspecific.

Progression: Trends can support monitoring.

Clinical manifestations: No direct symptom.

Diagnostics / labs / imaging: CRP/ESR, fecal calprotectin/lactoferrin where appropriate.

Complications: Misclassification if biomarker is equated with IBD.

Treatment categories: Use with clinical/endoscopic context.

Medical-record relevance: Markers support but do not replace diagnosis.

Related terminology: calprotectin; CRP

Related anatomy: GI tract; blood

Source: StatPearls — Inflammatory Bowel Disease

Acute pancreatitisDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Gallstones, alcohol, hypertriglyceridemia, drugs, ERCP and other causes

Pathophysiologic mechanism: Premature pancreatic enzyme activation causes acinar injury and autodigestion.

Progression: Ranges from mild interstitial disease to necrotizing disease with organ failure.

Clinical manifestations: Acute epigastric pain radiating to back, nausea/vomiting.

Diagnostics / labs / imaging: Two of characteristic pain, enzymes ≥3x ULN, or imaging findings support diagnosis.

Complications: Necrosis, fluid collections, organ failure.

Treatment categories: Supportive care plus cause treatment.

Medical-record relevance: Lipase elevation alone does not establish pancreatitis without criteria/context.

Related terminology: acute pancreatitis

Related anatomy: Pancreas

Source: StatPearls — Acute Pancreatitis

Pancreatic necrosisDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Severe pancreatic inflammation/ischemic injury

Pathophysiologic mechanism: Acinar and peripancreatic tissue death develops.

Progression: May become infected or organize into collections.

Clinical manifestations: Persistent pain, fever, systemic illness.

Diagnostics / labs / imaging: Contrast CT/MRI when indicated.

Complications: Infected necrosis, sepsis, organ failure.

Treatment categories: Supportive care; antibiotics/drainage/debridement selectively.

Medical-record relevance: Necrotizing versus interstitial pancreatitis changes severity.

Related terminology: pancreatic necrosis

Related anatomy: Pancreas

Source: StatPearls — Acute Pancreatitis

Pancreatic enzyme elevationDigestive / hepatobiliary · CROSS-LINK

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Pancreatic injury and some nonpancreatic conditions

Pathophysiologic mechanism: Amylase/lipase enter circulation when acinar injury occurs.

Progression: Levels may normalize despite ongoing disease.

Clinical manifestations: No direct symptom.

Diagnostics / labs / imaging: Serum lipase/amylase.

Complications: Overdiagnosis if isolated elevation is misused.

Treatment categories: Treat confirmed cause.

Medical-record relevance: Enzyme result is an indicator, not by itself the full diagnosis.

Related terminology: lipase; amylase

Related anatomy: Pancreas

Source: StatPearls — Acute Pancreatitis

CirrhosisDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Chronic hepatic injury from viral, metabolic, alcohol, autoimmune, cholestatic or other causes

Pathophysiologic mechanism: Fibrosis and regenerative nodules distort hepatic architecture.

Progression: Progresses from compensated to decompensated disease.

Clinical manifestations: Fatigue, portal-hypertension/decompensation findings.

Diagnostics / labs / imaging: Liver labs, imaging/elastography, endoscopy and clinical scoring.

Complications: Ascites, variceal bleeding, encephalopathy, HCC.

Treatment categories: Treat cause and complications; transplant evaluation when advanced.

Medical-record relevance: Etiology and compensation/decompensation status matter.

Related terminology: cirrhosis

Related anatomy: Liver

Source: StatPearls — Hepatic Cirrhosis

Portal hypertensionDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Cirrhosis or other portal-flow resistance

Pathophysiologic mechanism: Increased portal vascular resistance raises pressure in portal venous system.

Progression: Drives collateral formation and splenic congestion.

Clinical manifestations: Varices, splenomegaly, ascites.

Diagnostics / labs / imaging: Imaging, endoscopy and clinical evidence; invasive measurement selectively.

Complications: Variceal hemorrhage, ascites.

Treatment categories: Manage cirrhosis/variceal risk and portal pressure.

Medical-record relevance: Portal hypertension is a major cirrhosis complication.

Related terminology: portal hypertension

Related anatomy: Portal vein; liver

Source: StatPearls — Hepatic Cirrhosis

Ascites from cirrhosisDigestive / hepatobiliary · CROSS-LINK

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Portal hypertension, splanchnic vasodilation and sodium retention

Pathophysiologic mechanism: Fluid accumulates in peritoneal cavity.

Progression: May recur or become refractory.

Clinical manifestations: Abdominal distention, edema.

Diagnostics / labs / imaging: Exam, ultrasound, diagnostic paracentesis when new/decompensated.

Complications: Spontaneous bacterial peritonitis, respiratory compromise.

Treatment categories: Sodium/diuretic management, paracentesis, cause care.

Medical-record relevance: Cause and complications should be documented.

Related terminology: ascites

Related anatomy: Peritoneal cavity; liver

Source: StatPearls — Hepatic Cirrhosis

Hepatic encephalopathyDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Advanced liver dysfunction/portosystemic shunting

Pathophysiologic mechanism: Neurotoxins such as ammonia contribute to altered brain function.

Progression: Episodic or persistent.

Clinical manifestations: Confusion, asterixis, altered consciousness.

Diagnostics / labs / imaging: Clinical diagnosis; search for precipitating factors.

Complications: Aspiration, falls, coma.

Treatment categories: Reduce gut-derived toxins and treat triggers.

Medical-record relevance: Ammonia level alone does not define encephalopathy.

Related terminology: hepatic encephalopathy

Related anatomy: Liver; brain

Source: StatPearls — Hepatic Cirrhosis

Variceal bleedingDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Portal hypertension

Pathophysiologic mechanism: Portosystemic collateral veins dilate and may rupture.

Progression: Can cause abrupt major hemorrhage.

Clinical manifestations: Hematemesis, melena, shock.

Diagnostics / labs / imaging: Urgent endoscopy, CBC/coagulation, hemodynamic assessment.

Complications: Shock, death.

Treatment categories: Resuscitation, vasoactive therapy, endoscopic control, prophylaxis.

Medical-record relevance: Variceal source should be documented distinctly.

Related terminology: esophageal varices

Related anatomy: Esophagus; portal system

Source: StatPearls — Hepatic Cirrhosis

MalabsorptionDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Mucosal disease, pancreatic insufficiency, bile disorders or intestinal resection

Pathophysiologic mechanism: Nutrient digestion/absorption is impaired.

Progression: Can cause chronic nutritional deficiency.

Clinical manifestations: Diarrhea, weight loss, anemia/deficiencies.

Diagnostics / labs / imaging: Stool, nutritional, serologic/endoscopic tests by suspected cause.

Complications: Protein-calorie and micronutrient deficiency.

Treatment categories: Treat cause and replace nutrients.

Medical-record relevance: Malabsorption is a mechanism requiring etiology when known.

Related terminology: malabsorption

Related anatomy: Small intestine; pancreas; bile system

Source: StatPearls — Inflammatory Bowel Disease

GI bleedingDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Ulcer, varices, inflammation, malignancy and other lesions

Pathophysiologic mechanism: Blood loss occurs into GI lumen.

Progression: Acute or occult/chronic.

Clinical manifestations: Hematemesis, melena, hematochezia or iron-deficiency anemia.

Diagnostics / labs / imaging: CBC, stool tests selectively, endoscopy/colonoscopy, imaging based on severity.

Complications: Shock, anemia.

Treatment categories: Resuscitation and endoscopic/medical/surgical source control.

Medical-record relevance: Upper/lower source and acuity should be specified when known.

Related terminology: GI bleed

Related anatomy: GI tract

Source: StatPearls — Gastroesophageal Reflux Disease (GERD)

Bowel obstructionDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Adhesions, hernia, tumor, stricture, volvulus

Pathophysiologic mechanism: Mechanical blockage prevents normal transit and causes dilation/fluid shifts.

Progression: May progress to ischemia/perforation.

Clinical manifestations: Pain, distention, vomiting, obstipation.

Diagnostics / labs / imaging: Abdominal imaging and exam.

Complications: Ischemia, perforation, sepsis.

Treatment categories: Bowel rest/decompression and surgery when indicated.

Medical-record relevance: Mechanical obstruction differs from ileus.

Related terminology: bowel obstruction

Related anatomy: Intestine

Source: StatPearls — Inflammatory Bowel Disease

Digestive imaging/endoscopy finding versus diagnosisDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Wall thickening, lesion, inflammation, polyp, dilation or incidental finding

Pathophysiologic mechanism: Structural findings require correlation with symptoms, pathology and clinical criteria.

Progression: May remain incidental or prompt definitive workup.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Endoscopy, biopsy, CT/MRI/ultrasound and labs.

Complications: Overdiagnosis or missed disease.

Treatment categories: Complete appropriate workup.

Medical-record relevance: Finding and disease diagnosis are separate layers.

Related terminology: imaging finding; endoscopy

Related anatomy: GI tract

Source: StatPearls — Inflammatory Bowel Disease

Digestive clinical indicator versus diagnosisDigestive / hepatobiliary · NEW

Normal function anchor: The GI tract, liver, pancreas and biliary system coordinate digestion, absorption, motility, barrier defense and metabolic processing.

Etiology / risk factors: Pain, enzyme/liver abnormality, stool change or imaging finding

Pathophysiologic mechanism: Indicators narrow mechanism but remain nonspecific without diagnostic synthesis.

Progression: Diagnosis may evolve after endoscopy/pathology/imaging.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Cause-specific labs, imaging, endoscopy and pathology.

Complications: Documentation/coding ambiguity.

Treatment categories: Document confirmed disease, site, acuity and complications.

Medical-record relevance: Direct CDI/coding bridge.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Acute Pancreatitis

Pathophysiology section 19

Musculoskeletal & Integumentary Disorders

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

OsteoarthritisMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Age, mechanical load, prior injury, obesity, joint factors

Pathophysiologic mechanism: Cartilage loss, subchondral bone remodeling and osteophytes produce degenerative joint disease.

Progression: Usually slowly progressive.

Clinical manifestations: Activity-related pain, stiffness, reduced ROM, crepitus.

Diagnostics / labs / imaging: Clinical assessment; X-ray when needed.

Complications: Functional loss, deformity, falls.

Treatment categories: Exercise/weight management, analgesia, injections and arthroplasty when indicated.

Medical-record relevance: Radiographic severity may not match symptom severity.

Related terminology: osteoarthritis

Related anatomy: Synovial joints

Source: StatPearls — Osteoarthritis

Rheumatoid arthritisMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Autoimmune susceptibility and environmental triggers

Pathophysiologic mechanism: Synovial immune inflammation causes pannus, cartilage damage and erosions.

Progression: Chronic systemic inflammatory disease with flares.

Clinical manifestations: Symmetric joint pain/swelling, prolonged morning stiffness.

Diagnostics / labs / imaging: Clinical criteria, RF/anti-CCP, inflammatory markers, imaging.

Complications: Joint deformity, extra-articular disease.

Treatment categories: Early DMARD/biologic therapy and supportive care.

Medical-record relevance: Serology supports but does not alone establish RA.

Related terminology: rheumatoid arthritis

Related anatomy: Synovium; joints

Source: StatPearls — Rheumatoid Arthritis

Inflammatory arthritis patternMusculoskeletal / integumentary · CROSS-LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Autoimmune/crystal/infectious and other causes

Pathophysiologic mechanism: Synovial inflammation causes pain, warmth, swelling and stiffness.

Progression: May be acute or chronic.

Clinical manifestations: Inflammatory joint symptoms.

Diagnostics / labs / imaging: Exam, ESR/CRP, serologies, joint aspiration when indicated.

Complications: Joint destruction.

Treatment categories: Treat specific cause.

Medical-record relevance: Pattern is an indicator requiring etiologic diagnosis.

Related terminology: synovitis

Related anatomy: Joints

Source: StatPearls — Rheumatoid Arthritis

Degenerative cartilage lossMusculoskeletal / integumentary · A&P LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Aging/mechanical stress/injury

Pathophysiologic mechanism: Extracellular-matrix breakdown exceeds cartilage repair.

Progression: Progressive narrowing and altered joint mechanics.

Clinical manifestations: Pain with use, stiffness.

Diagnostics / labs / imaging: X-ray/MRI selectively.

Complications: Subchondral change, deformity.

Treatment categories: OA-directed management.

Medical-record relevance: Mechanistic component of osteoarthritis.

Related terminology: cartilage degeneration

Related anatomy: Articular cartilage

Source: StatPearls — Osteoarthritis

Osteophyte formationMusculoskeletal / integumentary · CROSS-LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Joint instability and remodeling

Pathophysiologic mechanism: Marginal bone proliferation develops in degenerative joints.

Progression: Often progresses with OA.

Clinical manifestations: Bony enlargement and limited motion.

Diagnostics / labs / imaging: X-ray.

Complications: Impingement, deformity.

Treatment categories: Treat underlying OA.

Medical-record relevance: Osteophyte is an imaging finding within broader disease context.

Related terminology: osteophyte

Related anatomy: Bone; joint margin

Source: StatPearls — Osteoarthritis

OsteopeniaMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Age, hormonal, nutritional, medication and secondary causes

Pathophysiologic mechanism: Bone mineral density is reduced but above osteoporosis threshold.

Progression: Can progress with ongoing bone loss.

Clinical manifestations: Usually asymptomatic.

Diagnostics / labs / imaging: DXA T-score.

Complications: Higher fracture risk than normal bone.

Treatment categories: Risk-factor and bone-health management.

Medical-record relevance: Osteopenia and osteoporosis have distinct DXA thresholds.

Related terminology: osteopenia

Related anatomy: Bone

Source: StatPearls — Osteopenia

OsteoporosisMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Age-related/secondary bone loss and microarchitectural deterioration

Pathophysiologic mechanism: Bone resorption exceeds formation, reducing strength.

Progression: Often silent until fragility fracture.

Clinical manifestations: Fracture, height loss in advanced disease.

Diagnostics / labs / imaging: DXA; fracture-risk assessment; secondary-cause labs.

Complications: Hip/vertebral fractures.

Treatment categories: Bone-active therapy plus calcium/vitamin D/exercise and fall prevention as indicated.

Medical-record relevance: Fragility fracture can establish clinical osteoporosis in appropriate context.

Related terminology: osteoporosis

Related anatomy: Bone

Source: StatPearls — Osteopenia

Fragility fractureMusculoskeletal / integumentary · CROSS-LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Low bone strength plus low-energy trauma

Pathophysiologic mechanism: Structural failure occurs under forces that would not fracture normal bone.

Progression: May reveal previously unrecognized osteoporosis.

Clinical manifestations: Acute pain/deformity.

Diagnostics / labs / imaging: X-ray/CT/MRI; osteoporosis evaluation.

Complications: Disability, mortality after hip fracture.

Treatment categories: Fracture care plus secondary prevention.

Medical-record relevance: Trauma mechanism and underlying bone disease are separate record elements.

Related terminology: fragility fracture

Related anatomy: Bone

Source: StatPearls — Osteopenia

Pressure injuryMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Prolonged pressure/shear, immobility, moisture, poor perfusion/nutrition

Pathophysiologic mechanism: Local tissue ischemia and deformation damage skin/soft tissue over pressure points or devices.

Progression: Can deepen from intact-skin injury to full-thickness loss.

Clinical manifestations: Localized discoloration, ulceration, drainage.

Diagnostics / labs / imaging: Clinical wound assessment and staging.

Complications: Infection, osteomyelitis, sepsis.

Treatment categories: Offloading, support surfaces, wound care, nutrition and debridement as indicated.

Medical-record relevance: Stage, site, laterality and device association are critical.

Related terminology: pressure injury

Related anatomy: Skin; subcutaneous tissue

Source: StatPearls — Pressure Injury

Stage 1 pressure injuryMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Pressure/shear

Pathophysiologic mechanism: Intact skin develops persistent nonblanchable erythema/discoloration from early tissue injury.

Progression: May reverse with pressure relief or progress.

Clinical manifestations: Localized color/temperature/consistency change.

Diagnostics / labs / imaging: Clinical skin exam.

Complications: Progression to open ulcer.

Treatment categories: Immediate offloading and prevention.

Medical-record relevance: Intact skin distinguishes stage 1.

Related terminology: pressure injury stage 1

Related anatomy: Skin

Source: StatPearls — Pressure Injury

Stage 2 pressure injuryMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Pressure/shear

Pathophysiologic mechanism: Partial-thickness skin loss exposes dermis.

Progression: May heal with offloading or worsen.

Clinical manifestations: Shallow open ulcer or blister-like wound.

Diagnostics / labs / imaging: Clinical staging.

Complications: Infection/progression.

Treatment categories: Offload and maintain wound environment.

Medical-record relevance: Do not use stage 2 for deeper tissue loss.

Related terminology: pressure injury stage 2

Related anatomy: Epidermis; dermis

Source: StatPearls — Pressure Injury

Deep pressure injuryMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Sustained pressure/shear

Pathophysiologic mechanism: Damage extends into deeper soft tissue with progressively greater tissue loss.

Progression: May involve muscle/bone in advanced stages.

Clinical manifestations: Open wound, slough/eschar depending on stage.

Diagnostics / labs / imaging: Clinical staging and depth assessment.

Complications: Osteomyelitis, systemic infection.

Treatment categories: Advanced wound care/debridement/surgery selectively.

Medical-record relevance: Depth and exposed structures determine stage.

Related terminology: pressure ulcer

Related anatomy: Skin; fascia; muscle; bone

Source: StatPearls — Pressure Injury

PsoriasisMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Genetic/immune susceptibility and triggers

Pathophysiologic mechanism: T-cell/cytokine-driven inflammation accelerates keratinocyte proliferation.

Progression: Chronic relapsing disease.

Clinical manifestations: Well-demarcated plaques with scale; nail changes.

Diagnostics / labs / imaging: Usually clinical; biopsy if uncertain.

Complications: Psoriatic arthritis, cardiometabolic comorbidity.

Treatment categories: Topical, phototherapy, systemic/biologic therapy by severity.

Medical-record relevance: Skin disease and psoriatic arthritis should be distinguished.

Related terminology: psoriasis

Related anatomy: Skin; immune system

Source: StatPearls — Psoriasis

Psoriatic arthritis riskMusculoskeletal / integumentary · CROSS-LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Psoriasis-associated immune inflammation

Pathophysiologic mechanism: Inflammation affects peripheral joints, spine, entheses or digits.

Progression: Can progress to erosive/deforming disease.

Clinical manifestations: Joint pain/swelling, dactylitis, enthesitis.

Diagnostics / labs / imaging: Clinical rheumatologic evaluation, imaging, inflammatory markers.

Complications: Joint damage/disability.

Treatment categories: DMARD/biologic therapy.

Medical-record relevance: Presence of psoriasis does not automatically establish arthritis.

Related terminology: psoriatic arthritis

Related anatomy: Joints; entheses

Source: StatPearls — Psoriasis

Dermatitis / eczematous inflammationMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Barrier dysfunction, irritants, allergens or atopic immune patterns

Pathophysiologic mechanism: Epidermal barrier disruption and inflammation cause pruritic lesions.

Progression: Acute, subacute or chronic.

Clinical manifestations: Itch, erythema, scaling/oozing.

Diagnostics / labs / imaging: Clinical assessment; patch testing/biopsy selectively.

Complications: Infection, lichenification.

Treatment categories: Trigger avoidance, emollients, anti-inflammatory therapy.

Medical-record relevance: Dermatitis subtype should be specified when known.

Related terminology: dermatitis

Related anatomy: Skin

Source: StatPearls — Psoriasis

Wound healing impairmentMusculoskeletal / integumentary · CROSS-LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Diabetes, vascular disease, pressure, infection, nutrition deficits

Pathophysiologic mechanism: Inflammation, perfusion, matrix deposition or epithelialization is disrupted.

Progression: Acute wound may become chronic.

Clinical manifestations: Persistent open wound, poor granulation.

Diagnostics / labs / imaging: Serial wound measurements, perfusion/metabolic/infection evaluation.

Complications: Infection, tissue loss.

Treatment categories: Correct barriers and provide wound-specific care.

Medical-record relevance: Cause and wound characteristics should be documented separately.

Related terminology: delayed wound healing

Related anatomy: Skin; connective tissue

Source: StatPearls — Pressure Injury

Muscle atrophyMusculoskeletal / integumentary · CROSS-LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Disuse, denervation, cachexia, aging, systemic disease

Pathophysiologic mechanism: Reduced protein synthesis and increased breakdown decrease muscle mass.

Progression: Can be reversible or progressive.

Clinical manifestations: Weakness, reduced function.

Diagnostics / labs / imaging: Exam, imaging/body composition, EMG/labs depending on cause.

Complications: Falls, disability.

Treatment categories: Resistance/rehab/nutrition and cause treatment.

Medical-record relevance: Atrophy is a structural finding; cause matters.

Related terminology: muscle atrophy

Related anatomy: Skeletal muscle

Source: StatPearls — Osteoarthritis

Joint effusionMusculoskeletal / integumentary · CROSS-LINK

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Inflammatory, degenerative, infectious, traumatic or crystal causes

Pathophysiologic mechanism: Fluid accumulates in synovial cavity.

Progression: May resolve or recur.

Clinical manifestations: Swelling, limited motion, pain.

Diagnostics / labs / imaging: Exam, ultrasound/X-ray; arthrocentesis when indicated.

Complications: Septic joint if infectious cause missed.

Treatment categories: Treat cause.

Medical-record relevance: Effusion is a finding, not a disease-specific diagnosis.

Related terminology: joint effusion

Related anatomy: Synovial joint

Source: StatPearls — Rheumatoid Arthritis

MSK imaging finding versus diagnosisMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Degeneration, erosion, fracture, edema or soft-tissue abnormality

Pathophysiologic mechanism: Imaging demonstrates structure but does not always correlate with symptoms or etiology.

Progression: May be incidental.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: X-ray, ultrasound, CT, MRI plus clinical correlation.

Complications: Overdiagnosis if incidental findings are treated as symptomatic disease.

Treatment categories: Manage confirmed clinical condition.

Medical-record relevance: Imaging finding and diagnosis are separate record layers.

Related terminology: imaging finding

Related anatomy: Musculoskeletal system

Source: StatPearls — Osteoarthritis

MSK/skin clinical indicator versus diagnosisMusculoskeletal / integumentary · NEW

Normal function anchor: Bone, joints, muscle, connective tissue and skin provide support, mobility, protection and barrier function.

Etiology / risk factors: Pain, rash, wound, inflammatory marker or imaging change

Pathophysiologic mechanism: Indicators require pattern recognition and diagnostic criteria.

Progression: Diagnosis may evolve after exam/pathology/imaging.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Exam, labs, imaging, biopsy/aspiration as indicated.

Complications: Documentation/coding ambiguity.

Treatment categories: Document confirmed condition, site, stage/severity and complications.

Medical-record relevance: Direct CDI/coding bridge.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Pressure Injury

Pathophysiology section 20

Clinical Indicators, Diagnostics & Quality Measures

Review disease mechanisms, clinical indicators, diagnostics, complications, treatment categories, and medical-record relevance.

Clinical indicatorClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Any abnormal symptom, sign, lab, imaging or test result

Pathophysiologic mechanism: A finding changes diagnostic probability but does not necessarily establish a disease.

Progression: Meaning changes with context and trends.

Clinical manifestations: No direct manifestation beyond the finding.

Diagnostics / labs / imaging: Source-specific test or observation.

Complications: Misdiagnosis if treated as a diagnosis automatically.

Treatment categories: Use as evidence within clinical synthesis.

Medical-record relevance: Core bridge between pathophysiology and documentation/coding.

Related terminology: clinical indicator

Related anatomy: Medical record

Source: StatPearls — Diagnostic Testing Accuracy

SensitivityClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Test design and disease spectrum

Pathophysiologic mechanism: Proportion of people with disease who test positive.

Progression: Varies by threshold and population.

Clinical manifestations: None.

Diagnostics / labs / imaging: 2×2 diagnostic table/reference standard.

Complications: False negatives when sensitivity is insufficient.

Treatment categories: Choose/use test according to clinical purpose.

Medical-record relevance: High sensitivity helps rule out when negative in appropriate contexts, but does not alone determine diagnosis.

Related terminology: sensitivity

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

SpecificityClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Test design and non-disease spectrum

Pathophysiologic mechanism: Proportion without disease who test negative.

Progression: Varies by threshold and population.

Clinical manifestations: None.

Diagnostics / labs / imaging: 2×2 diagnostic table/reference standard.

Complications: False positives when specificity is insufficient.

Treatment categories: Interpret with pretest probability.

Medical-record relevance: High specificity helps rule in when positive in appropriate contexts.

Related terminology: specificity

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Positive predictive valueClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Disease prevalence/pretest probability plus test performance

Pathophysiologic mechanism: Probability of disease given a positive result.

Progression: Changes substantially with prevalence.

Clinical manifestations: None.

Diagnostics / labs / imaging: Calculated from test/population data.

Complications: Overinterpretation in low-prevalence settings.

Treatment categories: Use with clinical context.

Medical-record relevance: PPV is population-dependent.

Related terminology: PPV

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Negative predictive valueClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Disease prevalence/pretest probability plus test performance

Pathophysiologic mechanism: Probability of no disease given a negative result.

Progression: Changes with prevalence.

Clinical manifestations: None.

Diagnostics / labs / imaging: Calculated from test/population data.

Complications: False reassurance in high-prevalence/high-risk settings.

Treatment categories: Use with clinical context.

Medical-record relevance: NPV is population-dependent.

Related terminology: NPV

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Likelihood ratioClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Sensitivity and specificity

Pathophysiologic mechanism: Quantifies how much a test result changes odds of disease.

Progression: Can be applied to pretest odds.

Clinical manifestations: None.

Diagnostics / labs / imaging: Calculated LR+ or LR-.

Complications: Misinterpretation if pretest probability ignored.

Treatment categories: Use for Bayesian diagnostic updating.

Medical-record relevance: A more portable test-performance measure than predictive value.

Related terminology: likelihood ratio

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Pretest probabilityClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: History, exam, prevalence and risk factors

Pathophysiologic mechanism: Baseline probability determines how test results should be interpreted.

Progression: Changes before and after new evidence.

Clinical manifestations: None.

Diagnostics / labs / imaging: Clinical risk tools/history/exam.

Complications: Testing low-risk patients can increase false-positive burden.

Treatment categories: Select tests based on appropriate threshold.

Medical-record relevance: Testing is not context-free.

Related terminology: pretest probability

Related anatomy: Clinical reasoning

Source: StatPearls — Diagnostic Testing Accuracy

Post-test probabilityClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Pretest probability plus test likelihood ratio

Pathophysiologic mechanism: Diagnostic probability is updated after receiving a result.

Progression: May cross treatment or further-testing thresholds.

Clinical manifestations: None.

Diagnostics / labs / imaging: Bayesian calculation or clinical decision tools.

Complications: Over/undertreatment if result is treated as absolute.

Treatment categories: Integrate result with full clinical picture.

Medical-record relevance: Supports why the same result means different things in different populations.

Related terminology: post-test probability

Related anatomy: Clinical reasoning

Source: StatPearls — Diagnostic Testing Accuracy

Reference standardClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Validated comparator used to assess a diagnostic test

Pathophysiologic mechanism: Test accuracy is measured relative to an accepted standard.

Progression: Standards can themselves be imperfect.

Clinical manifestations: None.

Diagnostics / labs / imaging: Study/validation design.

Complications: Biased accuracy estimates if reference standard is weak.

Treatment categories: Use best available standard.

Medical-record relevance: Important when evaluating reported diagnostic accuracy.

Related terminology: gold standard

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Screening testClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Asymptomatic population selected by age/risk/program criteria

Pathophysiologic mechanism: Testing seeks disease/risk before symptoms appear.

Progression: Positive screens generally require diagnostic confirmation.

Clinical manifestations: Usually no symptoms.

Diagnostics / labs / imaging: Program-specific screening assay.

Complications: False positives, overdiagnosis, missed follow-up.

Treatment categories: Follow recommended screening and confirmatory pathways.

Medical-record relevance: Screening result is not automatically a confirmed diagnosis.

Related terminology: screening

Related anatomy: Population health

Source: CMS — Quality Measures

Diagnostic testClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Symptoms/signs or abnormal screen

Pathophysiologic mechanism: Testing evaluates a suspected disease in an individual.

Progression: May confirm, exclude or refine disease.

Clinical manifestations: Disease-specific.

Diagnostics / labs / imaging: Lab, imaging, procedure or pathology.

Complications: Misclassification if test limitations ignored.

Treatment categories: Use within clinical criteria.

Medical-record relevance: Diagnostic purpose differs from screening purpose.

Related terminology: diagnostic testing

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Confirmatory testingClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Initial positive/indeterminate result

Pathophysiologic mechanism: Second method or repeat test increases diagnostic confidence or resolves discordance.

Progression: Applied according to disease/test standards.

Clinical manifestations: None.

Diagnostics / labs / imaging: Disease-specific confirmatory assay.

Complications: False diagnosis if confirmation is skipped where required.

Treatment categories: Complete recommended confirmation.

Medical-record relevance: Some findings require confirmation before diagnosis.

Related terminology: confirmatory test

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Serial testing / trendClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Dynamic disease process

Pathophysiologic mechanism: Change over time may be more informative than a single value.

Progression: Trend can show progression, response or resolution.

Clinical manifestations: None.

Diagnostics / labs / imaging: Repeated measurements under comparable conditions.

Complications: Overreaction to isolated outlier.

Treatment categories: Interpret trajectory and clinical context.

Medical-record relevance: A trend may support acuity/chronicity documentation.

Related terminology: trend

Related anatomy: Diagnostics

Source: StatPearls — Diagnostic Testing Accuracy

Clinical quality measureClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Defined healthcare process/outcome/patient/structure measure

Pathophysiologic mechanism: Numerator, denominator and specifications quantify performance against a quality goal.

Progression: Updated by steward/program rules.

Clinical manifestations: None.

Diagnostics / labs / imaging: Measure specification and source data.

Complications: Invalid reporting if definitions/exclusions are misapplied.

Treatment categories: Follow current official specifications.

Medical-record relevance: A quality measure is not a patient diagnosis.

Related terminology: quality measure

Related anatomy: Quality reporting

Source: CMS — Quality Measures

Measure numeratorClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Specified qualifying events/outcomes within eligible population

Pathophysiologic mechanism: Numerator counts performance events meeting measure criteria.

Progression: Depends on measure specification.

Clinical manifestations: None.

Diagnostics / labs / imaging: Structured EHR/claims/registry data.

Complications: Incorrect rate if numerator logic is wrong.

Treatment categories: Apply exact measure logic.

Medical-record relevance: Numerator must be tied to current measure version.

Related terminology: numerator

Related anatomy: Quality reporting

Source: CMS — Quality Measures

Measure denominatorClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Defined eligible population for a measure

Pathophysiologic mechanism: Denominator sets who is included before exclusions/exceptions.

Progression: Depends on measure specification.

Clinical manifestations: None.

Diagnostics / labs / imaging: Structured EHR/claims/registry data.

Complications: Invalid comparisons if eligibility is wrong.

Treatment categories: Apply exact denominator criteria.

Medical-record relevance: Denominator definition determines measure population.

Related terminology: denominator

Related anatomy: Quality reporting

Source: CMS — Quality Measures

Measure exclusion / exceptionClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Specified clinical or administrative condition

Pathophysiologic mechanism: Eligible records are removed or handled according to official measure logic.

Progression: Program- and version-specific.

Clinical manifestations: None.

Diagnostics / labs / imaging: Measure specification and documented data.

Complications: Artificial performance distortion if exclusions are misused.

Treatment categories: Use only documented, permitted criteria.

Medical-record relevance: Exclusions must be supported by documentation.

Related terminology: measure exclusion

Related anatomy: Quality reporting

Source: CMS — Quality Measures

eCQMClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Electronically specified quality measure

Pathophysiologic mechanism: Structured electronic data from EHR/health IT are evaluated against standardized logic.

Progression: Specifications update by performance year/program.

Clinical manifestations: None.

Diagnostics / labs / imaging: EHR/health-IT data meeting current specification.

Complications: Submission failure or incorrect rates if data mapping/version is wrong.

Treatment categories: Follow current CMS/eCQI specifications.

Medical-record relevance: Performance year/version is essential.

Related terminology: eCQM

Related anatomy: EHR; quality reporting

Source: CMS — Electronic Clinical Quality Measures Basics

Outcome versus process measureClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Quality-program design

Pathophysiologic mechanism: Outcome measures assess results; process measures assess whether recommended actions occurred.

Progression: Each has distinct risk adjustment and interpretation needs.

Clinical manifestations: None.

Diagnostics / labs / imaging: Measure metadata/specification.

Complications: Wrong interpretation across measure types.

Treatment categories: Use according to program goal.

Medical-record relevance: Measure type should be identified before analysis.

Related terminology: outcome measure; process measure

Related anatomy: Quality reporting

Source: CMS — Quality Measures

Clinical evidence, diagnosis, and quality reporting boundaryClinical diagnostics / quality · NEW

Normal function anchor: Clinical decisions integrate symptoms, findings, tests, diagnostic criteria, documentation and current quality-measure specifications.

Etiology / risk factors: Patient findings plus provider documentation plus measure rules

Pathophysiologic mechanism: Clinical indicators support diagnosis; diagnoses support care/coding; quality measures apply separate specification logic.

Progression: These layers can overlap but are not interchangeable.

Clinical manifestations: Variable.

Diagnostics / labs / imaging: Medical record, coded data, EHR fields, measure specifications.

Complications: Compliance/coding errors if one layer substitutes for another.

Treatment categories: Preserve source-of-truth and rule set for each layer.

Medical-record relevance: Final bridge into medical billing/coding and AAPC-oriented workflows.

Related terminology: documentation; coding; quality

Related anatomy: Medical record

Source: CMS — Quality Measures

Quick lookup

A–Z Pathophysiology Appendix

Browse the conditions, mechanisms, and clinical concepts included in this reference library.

A
Abnormal uterine bleeding from ovulatory dysfunction — Irregular endometrial proliferation and shedding causes unpredictable bleeding.
Acid-base clinical indicator versus diagnosis — Laboratory abnormalities narrow mechanisms but require synthesis with disease cause and documentation.
Acidemia — Arterial pH falls below the physiologic range when acid load exceeds buffering and compensatory capacity.
Acute decompensated heart failure — Filling pressures rise and congestion/perfusion worsen.
Acute inflammation — Vascular changes and soluble mediators recruit neutrophils and other innate immune cells.
Acute kidney injury — Abrupt fall in filtration causes creatinine rise and/or oliguria.
Acute pancreatitis — Premature pancreatic enzyme activation causes acinar injury and autodigestion.
Acute respiratory acidosis — Rapid CO2 accumulation lowers pH before kidneys can significantly retain bicarbonate.
Acute respiratory failure — Gas exchange cannot meet physiologic needs.
Acute stress response — SAM and HPA activation increase perfusion, alertness, glucose availability, and inflammatory coordination.
Acute tubular injury — Tubular epithelial injury impairs reabsorption and causes obstruction/backleak.
Acute-phase response — Hepatic production of acute-phase proteins changes in response to inflammatory mediators.
Adrenal stress-hormone disorder — Cortisol/aldosterone abnormalities disrupt vascular, metabolic and electrolyte regulation.
Air trapping — Incomplete exhalation increases residual volume and hyperinflation.
Airflow obstruction — Expiratory flow is limited by narrowed/collapsible airways.
Albuminuria — Albumin leaks into urine.
Alkalemia — Arterial pH rises when alkalinizing forces exceed buffering and compensation.
Allergic inflammation — Repeated IgE-mediated and cytokine responses recruit eosinophils and sustain local inflammation.
Allostatic load — Cumulative wear from repeated adaptation affects cardiovascular, metabolic, neuroendocrine, and immune systems.
Altered mental status — Global cerebral function is disrupted by one or more acute processes.
Anaphylaxis — Systemic mast-cell/basophil mediator release causes vasodilation, capillary leak, bronchoconstriction, and mucosal edema.
Anemia — Reduced red-cell mass lowers oxygen-carrying capacity.
Angiogenesis — Tumor stimulates new vessel formation to support growth.
Anion gap — Calculated sodium minus chloride and bicarbonate estimates unmeasured anion burden.
Antibody deficiency — Reduced quantity or function of antibodies impairs neutralization and opsonization.
Aphasia — Damage disrupts language production, comprehension, naming or repetition.
Apoptosis — Caspase-driven programmed death causes cell shrinkage, chromatin condensation, fragmentation, and phagocytic clearance.
Ascites from cirrhosis — Fluid accumulates in peritoneal cavity.
Asthma — Airway inflammation, hyperresponsiveness and reversible bronchoconstriction cause variable airflow limitation.
Asthma exacerbation — Acute inflammation and smooth-muscle constriction narrow airways.
Atherosclerosis — Endothelial dysfunction and lipid accumulation form plaques.
Atrial fibrillation — Chaotic atrial activation eliminates coordinated atrial contraction.
Atrophy — Reduced protein synthesis and increased breakdown decrease cell and organ size.
Autoimmune disease — Sustained autoreactive immune responses damage self tissues through antibodies, T cells, cytokines, or complexes.
Autonomic dysfunction — Autonomic control of cardiovascular, GI, urinary and sudomotor function becomes impaired.
Autosomal dominant inheritance — A heterozygous pathogenic variant can be transmitted vertically across generations.
Autosomal recessive inheritance — Disease manifests when biallelic loss or dysfunction crosses a functional threshold.
B
Bacteremia — Viable bacteria enter circulation; host defenses may clear them or systemic disease may follow.
Barrett esophagus mechanism — Distal esophageal squamous epithelium undergoes intestinal metaplasia.
Bicarbonate loss — Loss of bicarbonate lowers buffering capacity and produces hyperchloremic acidosis.
Blood culture interpretation — Growth of organisms may represent true bacteremia or contamination depending on organism, number of sets, and clinical context.
Blood-brain barrier disruption — Endothelial barrier permeability increases, allowing fluid/proteins/cells into CNS tissue.
Blood-gas interpretation — pH, PaCO2 and bicarbonate are integrated to identify primary process and compensation.
Bone-marrow failure — Hematopoietic production falls across one or more lineages.
Bowel obstruction — Mechanical blockage prevents normal transit and causes dilation/fluid shifts.
Bronchial hyperresponsiveness — Airways constrict excessively to stimuli.
C
Cancer clinical indicators versus diagnosis — Indicators can raise suspicion but diagnosis usually requires integrated clinical/pathologic confirmation.
Cancer metabolism reprogramming — Tumor cells alter nutrient uptake and energy pathways to support rapid growth.
Cancer staging — Staging summarizes anatomic disease burden and sometimes biologic features.
Carcinogenesis — Sequential molecular alterations confer growth and survival advantages.
Cardiac biomarker interpretation — Troponin reflects myocardial injury; natriuretic peptides reflect wall stress but are not perfectly disease-specific.
Cardiogenic shock — Cardiac output falls enough to cause tissue hypoperfusion.
Cardiovascular indicator versus diagnosis — Findings support diagnostic probability but require synthesis with symptoms and criteria.
CBC interpretation — Counts and indices summarize circulating blood-cell populations.
Cell injury biomarker release — Damaged cells release intracellular molecules into blood or other fluids.
Cell swelling — Pump failure causes sodium and water influx and organelle swelling.
Cellular adaptation — Adaptive signaling changes cell size, number, phenotype, or metabolic activity without immediate cell death.
Cellular stress threshold — When adaptive capacity is exceeded, biochemical and structural injury accumulates.
Cerebral edema — Cellular or vasogenic fluid accumulation increases brain volume.
Chromatin remodeling — ATP-dependent complexes reposition nucleosomes and alter DNA accessibility.
Chromosomal abnormality — Large-scale genomic imbalance alters dosage or disrupts genes.
Chronic anovulation — Endometrium experiences prolonged unopposed estrogen in some patients.
Chronic bronchitis phenotype — Mucus-gland enlargement and airway inflammation increase sputum and obstruction.
Chronic hyperglycemia — Excess glucose causes osmotic, glycation, oxidative and vascular injury.
Chronic inflammation — Ongoing macrophage/lymphocyte signaling causes simultaneous tissue injury and repair.
Chronic kidney disease — Persistent kidney damage or reduced GFR leads to nephron loss and maladaptive hyperfiltration.
Chronic respiratory acidosis — Persistent CO2 retention triggers renal bicarbonate retention over days.
Chronic respiratory failure — Long-term gas-exchange impairment persists despite compensation.
Chronic stress physiology — Repeated neuroendocrine/autonomic activation alters metabolic, immune, cardiovascular, and sleep regulation.
Chronic venous insufficiency — Venous hypertension causes edema and skin/tissue changes.
Chronic wound — Wound becomes stalled, commonly in a prolonged inflammatory state, with impaired granulation or epithelialization.
Cirrhosis — Fibrosis and regenerative nodules distort hepatic architecture.
CKD mineral-bone disorder — Disordered calcium/phosphate/PTH metabolism alters bone and vascular tissue.
Clinical evidence, diagnosis, and quality reporting boundary — Clinical indicators support diagnosis; diagnoses support care/coding; quality measures apply separate specification logic.
Clinical indicator — A finding changes diagnostic probability but does not necessarily establish a disease.
Clinical indicators versus documented infection diagnosis — Indicators increase or decrease diagnostic probability but do not substitute for provider-established disease when documentation rules require diagnosis.
Clinical quality measure — Numerator, denominator and specifications quantify performance against a quality goal.
Clinical stress findings versus diagnosis — Stress physiology can explain findings but does not establish a psychiatric, endocrine, or other disorder by itself.
Coagulopathy — Secondary hemostasis is impaired.
Colonization — Microorganisms are present and may multiply without causing host tissue damage.
Combined immunodeficiency — Both cellular and humoral immunity are compromised.
Compensation — Lungs alter CO2 rapidly; kidneys alter bicarbonate more slowly.
Complement activation in infection — Cascade activation enhances phagocytosis, chemotaxis, and membrane attack.
Complement deficiency — Loss of specific components impairs microbial clearance or immune-complex handling.
Confirmatory testing — Second method or repeat test increases diagnostic confidence or resolves discordance.
COPD — Small-airway disease and emphysema produce persistent airflow obstruction.
COPD exacerbation — Acute increase in airway inflammation and gas-exchange impairment.
Cor pulmonale — Right ventricle hypertrophies/dilates under increased pulmonary pressure.
Coronary artery disease — Fixed stenosis or plaque rupture reduces myocardial perfusion.
Cortisol-mediated stress effects — Cortisol increases gluconeogenic substrate availability and modifies inflammatory signaling.
Crohn disease pattern — Transmural, discontinuous inflammation can affect any GI segment.
Cytokine-mediated inflammation — Mediator release amplifies leukocyte recruitment, vascular change, fever, and acute-phase responses.
D
De novo variant — Variant appears in an affected individual without being present in either parent’s tested germline.
Deep pressure injury — Damage extends into deeper soft tissue with progressively greater tissue loss.
Degenerative cartilage loss — Extracellular-matrix breakdown exceeds cartilage repair.
Dehydration — Net water loss raises osmolality and can reduce extracellular volume.
Delayed wound healing — Repair phases are prolonged or disrupted, reducing collagen deposition, angiogenesis, epithelialization, or immune clearance.
Delta gap / delta ratio — Comparison of gap increase with bicarbonate decrease helps detect a second metabolic process.
Demyelination — Loss of myelin slows or blocks axonal conduction.
Dermatitis / eczematous inflammation — Epidermal barrier disruption and inflammation cause pruritic lesions.
Diabetic ketoacidosis — Lipolysis and hepatic ketogenesis produce high-gap metabolic acidosis and osmotic diuresis.
Diabetic macrovascular disease — Atherosclerotic risk is accelerated.
Diabetic microvascular injury — Basement membrane, endothelial and metabolic changes damage small vessels.
Diabetic nephropathy — Glomerular injury causes albuminuria and progressive nephron loss.
Diabetic neuropathy — Axonal dysfunction/loss affects sensory, motor and autonomic nerves.
Diabetic retinopathy — Capillary leakage, ischemia and neovascular signaling damage retina.
Diagnostic test — Testing evaluates a suspected disease in an individual.
Diffusion impairment — Gas transfer across alveolar-capillary membrane becomes inefficient.
Digestive clinical indicator versus diagnosis — Indicators narrow mechanism but remain nonspecific without diagnostic synthesis.
Digestive imaging/endoscopy finding versus diagnosis — Structural findings require correlation with symptoms, pathology and clinical criteria.
Diminished ovarian reserve — Reduced follicle pool lowers reproductive potential.
Disseminated infection — Pathogen spreads hematogenously or through lymphatics to distant tissues.
Disseminated intravascular coagulation — Systemic coagulation activation consumes platelets/factors and causes microthrombi plus bleeding.
DNA methylation — Methyl groups added to DNA can alter transcriptional accessibility and gene expression.
DNA methyltransferase activity — DNMT activity changes methylation patterns and therefore transcriptional potential.
Dysplasia — Cells develop disordered growth, atypia, and architectural abnormalities.
Dysplasia-to-carcinoma progression — Preinvasive atypia acquires sufficient changes for malignant invasion.
E
eCQM — Structured electronic data from EHR/health IT are evaluated against standardized logic.
Ectopic pregnancy mechanism — Implantation occurs outside endometrial cavity, usually in tube.
Edema — Net filtration exceeds lymphatic return, expanding interstitial fluid.
Electrolyte disturbance and cardiac conduction — Altered ion gradients change depolarization/repolarization and conduction.
Emphysema — Alveolar wall destruction reduces elastic recoil and gas-exchange surface.
Endocrine clinical indicator versus diagnosis — Single laboratory abnormalities may be transient, medication-related or physiologic; diagnosis requires appropriate criteria and context.
Endocrine negative-feedback failure — Hormone concentrations no longer produce expected feedback relationships.
Endometrial hyperplasia risk from chronic anovulation — Persistent endometrial proliferation without cyclic progesterone increases hyperplasia risk.
Endometrioma — Repeated bleeding/inflammation forms ovarian cystic lesions.
Endometriosis — Ectopic endometrial-like tissue drives estrogen-dependent inflammation, fibrosis and adhesions.
Endothelial dysfunction — Reduced vasodilatory and antithrombotic endothelial function promotes vascular disease.
Environmental influence on epigenetic state — Environmental signals can alter regulatory pathways that modify chromatin and gene expression.
Epigenetic activation of oncogenic programs — Regulatory changes increase expression of genes that promote proliferation or survival.
Epigenetic biomarker — A reproducible epigenetic pattern may correlate with diagnosis, prognosis, tissue origin, or treatment response.
Epigenetic dysregulation in autoimmunity — Abnormal methylation and histone patterns can alter expression of immune-regulatory genes.
Epigenetic inheritance through cell division — Epigenetic marks can be copied during mitosis, preserving lineage-specific states.
Epigenetic regulation — Chemical and chromatin changes alter gene activity without changing the underlying DNA sequence.
Epigenetic reversibility — Because many epigenetic marks are enzymatically written and removed, some abnormal states can be modified.
Epigenetic silencing of tumor suppressor genes — Epigenetic repression reduces protective gene expression without requiring DNA deletion.
Epigenetic tissue specificity — Tissue-specific epigenetic marks determine which genes are active or silent.
Epigenetic–genetic interaction — Genetic changes can alter epigenetic enzymes, while epigenetic states can modify effects of variants.
Epilepsy — Network excitability and structural/genetic causes create ongoing seizure susceptibility.
Epimutation — Abnormal epigenetic state changes gene expression without necessarily altering DNA sequence.
Erectile dysfunction — Insufficient arterial inflow, smooth-muscle relaxation or veno-occlusion prevents sustained erection.
Evasion of apoptosis — Cancer cells resist programmed cell death despite damage or stress.
F
Female infertility — Failure at ovulation, fertilization, transport or implantation reduces probability of conception.
Fever response to infection — Pyrogenic cytokines increase prostaglandin signaling and raise the hypothalamic set point.
Fibrosis — Activated fibroblasts deposit excess extracellular matrix and collagen, replacing functional tissue.
Fluid volume depletion — Loss of extracellular fluid reduces venous return and tissue perfusion.
Fluid volume overload — Sodium and water accumulate in vascular/interstitial compartments.
Fragility fracture — Structural failure occurs under forces that would not fracture normal bone.
Free-water deficit — Water loss exceeds sodium loss, concentrating extracellular sodium.
G
Gain-of-function variant — Excess or novel activity disrupts signaling or cell behavior.
Gene dosage alteration — Too little or too much gene product disrupts normal cellular pathways.
Gene–environment interaction — Environmental factors modify the effect of genetic susceptibility or disease-causing variants.
Genetic susceptibility — Variants increase probability of disease without being sufficient alone.
Genomic instability — Increased mutation rate accelerates acquisition of oncogenic changes.
Genotype — Genotype influences but does not always determine phenotype.
GERD — Retrograde gastric contents injure esophageal/extraesophageal mucosa.
Germline variant — Variant can be present across many tissues and transmitted to offspring.
GI bleeding — Blood loss occurs into GI lumen.
GI inflammation marker interpretation — Inflammatory biomarkers reflect mucosal/systemic activity but are nonspecific.
Global DNA hypomethylation in cancer — Loss of methylation across broad genomic regions can increase instability and aberrant gene expression.
Glomerular filtration decline — Reduced filtration raises nitrogenous waste and alters fluid/electrolyte handling.
H
Heart failure — Heart cannot meet circulatory demand without elevated filling pressures.
Hematogenous spread — Circulating tumor cells seed distant organs.
Hematologic indicator versus diagnosis — Laboratory patterns narrow mechanisms but require clinical synthesis.
Hemiparesis — Motor pathway disruption causes unilateral weakness.
Hemolytic anemia — RBC destruction exceeds marrow replacement.
Hemostasis — Coordinated clot formation limits bleeding then fibrinolysis restores flow.
Hemostasis phase of wound healing — Vasoconstriction, platelet activation, and fibrin clot formation limit blood loss and provide a provisional matrix.
Hepatic encephalopathy — Neurotoxins such as ammonia contribute to altered brain function.
HFpEF — Filling pressures rise despite preserved EF.
HFrEF — Reduced contractility lowers ejection fraction and forward output.
High-anion-gap metabolic acidosis — Unmeasured anions increase as bicarbonate buffers excess acid.
Histone acetylation — Acetylation generally loosens chromatin and can facilitate transcription; deacetylation can favor repression.
Histone modification — Acetylation, methylation and other histone marks alter chromatin and transcriptional programs.
Hormone deficiency — Insufficient hormone signaling reduces target-organ activity.
Hormone excess — Excess receptor stimulation disrupts normal target-organ regulation.
Host defense barrier failure — Barrier disruption creates a portal of entry for colonizing or environmental organisms.
HPA-axis activation — CRH stimulates ACTH, which increases cortisol to support energy availability and modulate immunity.
Hydronephrosis — Renal collecting system dilates from impaired urine drainage.
Hydrostatic edema — Elevated capillary hydrostatic pressure pushes fluid into interstitial spaces.
Hyperandrogenism — Excess androgen production/action alters hair, skin and ovulatory function.
Hypercapnia — CO2 elimination becomes inadequate.
Hypercoagulability — Balance shifts toward clot formation through excess procoagulant activity or reduced anticoagulant function.
Hyperkalemia — Excess extracellular potassium depolarizes membranes and disrupts cardiac conduction.
Hypernatremia — High serum sodium reflects hypertonicity, drawing water out of cells.
Hyperosmolar hyperglycemic state — Extreme hyperglycemia causes osmotic diuresis and hyperosmolality with minimal ketosis.
Hyperplasia — Cell number increases through proliferation in tissues capable of division.
Hypertension — Sustained arterial pressure increases vascular and myocardial load.
Hypertensive heart disease — Pressure overload produces LV hypertrophy and diastolic/systolic dysfunction.
Hypertrophic scar — Excess collagen remains within original wound boundaries.
Hypertrophy — Existing cells enlarge through increased synthesis of structural proteins and organelles.
Hypoglycemia — Plasma glucose falls below supply needs, triggering autonomic and neuroglycopenic responses.
Hypogonadism — Low sex-hormone production impairs reproductive and systemic functions.
Hypokalemia — Reduced extracellular potassium hyperpolarizes excitable membranes and alters cardiac repolarization.
Hyponatremia — Low serum sodium usually reflects excess water relative to sodium; hypotonicity drives water into cells.
Hypotonic hyponatremia — Low effective osmolality causes water movement into cells.
Hypoxemia — Arterial oxygen falls below normal.
Hypoxic cell injury — ATP depletion disrupts ion pumps, cellular metabolism, and organelle stability.
I
Immune dysfunction — One or more immune components are absent, overactive, misdirected, or poorly regulated.
Immune dysregulation — Feedback controls fail, allowing excessive inflammation, autoimmunity, or lymphoproliferation.
Immune evasion — Tumor reduces effective antitumor immune recognition or function.
Immune reconstitution / restoration — Cell counts or immune function recover, changing infection and inflammatory risk.
Immune thrombocytopenia — Immune clearance lowers platelets.
Immune-mediated cytopenia — Antibodies or immune effector cells accelerate destruction of red cells, platelets, or neutrophils.
Increased vascular permeability — Endothelial gaps or damage allow plasma proteins and fluid into tissues.
Infection-associated endothelial dysfunction — Endothelial activation increases permeability, vasodilation, leukocyte adhesion, and procoagulant signaling.
Infection-related leukocytosis / leukopenia — Cytokines alter marrow release and peripheral distribution; severe illness may deplete or suppress counts.
Inflammation-related tissue damage — Reactive species, proteases, cytokines, and immune-cell activity injure nearby tissue.
Inflammatory arthritis pattern — Synovial inflammation causes pain, warmth, swelling and stiffness.
Inflammatory bowel disease — Abnormal immune response drives chronic intestinal inflammation.
Inflammatory phase of wound healing — Neutrophils and macrophages clear microbes/debris and produce signals that initiate repair.
Insulin resistance — Target tissues respond less effectively to insulin, increasing insulin requirements.
Intracellular calcium overload — Excess cytosolic calcium activates phospholipases, proteases, endonucleases, and ATPases.
Intracerebral hemorrhage — Vessel rupture causes bleeding into brain parenchyma with mass effect and tissue injury.
Intrinsic AKI — Renal parenchymal damage impairs filtration and tubular function.
Iron-deficiency anemia — Iron depletion limits hemoglobin synthesis and produces microcytosis.
Irreversible cell injury — Critical mitochondrial and membrane damage prevents recovery and commits the cell to death.
Ischemic cell injury — Reduced blood flow causes combined oxygen and nutrient deprivation with impaired waste removal.
Ischemic stroke — Abrupt loss of cerebral blood flow produces infarction if perfusion is not restored.
J
Joint effusion — Fluid accumulates in synovial cavity.
K
Keloid — Persistent inflammation and excess extracellular-matrix deposition produce scar growth beyond the original injury.
Ketoacidosis — Excess ketone production generates organic acids and depletes bicarbonate.
L
Lactate elevation in severe infection — Increased production and/or reduced clearance raises serum lactate.
Lactic acidosis — Lactate production exceeds utilization/clearance, consuming bicarbonate.
Left ventricular hypertrophy — Myocytes enlarge to normalize wall stress.
Leukemia — Abnormal leukocyte precursors proliferate and crowd normal marrow.
Leukocytosis — WBC production/release increases.
Leukopenia — Circulating leukocytes fall below normal reserve.
Likelihood ratio — Quantifies how much a test result changes odds of disease.
Liquefactive necrosis — Dead tissue is digested into a liquid or viscous mass.
Local infection — Pathogen replication triggers localized inflammation and tissue injury.
Local invasion — Malignant cells breach basement membranes and infiltrate adjacent tissue.
Loss of self-tolerance — Autoreactive T or B cells escape control and target self-antigens.
Loss-of-function variant — Insufficient functional protein impairs the pathway controlled by the gene.
Low-oncotic-pressure edema — Reduced plasma oncotic pressure favors fluid movement into interstitium.
Lymphatic edema — Impaired lymph drainage causes protein-rich interstitial fluid accumulation.
Lymphatic spread — Malignant cells travel through draining lymphatics to regional nodes.
Lymphedema — Protein-rich interstitial fluid accumulates when lymph drainage is impaired.
M
Macrocytic anemia — Impaired DNA synthesis or other causes enlarge circulating RBCs.
Macrophage response — Macrophages phagocytose debris, secrete cytokines, and help transition wounds from inflammation toward repair.
Malabsorption — Nutrient digestion/absorption is impaired.
Maladaptive stress response — Regulatory systems remain activated or become dysregulated, producing physiologic cost.
Male-factor infertility — Sperm quantity, quality or delivery is impaired.
Measure denominator — Denominator sets who is included before exclusions/exceptions.
Measure exclusion / exception — Eligible records are removed or handled according to official measure logic.
Measure numerator — Numerator counts performance events meeting measure criteria.
Metabolic acidosis — Primary fall in bicarbonate lowers pH; lungs compensate by lowering PaCO2.
Metabolic alkalosis — Elevated bicarbonate raises pH; hypoventilation provides limited compensation.
Metabolic syndrome — Clustered metabolic abnormalities amplify vascular risk.
Metaplasia — Stem-cell reprogramming replaces one mature cell type with another better suited to stress.
Metastasis — Cancer spreads to noncontiguous distant sites.
Mitochondrial dysfunction in cell injury — Loss of ATP generation and membrane-potential stability disrupts cell survival and can activate death pathways.
Mitochondrial inheritance — Mitochondrial variants are typically maternally transmitted and may show heteroplasmy.
Mixed acid-base disorder — Observed pH, PaCO2 and bicarbonate do not fit expected compensation for a single disorder.
Mosaicism — Only a subset of cells carries the variant, so phenotype depends on tissue distribution and proportion.
MSK imaging finding versus diagnosis — Imaging demonstrates structure but does not always correlate with symptoms or etiology.
MSK/skin clinical indicator versus diagnosis — Indicators require pattern recognition and diagnostic criteria.
Mucus hypersecretion — Goblet-cell/gland activity increases airway secretions.
Multifactorial disease — No single variant is sufficient; combined genetic and non-genetic factors alter risk.
Muscle atrophy — Reduced protein synthesis and increased breakdown decrease muscle mass.
Myocardial infarction — Prolonged ischemia causes irreversible myocyte necrosis.
Myocardial ischemia — Myocardial oxygen delivery is insufficient for demand.
N
Necrosis — Uncontrolled cell death with membrane failure and release of intracellular contents.
Negative predictive value — Probability of no disease given a negative result.
Nephritic pattern — Hematuria, reduced filtration and variable proteinuria occur from glomerular inflammation.
Nephrotic pattern — Heavy protein loss causes hypoalbuminemia, edema and lipid abnormalities.
Neurodegeneration — Progressive neuronal dysfunction and loss affect specific neural networks.
Neuroinflammation — Activated glia and immune mediators alter neuronal function and can produce tissue injury.
Neurologic clinical indicator versus diagnosis — Indicators support probability and localization but require clinical synthesis.
Neurologic deficit versus lesion — Observed deficits reflect affected pathways but do not always specify etiology.
Neutropenia — Reduced neutrophil count impairs innate bacterial/fungal defense.
Neutrophil antimicrobial response — Chemotaxis, phagocytosis, oxidative burst, granule enzymes, and extracellular traps attack pathogens.
Neutrophil recruitment — Neutrophils adhere, migrate into tissue, phagocytose microbes/debris, and release antimicrobial enzymes and reactive species.
Non-coding RNA regulation — MicroRNAs and other non-coding RNAs can suppress or coordinate target-gene expression.
Normal-anion-gap metabolic acidosis — Bicarbonate falls while chloride rises, keeping anion gap near normal.
O
Obesity-related metabolic dysfunction — Adipose expansion alters insulin sensitivity, inflammatory signaling and ectopic fat deposition.
Obstructive uropathy — Urine flow obstruction raises upstream pressure and damages kidney/urinary tract.
Oncogene activation — Growth-promoting genes become constitutively active.
Opportunistic infection — Loss of specific immune defenses allows pathogens that rarely cause disease in healthy hosts.
Opportunistic infection susceptibility — Loss of specific host-defense pathways permits unusual organisms or disseminated infection.
Osteoarthritis — Cartilage loss, subchondral bone remodeling and osteophytes produce degenerative joint disease.
Osteopenia — Bone mineral density is reduced but above osteoporosis threshold.
Osteophyte formation — Marginal bone proliferation develops in degenerative joints.
Osteoporosis — Bone resorption exceeds formation, reducing strength.
Outcome versus process measure — Outcome measures assess results; process measures assess whether recommended actions occurred.
Ovulatory dysfunction — Disrupted follicular development or endocrine signaling prevents predictable ovulation.
Oxidative cellular injury — Reactive oxygen species damage lipids, proteins, and DNA when antioxidant defenses are exceeded.
P
Pancreatic enzyme elevation — Amylase/lipase enter circulation when acinar injury occurs.
Pancreatic necrosis — Acinar and peripancreatic tissue death develops.
Pancytopenia — All major blood-cell lines fall.
Pathogen recognition — Host receptors detect pathogen-associated patterns and initiate cytokine, complement, and leukocyte responses.
Pathogenic genetic variant — A variant alters gene function or regulation enough to contribute to disease.
PCOS / polyendocrine metabolic ovarian syndrome — Hormonal/metabolic dysregulation disrupts follicular maturation and ovulation.
Pelvic inflammatory sequelae — Inflammation/scarring damages tubes and pelvic tissues.
Penetrance — Not every person with a disease-associated genotype manifests the phenotype.
Peripheral arterial disease — Flow limitation causes exertional or critical limb ischemia.
Peripheral neuropathy — Axonal or myelin injury disrupts peripheral nerve signaling.
Phagocyte dysfunction — Reduced number or killing function impairs containment of bacteria and fungi.
Phenotype — Clinical characteristics emerge from the combined effects of genotype and modifiers.
Physiologic stress response — Sympathetic-adrenomedullary and HPA systems mobilize energy and cardiovascular resources.
Pituitary hormone disorder — Trophic hormone excess or deficiency alters downstream endocrine glands.
Plasma membrane injury — Membrane disruption causes ion imbalance, enzyme leakage, and loss of cellular homeostasis.
Portal hypertension — Increased portal vascular resistance raises pressure in portal venous system.
Positive predictive value — Probability of disease given a positive result.
Post-obstructive diuresis — Kidneys excrete retained salt/water and may have impaired concentrating ability after decompression.
Post-test probability — Diagnostic probability is updated after receiving a result.
Postrenal AKI — Back pressure reduces filtration; prolonged obstruction causes inflammation/fibrosis.
Potassium shift disorder — Potassium moves between intracellular and extracellular compartments without equivalent change in total-body stores.
Prerenal AKI — Reduced renal blood flow lowers GFR without primary parenchymal injury initially.
Pressure injury — Local tissue ischemia and deformation damage skin/soft tissue over pressure points or devices.
Pretest probability — Baseline probability determines how test results should be interpreted.
Primary immunodeficiency / inborn error of immunity — Inherited defects impair antibody, T-cell, phagocyte, complement, or regulatory pathways.
Proliferative phase of wound healing — Fibroblasts, endothelial cells, and keratinocytes generate granulation tissue, angiogenesis, extracellular matrix, and re-epithelialization.
Promoter hypermethylation — Excess promoter methylation can silence genes, including tumor suppressor genes.
Proteinuria — Protein excretion exceeds normal handling.
Pseudohyperkalemia — Potassium is released from cells after or during collection, producing a falsely elevated result.
Psoriasis — T-cell/cytokine-driven inflammation accelerates keratinocyte proliferation.
Psoriatic arthritis risk — Inflammation affects peripheral joints, spine, entheses or digits.
Pulmonary edema — Fluid accumulates in lung interstitium/alveoli, increasing diffusion distance and reducing compliance.
Pulmonary hypertension from lung disease — Pulmonary vascular resistance rises.
Pulmonary indicator versus diagnosis — Symptoms and tests narrow mechanism but do not automatically establish a specific lung disease.
R
Raised intracranial pressure — Intracranial volume increase exceeds compensatory reserve, reducing cerebral perfusion.
Reference standard — Test accuracy is measured relative to an accepted standard.
Reflux esophagitis — Mucosal inflammation/erosion develops from reflux.
Remodeling phase of wound healing — Collagen is reorganized and tensile strength gradually increases.
Renal acid retention — Hydrogen ion excretion and bicarbonate regeneration become inadequate.
Renal anemia — Marrow RBC production falls.
Renal hyperkalemia — Potassium accumulates when renal clearance is inadequate.
Renal indicator versus diagnosis — Indicators support kidney injury/chronicity but require timing, baseline and clinical interpretation.
Renal metabolic acidosis — Hydrogen retention lowers serum bicarbonate.
Reproductive clinical indicator versus diagnosis — Indicators narrow the mechanism but require integrated clinical criteria.
Reproductive endocrine axis dysfunction — Altered GnRH/LH/FSH/sex-hormone signaling disrupts cycles and gametogenesis.
Reproductive imaging finding versus diagnosis — Structural findings may be incidental or clinically meaningful depending on symptoms and criteria.
Resolution of inflammation — Neutrophils undergo apoptosis/clearance, macrophage phenotype shifts, and inflammatory mediators decline.
Respiratory acidosis — CO2 retention increases carbonic acid and lowers pH.
Respiratory alkalosis — CO2 falls, shifting carbonic acid equilibrium and raising pH.
Reversible cell injury — Metabolic and organelle dysfunction occurs without permanent loss of viability.
Rheumatoid arthritis — Synovial immune inflammation causes pannus, cartilage damage and erosions.
S
Screening test — Testing seeks disease/risk before symptoms appear.
Secondary immunodeficiency — An acquired condition suppresses previously developed immune function.
Seizure — Transient network hyperexcitability produces motor, sensory, autonomic or awareness changes.
Sensitivity — Proportion of people with disease who test positive.
Sepsis — Maladaptive inflammatory, endothelial, metabolic, and coagulation changes cause acute organ dysfunction.
Septic shock — Vasodilation, capillary leak, myocardial effects, and microcirculatory dysfunction produce persistent hypotension and impaired perfusion.
Serial testing / trend — Change over time may be more informative than a single value.
SIADH pattern — Inappropriately persistent ADH causes water retention with concentrated urine and dilutional hyponatremia.
Somatic variant — Variant arises after conception in a subset of cells and is not generally inherited.
Source control — Persistent nidus sustains microbial growth despite systemic therapy.
Specificity — Proportion without disease who test negative.
Spirometry interpretation — FEV1, FVC and ratio quantify expiratory airflow.
Stage 1 pressure injury — Intact skin develops persistent nonblanchable erythema/discoloration from early tissue injury.
Stage 2 pressure injury — Partial-thickness skin loss exposes dermis.
Status epilepticus — Persistent neuronal firing becomes self-sustaining and injurious.
Stress and gastrointestinal function — Autonomic and HPA changes alter motility, permeability, secretion, and visceral sensitivity.
Stress and immune modulation — Catecholamines and glucocorticoids alter cytokine production, leukocyte trafficking, and immune activity.
Stress and inflammatory signaling — Chronic stress can alter cytokine regulation and glucocorticoid responsiveness.
Stress and pain amplification — Stress-related arousal and central modulation can increase pain sensitivity and vigilance.
Stress and sleep disruption — Heightened arousal and altered HPA/autonomic signaling interfere with sleep initiation and maintenance.
Stress as disease modifier — Stress-related autonomic, endocrine, behavioral, and immune changes can alter symptom burden or disease control.
Stress recovery / negative feedback — HPA/autonomic output declines, restoring baseline metabolic and immune regulation.
Stress response in surgery and trauma — Catecholamines, cortisol, inflammatory mediators, fluid shifts, and catabolism support immediate survival.
Stress-induced hyperglycemia — Counter-regulatory hormones increase hepatic glucose output and insulin resistance.
Stress-related cardiovascular load — Heart rate, BP, vascular tone, and metabolic demand rise repeatedly.
Stress-related insulin resistance — Stress hormones reduce insulin sensitivity and increase hepatic glucose production.
Subarachnoid hemorrhage — Blood enters subarachnoid space, raising intracranial pressure and irritating meninges/vessels.
Sustained proliferative signaling — Mitogenic signaling remains active independent of normal controls.
Sympathetic-adrenomedullary activation — Sympathetic nerves and adrenal medulla release catecholamines, raising cardiac output and substrate availability.
Systemic inflammatory response to infection — Widespread cytokine, leukocyte, endothelial, complement, and coagulation activation affects multiple organs.
T
T-cell deficiency — Reduced T-cell number or function weakens defense against intracellular pathogens and immune coordination.
TET-mediated DNA demethylation — TET proteins participate in active demethylation and dynamic epigenetic regulation.
Third spacing — Fluid leaves effective circulating space and accumulates in interstitial or body-cavity compartments.
Thrombocytopenia — Low platelet count impairs primary hemostasis.
Thrombocytosis — Platelet count increases from cytokine-driven or clonal production.
Thyroid-axis dysfunction — Altered thyroid hormone signaling changes metabolic rate and organ function.
Transient ischemic attack — Temporary perfusion failure produces reversible neurologic dysfunction.
Tubal-factor infertility — Tubal obstruction/dysfunction impairs sperm-oocyte transport.
Tumor grade — Poor differentiation and high proliferative activity often indicate more aggressive biology.
Tumor heterogeneity — Subclones differ in genotype, phenotype and treatment sensitivity.
Tumor microenvironment — Reciprocal signaling supports growth, immune evasion and invasion.
Tumor suppressor loss — Loss of growth restraints/checkpoints permits abnormal proliferation.
Tumor-promoting inflammation — Cytokines and immune-cell interactions can support mutation, growth, angiogenesis and invasion.
Type 2 diabetes mellitus — Persistent hyperglycemia develops when insulin supply no longer matches metabolic demand.
Type I hypersensitivity — Allergen cross-links mast-cell/basophil-bound IgE, releasing histamine and other mediators.
Type II hypersensitivity — IgG/IgM binds cell-surface or matrix antigens, causing complement/Fc-mediated injury or receptor dysfunction.
Type III hypersensitivity — Soluble antigen-antibody complexes deposit in tissues and activate complement/inflammation.
Type IV hypersensitivity — Sensitized T cells release cytokines or directly injure target cells rather than relying on antibodies.
U
Ulcerative colitis pattern — Continuous mucosal inflammation begins in rectum and extends proximally in colon.
Uremia — Retention of uremic solutes causes systemic toxicity.
Uterine-factor infertility — Cavity distortion or endometrial disruption impairs implantation.
V
Variable expressivity — The same pathogenic genotype can produce different manifestations or severity.
Variceal bleeding — Portosystemic collateral veins dilate and may rupture.
Vasodilation in inflammation — Arteriolar dilation increases blood flow to injured tissue.
Venous thromboembolism — Venous thrombus forms and may embolize.
Venous thrombosis — Fibrin-rich clot forms in venous circulation.
Ventilation-perfusion mismatch — Ventilation and perfusion become unevenly matched, lowering gas-exchange efficiency.
Viremia — Virus enters bloodstream and reaches distant tissues.
Volume status versus electrolyte concentration — A patient may have sodium/potassium abnormality with low, normal, or high extracellular volume depending on mechanism.
W
Wound dehiscence — Partial or complete separation occurs before adequate tissue strength is established.
Wound healing impairment — Inflammation, perfusion, matrix deposition or epithelialization is disrupted.
X
X-linked inheritance — Phenotype and transmission differ by sex chromosome complement and gene dosage.
Foundational pathway

Build the Foundation First

Pathophysiology makes more sense when you can already identify the medical language and normal anatomy and physiology behind a condition.

Return to the Main Reference Library

Use the main HVA Reference Library to move between medical terminology, anatomy and physiology, billing, coding, and the rest of your HVA reference tools.

Main Reference Library →

Continue into HVA 101

Use the HVA Academy learning pathway for structured training, lessons, and companion resources.

Open HVA 101 →

Continue Learning With the Academy

Get new guides, resources, toolkit recommendations, and Healthcare VA career insights.